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P450 discovery and history
It was in 1954 in Philadelphia that Klingenberg discovered a novel carbon monoxide-
binding pigment in rat liver microsomes.[1] He added a trace of sodium dithionite 
and bubbled carbon monoxide while studying the kinetics of cytochrome b5 in rat 
liver. Unexpectedly, he observed the appearance of a prominent absorption peak at 
450  nm. This unique optical spectral change in the presence of carbon monoxide 
shared no resemblances with any other known metallo-proteins. In 1962, Omura 
repeated Klingenberg’s experiments and named the mysterious “microsomal carbon 
monoxide-binding pigment” cytochrome P-450. “P” is the abbreviation of pigment 
and “450” was named after the unique optical absorption peak at 450 nm. In the 
first paper of “cytochrome P450”, Omura reported that the carbon monoxide-binding 
pigment in liver microsomes was a novel hemoprotein. The molar extinction coefficient 
of characteristic 450 nm peak (ε450nm = 91 mM-1cm-1) described in the paper is still 
widely used today to quantify the P450 content in biological samples.[1] 
P450 research soon expanded into various fields, from physiological functions to 
industrial chemistry. In the year following the first P450 paper, Estabrook, Cooper 
and Rosenthal reported that cytochrome P450 was involved in the biosynthesis of 
steroid hormones in bovine adrenal glands.[2] They also found that P450 is an enzyme 
that catalyzes hydroxylation reactions of substrates using molecular oxygen. In 1965, 
P450 in rat liver microsomes was shown to participate in the oxidative metabolism 
of pharmaceutical compounds.[3] At the end of 1960’s, the presence of P450 was 
discovered in various tissues and organisms.[4] Today, at least 57 different P450 genes 
are known in human beings;[5] some of which are involved in the metabolism of sex 
hormones and others in the biosynthesis of cholesterol. Besides the unique absorption 
peak at 450 nm, P450 members share conserved amino acid sequences and a similar 
fold. In 1987, Nebert et al. coined the nomenclature of “CYP” to classify various P450 
into families and sub-families based on primary sequences.[6] The family tree generated 
by CYP classification indicated that all of the P450 in various organisms evolved from 
a single ancestral P450. Thus, P450 members are all part of the CYP superfamily.[1]
Practical applications of P450 
Nowadays, approximately two thousand papers on CYPs are published annually.[1] 
One of the most useful features of P450 is regio- and stereo-specific hydroxylation. For 
instance, while chemical synthesis of drugs derived from vitamin D3 requires 20 steps 
with low yield, P450 (CYP107) dependent conversion proceeds through a single step.[4] 
At present several millions of patients are prescribed steroidal medicines, including 
cortisol and low density lipoprotein (LDL)-cholesterol lowering drugs. In  1952, a 
microbiologist called Murray published the first report of cortisol production in 
a single step by the use of the fungus Curvulavria lunata.[7] The mycelium of this fungal 




cortisol.[8] Even to date, industrial production of cortisol depends on the immobilized 
C. lunata and overexpression of P450lun is attempted to increase the product yield.[4] 
The invention of the “blue rose” is one of the most stunning applications of P450. 
Over the centuries, the creation of blue roses had been believed to be impossible due 
to the limitation of available colors of roses.[4] However, in 2007, an industrial team in 
Japan has made the blue rose possible by introducing P450 gene (CYP75A) from viola 
(Figure 1).[9] 
P450cam history 
For over a decade after the initial discovery of rat liver microsomal P450, CYPs were 
believed to be present only in higher eukaryotes.[1] However, in 1968, Katagiri et al. 
reported that an NADH-dependent P450 system was found in Pseudomonas putida.[10] 
This bacterial P450 system consists of three soluble components, namely, an FAD-
containing flavoprotein, an iron-sulfur containing ferredoxin and P450. Electrons are 
relayed from NADH to P450 to catalyze the hydroxylation of D-camphor. Due to its 
unique physiological substrate, P. putida P450 has been commonly known as P450cam. 
Moreover, the water solubility of P450cam advanced the P450 research and P450cam 
has become a model system of mammalian P450.[1] In 1985, Poulos reported the first 
crystal structure of P450cam, which illustrates the unique coordination of a thiolate 
to a heme iron.[11] The biophysical and biochemical analysis expanded and P450cam 
Figure 1. Production of blue roses by CYP75A. (A) CYP75A catalyzes the hydroxylation of flavanone 
to generate blue pigment, delphinidin. (B) Blue rose created by a Japanese company, Suntory. 
The picture was taken from www.suntory.com.
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has become the most extensively characterized P450 family member. By 2013, 109 
different structures of P450cam had been deposited in protein data bank.
P450cam catalytic cycle
Hydroxylation of camphor is part of a metabolic process in Pseudomonas putida to 
harvest carbon and obtain energy. Utilizing an oxygen molecule, P450cam catalyzes 
regio- and stereo-specific hydroxylation of D-camphor and generates 5-exo-
hydroxycamphor.[10] As shown in Figure 2, the enzymatic activity of P450cam proceeds 
through the series of the catalytic events: i) substrate binding; ii) the first electron 
transfer (ET1); iii) oxygen binding; iv) the second electron transfer (ET2); v) proton 
transfer; vi) oxygen activation and hydroxylation reaction; vii) product release. 




In the resting state of P450cam, the heme iron is coordinated by a water molecule as 
the sixth ligand. The substrate-free form of P450cam has been shown to exhibit an 
“open” conformation to allow the substrate to access to the active site.[13] The reaction 
cycle is initiated by binding of substrate, camphor. Camphor binding changes the 
spin state of heme iron from low spin to high spin. It was well documented that the 
transition of spin state is accompanied by the change of redox potential.[1] In the resting 
state, the substrate-free form of P450cam exhibits a redox potential of –300 mV.[14] 
However, upon binding of camphor, redox potential is elevated to –170 mV,[14] which 
promotes the first ET event.[1] The ferric state (Fe3+) of P450cam accepts the first 
electron from the physiological ET partner protein, putidaredoxin (Pdx). Recent results 
of mutagenesis and kinetics studies suggested that this ET event is the rate-limiting 
step for catalytic turnover (41 s-1).[15] Upon binding of an oxygen molecule, the ferrous 
heme iron (Fe2+) binds O2 to form oxygenated P450cam.
[12] In the second ET event, 
Pdx has two roles; ET and effector activity. The binding of Pdx to oxygenated P450cam 
results in some structural change in the P450cam. This conformation shift facilitates 
the ET2 as well as enables the following events of the oxygen activation and product 
formation.[16] The underlining mechanism of the Pdx effector activity is still under 
debate. However, the stringent requirement of Pdx for the ET2 process indicates that 
there is a drastic difference between ET1 and ET2.[15] The second electron is delivered 
to the ferrous iron and activates the O-O bond. After the protonation of the activated 
oxygen molecule, the oxenoid-iron (Fe4+=O), also known as compound I, is formed by 
displacement of a water molecule. The oxenoid-iron reacts with the camphor molecule 
to produce 5-exo-hydroxycamphor. The dissociation of the product from active site is 
accompanied by repositioning a water molecule as the axial ligand of the heme iron 
and reaction cycle in complete.[12]
P450cam structural properties
P450cam consists of 414 amino acid residues with a molecular weight of 46.6 kDa. As 
an archetypical P450 enzyme, its type b heme iron is coordinated by an axial thiolate 
ligand of Cys357 (Figure 3).[17]
The secondary structure elements of P450cam comprise thirteen α-helices and five 
β-sheets. The nomenclatures of the A–L helices and β1–5 sheets are based on their 
order in the P450cam amino acid sequence (Figure 4). The B’ helix has been added to 
the system by Poulos and co-workers after they found the additional α-helix in high-
resolution crystal structure.[19] The proximal and distal sides of P450cam have distinct 
functions. It has been reported that Pdx binds to the proximal side of P450cam while 
the distal side allows substrate access to the active site. 
The unique appearance of the Soret band at 450 nm is attributed to the reduction 
of the heme iron and the concomitant binding of carbon monoxide.[12] Besides CO 
and camphor, P450cam can accommodate a variety of compounds in the substrate 
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binding site. For instance, P450cam binds small molecules such as cyanide, imidazole, 
cysteine, DTT as well as substrate analogues such as adamantane-derivatives.[12] The 
binding of these molecules influences the coordination sphere of the iron, which can 
result in transitions of the spin state of ferric iron between high and low.[12] Although 
a number of ligands were known to interact with P450cam, the process of substrate 
binding had puzzled researchers for decades because atomic resolution structures 
of P450cam show that there is no channel present on the protein surface to allow a 
substrate to access the active site. In 2001, Dunn et al. demonstrated the opening of 
Figure 3. Crystal structure of P450cam bound to camphor (PDB entry, 1DZ4[17]). (A) ribbon 
representation of P450cam. (B) Zoom in view of active site of P450cam. The brown sphere 
represents the heme iron. 
Figure 4. Ribbon representation of P450cam structures (PDB entry 1DZ4[17]). (A) Nomenclature 
of the secondary structure elements of P450cam, facing the distal side (B) Arrows indicate the 




substrate access channel of P450cam by crystallizing P450cam bound to ruthenium 
sensitizer-linked substrates (Figure 5).[18] The adamantane moiety of the complex binds 
to the active site of P450cam and its ruthenium tethered linker protrudes toward the 
protein surface, thereby forcing the access channel to be in the open conformation. In 
2010, Lee et al. solved the crystal structure of substrate-free form, which showed the 
location of the access channel beyond any doubts.[13] 
Figure 5. Cartoon representation of the overlaid P450cam structures. Red, gray and blue 
represent P450cam bound to camphor (PDB entry 1DZ4[17]), ruthenium complex (1K2O[18]) and 
substrate-free (3L61[13]), respectively. The sticks chelating to the green sphere illustrate ruthenium 
sensitizer-linked substrate.
The helices B’, F, G and I as well as the F–G loop have been found to be involved 
in the conformation change between the open and closed state of the substrate 
access channel.[13, 18] It has been speculated that the synergistic movement of the 
B’, F and G helices optimizes the efficiency of the substrate uptake as well as the 
catalytic reaction.[13] The potassium ion binding site is another key feature of B’ helix.[19] 
It has been reported that the binding affinity of the substrate is dependent of the 
concentration of potassium ions. At a high concentration of potassium (> 50 mM), the 
stability of closed conformation increases, thereby decreasing the dissociation rate of 
the substrate.[20, 21] Mutagenesis demonstrated that the I helix residues, Asp251 and 
Thr252, facilitate the proton transfer to the activated oxygen molecule in the active 
site.[22] To further investigate the structure dynamics and the catalytic mechanism of 
P450cam, Pochapsky and co-workers studied the P450cam structure in solution state 
by NMR spectroscopy.[23, 24] Their NMR results indicated that the active site of P450cam 
18
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is more mobile than previously described.[24] In particular, significant dynamics was 
observed for the B’ helix.[23] It was speculated that the plasticity of the active site 
contributes to the ability of P450cam to accommodate a wide variety of substrates as 
well as inhibitors. 
Putidaredoxin
Putidaredoxin (Pdx), a [2Fe-2S] cluster containing ferredoxin, acts as a physiological 
electron transfer partner of P450cam in Pseudomonas putida. It shuttles two electrons 
from putidaredoxin reductase to P450cam during the camphor hydroxylation reaction.[25] 
The redox center of Pdx consists of two iron atoms (Fe1 and Fe2), both of which are 
coordinated to the two sulfide ions as well as two thiol groups of the cysteine residues. 
Atom Fe1 is positioned in close proximity of the protein surface (Figure 6). Therefore, 
it is believed to play a major role in the electron transfer process.
Figure 6. Ribbon representation of Pdx (PDB entry, 1XLP[26]). Sticks and spheres illustrate the side 
chain of Trp106 and [2Fe-2S] cluster, respectively. 
Over the decades, the [2Fe-2S] cluster of Pdx had hindered the structural studies 
of the protein. In NMR studies, vital information about the active site of the protein 
cannot be determined due to the significant broadening effect caused by high-spin 
state of iron atoms. Pochapsky and co-workers challenged the problem by replacing 
two irons by gallium ions.[27] However, the substitution of the redox center leads to a 
structure change in Pdx. The crystallization of Pdx was also very challenging. At high 




protein was observed. The identification of surface exposed cysteine residues led to 
a breakthrough in Pdx crystallization. Pdx contains six endogenous cysteine residues, 
four of which are the ligands for the two irons. It was found that the substitution of 
Cys73 and Cys85 greatly enhances the stability of the iron sulfur cluster.[28] In 2003, 
Sevrioukova et al. solved the crystal structures of Pdx C73S and Pdx C73S/C85S 
variants.[28] With the exception of the residues in the active site, the structures obtained 
by X-ray crystallography and NMR were in good agreement. The structural analysis 
indicated that the oxidized state of Pdx exhibits more dynamic than the reduced 
state.[26, 29] The regions nearby the [2Fe-2S] cluster (Tyr33, Asp34, His49 and Tyr51) as 
well as the C-terminus (Val74–Asn82 and Pro102–Trp106), in particular, were found to 
be mobile in the oxidized Pdx.[29] These residues play key roles in the recognition of 
the partners PdR and P450cam. 
Pdx comprises of 106 amino acid residues of which single tryptophan is present 
at the C-terminus. Despite the hydrophobic nature of the side chain, Trp106 of Pdx 
is fully exposed on protein surface and exhibits rotational freedom on the timescale 
of nanoseconds to sub-nanoseconds.[29] Early mutagenesis studies demonstrated that 
Trp106 primarily functions as a recognition motif for the partners.[30] The binding affinity 
and electron transfer rates dramatically reduced when Trp106 is either substituted or 
deleted from Pdx WT.[15, 30] The most intriguing feature of Pdx function is the effector 
activity, in which Pdx binding induces a conformation change in P450cam to start 
the catalytic action of the camphor hydroxylation reaction.[25] However, the underlying 
mechanism of the effector activity is poorly understood. Currently, two contradictory 
mechanisms have been proposed. According to Pochapsky and co-workers, Pdx acts 
as an effector by inducing a conformation change in oxy-P450cam.[31] A structural 
change in the Pdx binding site mechanically transmits to remote regions of P450cam. 
The isomerization of Ile88– Pro89 amide bond has been reported to be the key feature 
of the conformation change.[32] According to this study Pdx binding converts the trans 
conformer of the peptide bond into the cis conformer, which leads to the reorientation 
of the substrate in the active site as well as the closure of the substrate access channel. 
The substrate is thereby trapped in the active site of P450cam, which minimizes the 
solvation of the substrate and the escape of harmful peroxide intermediates.[31, 33] 
The recently determined crystal structure of Pdx-bound P450cam exhibits the open 
configuration and the substrate and/or product can freely access to the active site 
(structure details are discussed in the Chapter 3). Based on this observation, Poulos 
and co-workers proposed that the effector role of Pdx is to cause P450cam to open 
up the substrate access channel.[34] Opening of the substrate access channel allows 
the catalytic water molecule to enter the active site. It was speculated that this water 
mediates the hydrogen bonded networks required for the proton transfer.[34] Another 
key residue, Asp251, is freed from the salt bridge during the conformational shift to 
the open state. Together with the adjacent residue, Thr252, Asp251 plays a vital role 
in the proton transfer for O–O bond heterolysis.[34] The opening is thought also to 
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cause a change in the iron spin state and such a spin state shift has been observed 
in a resonance Raman spectroscopy study.[35] Champion and co-workers reported that 
Pdx binding produces a low spin state of heme iron, reflecting the open conformation 
of P450cam.[35] A recent study using double electron-electron resonance (DEER) 
spectroscopy indicated that the conformation change of P450cam is dependent on 
the oxidation states of Pdx.[21] In line with the suggestions of the previous studies, 
the authors report that binding of oxidized state of Pdx induces P450cam to be in 
open conformation. However, reduced and CO-bound P450cam remains in the closed 
conformation in the complex with the reduced state of Pdx.[21] Thus, not all studies 
paint a consistent picture of the mechanism of the effector function of Pdx binding. 
This phenomenon remains to be elucidated. 
Putidaredoxin reductase
Putidaredoxin reductase (PdR) is an FAD-containing flavoprotein (Figure 7). To reduce 
an oxygen molecule, P450cam requires two electrons. PdR transfers two electrons 
from NADH to Pdx which in turn shuttles them to P450cam. PdR consists of 421 amino 
acid residues and possesses FAD and NAD binding domains.[25]
The interaction of PdR with Pdx is often compared with the complex formation 
of adrenodoxin reductase (AdR) and adrenodoxin (Adx), which are the homologue of 




human proteins. The crystal structures of PdR-Pdx and AdR-Adx complexes highlighted 
the difference of binding modes in two systems (Figure 8).[25] The interaction of AdR-Adx 
complex is primarily driven by electrostatic interactions. The acidic patches on the Adx 
surface interact with the basic concave FAD-binding site of AdR.
PdR-Pdx binding, on the other hand, primarily involves hydrophobic contacts and 
polar interactions. Trp328 and Trp330 of PdR are key components of the complex 
formation and part of the electron transfer pathway between PdR and Pdx. The 
experimentally obtained ET rate from PdR to Pdx is 235 s-1 while theoretical maximal 
ET rate is estimated to be 2.7×105 s-1. The difference of three orders of magnitude has 
been attributed to the reorganization energy of Pdx reduction.[25]
Protein-protein interactions
During protein complex formation, the proteins undergo at least are intermediate 
step (illustrated in Figure 9).[38] First, the proteins form an encounter complex in which 
one protein searches for the docking surface of the other and then the well-defined, 
final complex is formed. It has been speculated that the long-range electrostatic 
interaction drive the transient state of protein-protein interaction.[39-41] However, the 
recent results of paramagnetic NMR analysis suggested that hydrophobic interactions 
also play an important role.[42, 43] The primary role of the encounter state is to minimize 
the dimensionality search of optimal binding, and thus to enhance the number of 
productive collisions. In classic textbooks, the dynamic encounter state is assumed to 
exist only transiently and to rapidly form the final well-defined complex. However, the 
latest NMR spectroscopy data have indicated that the encounter complex represents 
a significant population in weak protein-protein complexes (e.g. electron transfer 
Figure 8. Cartoon representation of AdR-Adx and PdR-Pdx complexes. Sticks represent the side chains 
of the interaction residues and FAD. (A) Green and light blue represent AdR and Adx, respectively 
(PDB entry 1E6E[37]). (B) Yellow and orange represent PdR and Pdx, respectively (PDB entry 1Q1R[36]).
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protein complexes).[38, 44] Kinetic data analysis also suggested that some proteins 
achieve electron-transfer active states in the encounter complex rather than in a single 
well-defined complex.[39, 40, 45-48] 
Paramagnetic NMR probes
A variety of paramagnetic NMR techniques have been rapidly developed in the last 
few decades. They enable protein chemists to analyze not only structural information 
of protein interfaces but also kinetics, binding affinity and transient intermediates of 
protein interactions.[49, 50] The presence of unpaired electrons causes paramagnetic 
effects in NMR spectra, which includes “line broadening” and “line shifts”. Line 
broadening is the consequence of enhanced relaxation by unpaired electrons. Since 
the effect is proportional to the sixth power of distance between the electrons and 
observed nuclei, it has been used as a sensitive tool of distance measurement in 
proteins.[51] Line shifts in NMR spectra can be categorized as contact shifts and 
pseudocontact shifts. Contact shifts are caused by the delocalization of unpaired 
electrons onto observed nuclei and can be observed only upto several bonds 
away from the paramagnetic center. Pseudocontact shifts (PCS) result from dipolar 
interactions between the electron(s) and nuclei. The magnitude of a pseudocontact 
shift depends on the anisotropy of the magnetic susceptibility described by the ∆χ 
tensors and is proportional to the third power of the distance between electron 
and nucleus.[51] Strongly paramagnetic metal ions can possess a large ∆χ tensor, 
enabling the observation of pseudocontact shifts for nuclei far from the unpaired 
electron.[52] Pseudocontact shifts, thereby, provide restrains to refine structures of 
macromolecules.[50]
Figure 9. Model of transient protein complex formation. A) Two proteins come close together by 
diffusion. B) The encounter complex: proteins sample each other’s surface in multiple orientations. 




Lanthanoid ions (Ln3+) are known to be excellent paramagnetic groups that possess 
unpaired electrons in the 4f orbitals. Different lanthanoids share similar ionic radii and 
geometries but exhibit a broad range of magnitudes of paramagnetic effects. For 
instance, lanthanum (La3+) and lutetium (Lu3+) ions are diamagnetic whereas dysprosium 
(Dy3+), thulium (Tm3+) and ytterbium (Yb3+) ions are strongly paramagnetic.[52, 53] 
Therefore, lanthanoid ions are widely used for paramagnetic NMR studies.
The lanthanoid tags offer several distinctive advantages over conventional bivalent 
ion (Mn2+, Co2+ etc.) probes. First of all, the substitution of different lanthanoid ions 
allows for a wide range of paramagnetic effects, providing a number of ∆χ tensor 
values with the same probe. Secondly, some lanthanoids possessing a high anisotropy 
magnetic tensor are able to align slightly to the external magnetic field. Therefore, 
those lanthanoid-labeled proteins and protein complexes achieve partial molecular 
alignments in the absence of alignment media. Residual dipolar couplings can be 
therefore measured under the same conditions between unaligned sample and partially 
aligned sample. Since the alignment induced by a paramagnetic ion will not be limited 
by molecular size, lanthanoid tags are an attractive tool for RDC measurements in 
macromolecules as well as in the study of intermolecular interactions.[54]
Many kinds of lanthanoid tags have been published over recent years, including 
protein fusions with lanthanoid-binding peptides[55, 56] as well as lanthanoid-binding 
peptide that are attached via a disulfide bond.[57] Caged lanthanoid NMR probe 
version 7, CLaNP-7, is a synthetic lanthanoid chelating molecule developed for the 
Figure 10. Caged lanthanoid NMR probe version 7, CLaNP-7.
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attachment of lanthanoid atoms on protein surfaces (Figure 10).[58] It has been designed 
to fulfill the following criteria: i) the probe is capable of accommodating different 
lanthanoid atoms, allowing to observe a range of paramagnetic effects; ii)  two thiol 
“arms” of the probe covalently binds to two cysteine residues on a protein surface. 
The “two-point attachment” restricts the flexibility of the probe movement, preventing 
averaging effects. The resonance averaging effect becomes detrimental when the 
magnitudes of the paramagnetic effects are strongly dependent on the distance 
between paramagnetic center and observed nuclei. It also reduces the degree of 
residual dipolar coupling (RDC) when the probe is used to induce partial alignment in 
a magnetic field.[59] With Tm3+ as a paramagnetic ion, CLaNP-7 showed PCS for nuclei 
as far as 60 Å distance from the lanthanoid. Tm3+ loaded CLaNP-7 induces RDC of 
about 20 Hz at 14 T (600 MHz) magnetic field strength.[58] Furthermore, paramagnetic 
relaxation enhancement caused by the gadolinium ion (Gd3+) contained in CLaNP-7 
is also a useful tool for macromolecular structure determination, with distances up to 
45 Å measured accurately (Chapter 3).[60] 
Pseudocontact shift
Pseudocontact shifts (PCSs) provide long-range distance restraints (in the range of 
10–60 Å) as well as relative orientations on the basis of the anisotropy of the magnetic 
susceptibility of paramagnetic metals.[61] PCSs offer opportunities to determine 
structures of proteins and protein-protein complexes. The PCS results from the dipolar 
coupling between the time averaged magnetic moment of the unpaired electron(s) of 
lanthanoid ion (Ln3+) and that of a given nucleus. Figure 11 illustrates the Δχ tensor 
of Ln3+-CLaNP-7 on a given protein surface. 
Figure 11. Cartoon representation of anisotropy of magnetic susceptibility of Yb3+-CLaNP-7. 
Sticks and ribbon show a model of CLaNP-7 on α-helix of a protein. Blue and red isosurfaces 




PCS can be described by the following equation:
 
proteins  and  protein-protein  complexes.  The  PCS  results  from  the  dipolar  coupling
between the time averaged magnetic moment of the unpaired electron(s) of lanthanoid
ion (Ln3+) and that of a given nucleus. Figure 11 illustrates the ∆χ tensor of Ln3+-CLaNP-
7 on a given protein surface. 
Figure  11: Cartoon  representation  of  anisotropy  of  magnetic  susceptibility  of  Yb3+-
CLaNP-7. Sticks and ribbon show a model of CLaNP-7 on α-helix of a protein. Blue and
red isosurfaces represent a nucleus with a PCS of a –1 and +1 ppm, respectively.
PCS can be described by the following equation:













where  θ and Ω  are  angles  of  position vectors  of a  given nucleus  with respect  to  the
reference frame of magnetic susceptibility tensor.  r represents the distance between the
unpaired electron of Ln3+ and a given nucleus (Figure 12). The magnitude of the PCS is
proportional to the inverse third power of the distance, which allows for obtaining long-
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where θ and Ω are angles of position vectors of a given nucleus with respect to the 
reference frame of magnetic susceptibility tensor. r represents the distance between 
the unpaired electron of Ln3+ and a given ucleus (Figur  12).[61] The magnitud  of 
the PCS is proportional to the inverse third power of the distance, which allows for 
obtaining long-range distance information compared to relaxation, which scales 
with  r-6. The anisotropy of magnetic susceptibility is described by axial (Δχax) and 
rhombic (Δχrh) components.
Residual dipolar coupling
Residual dipolar couplings (RDCs) were initially recognized as a useful NMR tool 
to provide distance independent orientation restraints for structure refinement. 
Nowadays, the application of RDC has been expanded to structure determination of 
protein-protein complexes.[61] RDC also offers valuable information about dynamics in 
proteins and protein-protein interactions.[62]
The RDC can be detected when tumbling of proteins is not completely isotropic 
but partially aligned with the external magnetic field. This is often achieved by addition 
of external alignment media to protein samples. Alternatively, paramagnetic metals, 
either natural present[63] or artificially introduced, to the protein of interest.[61] Partial 
Figure 12. Coordinate system describing PCS. Red and blue spheres represent a paramagnetic 
metal and an observed nucleus, respectively. 
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alignment of biomolecules leads to incomplete averaging of dipole-dipole interaction 
between two spins. The resulting residual dipolar couplings provide information about 
the orientation of the protein relative to the external magnetic field.[61]
Paramagnetic relaxation enhancement
Paramagnetic relaxation enhancement (PRE) was originally considered to be 
deleterious or at least a nuisance effect when metalloenzymes were investigated 
by NMR spectroscopy. Essential information about the active site was lost due to 
the fact that resonances of nuclei close to the metal were broadened out beyond 
detection. PRE arises from the dipole-dipole interactions of an unpaired electron in 
the paramagnetic center with nuclei in the proximity. PRE effect is dependent on the 
inverse sixth power of distance between an unpaired electron and a given nucleus.[44, 64] 
In comparison with the NOE effect, which yields measureable distances up to 6 Å, PRE 
causes effects over distances up to 20 Å and in some cases even up to 45 Å.[60, 64] The 
deleterious effect of line broadening by PRE was soon turned into a useful tool for 
NMR experiments. By artificially introducing an unpaired electron in a paramagnetic 
center into protein samples, PRE can be used as a molecular ruler, due to the strong 
distance dependency.[44] PRE is also extremely sensitive to lowly populated states 
of protein conformations and protein complexes.[64-67] Nowadays, PRE is the most 
common paramagnetic NMR experiment to determine distance restraints for structure 
determination of proteins and transient protein-protein complexes.[44, 61]
Thesis outline
At the start of this research in 2009, a model of Pdx-P450cam complex was available.[68] 
This model was generated on the basis of a series of NMR data and showed good 
correlations with earlier mutagenesis results. To test the validity of this model and 
further characterize the dynamics of Pdx-P450cam interaction, we decided to carry 
out paramagnetic NMR analysis. In Chapter 2, the attachment of a paramagnetic NMR 
probe, CLaNP-7, is evaluated at multiple sites of Pdx and P450cam. The Δχ tensors 
of Ln3+-CLaNP-7 were experimentally determined by PCS analysis. These results 
form the prelude for the intermolecular paramagnetic NMR experiments to study the 
Pdx-P450cam complex discussed in Chapter 3. To calculate the structure of the Pdx-
P450cam complex, 446 inter-protein distance and orientation restraints were used 
on the basis of the PCS, RDC and PRE experiments. After the structure had been 
determined by paramagnetic NMR analysis, our collaborator, Dr. Nojiri and co-workers 
in Osaka University (Japan) solved the crystal structure of the complex at a resolution 
of 2.5 Å. The crystal structure is identical to the solution structure within the variation of 
the ensemble. Compared with the previous model, the orientation of Pdx is rotated by 
90° perpendicular to the axis of P450cam heme. The structural analysis of the binding 




Pdx Asp38 and P450cam Arg112 as well as hydrophobic contacts between Trp106 
and P450cam Ala113. Moreover, several polar residues are found in the interface that 
had not been recognized to be relevant for binding before. In Chapter 4, site-directed 
mutagenesis and kinetic measurements were employed to probe the energetic 
importance and role of the polar residues in the Pdx-P450cam interaction. The results 
of the paramagnetic NMR analysis used for the structure calculations of the complex 
suggested the presence of an encounter sate in the Pdx-P450cam complex. To 
characterize this lowly populated state, Gd3+ loaded CLaNP-7 as well as an MTSL spin 
labels were attached at six different positions on Pdx and P450cam surfaces and inter-
protein PRE analysis was performed (Chapter 5). Dynamics in the P450cam enzyme is 
observed not only for the protein-protein interaction but also for the substrate binding 
process. Most of the crystal structures of P450cam exhibit a closed conformation in 
which there is no channel large enough for substrate to access the active site. In 
Chapter 6, using paramagnetic substrate analogues, the substrate access channel of 
P450cam was investigated by X-ray crystallography and paramagnetic NMR analysis. 
Finally, in the concluding remarks, the results from these chapters are discussed in 
relation to recent studies of the effector role of Pdx in the P450cam catalytic system. 
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lanthanoid tags for P450cam by 
paramagnetic NMR spectroscopy
Part of this chapter was published as Hiruma, Y.; Hass, M.A.; 
Kikui, Y.; Liu, W.M.; Olmez, B.; Skinner, S.P.; Blok, A.; 
Kloosterman, A.; Koteishi, H.; Löhr, F.; Schwalbe, H.; Nojiri, M.; 
Ubbink, M. (2013) The Structure of the Cytochrome P450cam-
Putidaredoxin Complex Determined by Paramagnetic NMR 
Spectroscopy and Crystallography, J Mol Biol 425, 4353–4365.
Abstract
Paramagnetic NMR techniques have opened up new possibilities to obtain molecular 
details of large proteins and/or protein complexes. With the use of lanthanoid 
(Ln3+) tags, structural information can be retrieved from simple 2D TROSY/HSQC 
experiments. Recently, Liu et al. developed a novel Ln3+ probe, CLaNP-7, which 
has been shown to provide valuable paramagnetic NMR effects on proteins. In this 
study, CLaNP-7 was applied to two proteins, cytochrome P450cam (P450cam) and 
its electron transfer partner protein, putidaredoxin (Pdx) to determine the structure 
of their complex in solution. The tag was attached at multiple sites to find the best 
positions for this purpose. The size and orientation of Δχ tensors of Ln3+-CLaNP-7 
and the metal positions were experimentally determined by pseudocontact shift (PCS) 
analysis. Moreover, using the distance restraints derived from PCSs, the conformational 
change of P450cam was examined upon binding of Pdx. In contrast to the recent 
report by Tripathi et al., the distinct conformational shift of P450cam from closed 
to open state was not detected. These results thus form the prelude parameters for 
the intermolecular paramagnetic NMR experiments to study Pdx-P450cam complex 
discussed in chapter 3. At the same time the work gives insight in the efficiency of 
lanthanoid tagging as a means for structure determination. 
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Introduction
Recent paramagnetic NMR techniques have advanced the possibilities for structure 
determination of protein complexes in solution.[1] By attaching artificially synthesized 
lanthanoid tags to protein surfaces, long-range distance information can be retrieved 
from simple NMR experiments,[2] which is radically different from conventional nuclear 
Overhaucer experiments. Moreover, by utilizing different lanthanoid ions, either 
pseudocontact shift (PCS) or paramagnetic relaxation enhancement (PRE) can be 
measured.[2] A prerequisite for reliable paramagnetic NMR experiments is the use of 
a rigid lanthanoid tag. The paramagnetic tag used in this work is a caged lanthanoid 
NMR probe (CLaNP), version 7,[3] which binds covalently to two Cys residues that are 
in close proximity. The two-point attachment of CLaNP-7 ensures a low mobility of the 
probe on the protein surface, and minimal averaging of the paramagnetic effects.[3-4] 
In this study, a series of double Cys mutants of Pdx and P450cam were produced. The 
attachment of CLaNP-7 was validated by assessing the intramolecular paramagnetic 
NMR effects, which is illustrated in Figure 1. 
Introduction
Recent  paramagnetic  NMR  techniques  have  advanced  the  possibilities  for  structure
determination  of  protein  complexes  in  solution.  By  attaching  artificially  synthesized
lanthanoid tags to protein surfaces, long-range distance information can be retrieved from
simple  NMR  experiments,  which  is  radically  different  from  conventional  nuclear
Overhaucer  experiments.  Moreover,  by  utilizing  different  lanthanoid  ions,  either
pseudocont ct  shift  (PCS)  or  paramagnetic  rel xation  nhancement  (PRE)  can  be
measured. A prerequisite for reliable paramagnetic NMR experiments is the use of a rigid
lanthanoid tag. The paramagnetic tag used in this work is a caged lanthanoid NMR probe
(CLaNP),  version  7,  which  binds  covalently  to  two  Cys  residues  that  are  in  close
proximity. The two-point attachment of CLaNP-7 ensures a l w mobility of the pr be on
the protein surface, and minimal averaging of the paramagnetic effects.[3-4] In this study, a
series of double Cys mutants of Pdx and P450cam were produced. The attachment of
CLaNP-7  was  validated  by  assessing  the  intramolecular  paramagnetic  NMR  effects,
which is illustrated in Figure 1. 
Figure 1: Schematic representation of the intramolecular PCS analysis used in this study.
Ln3+-CLaNP-7  was  labeled  to  isotopically  linked  proteins.  The  observed  PCS  is
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Figure 1. Schematic representation of the intramolecular PCS analysis used in this study. Ln3+-
CLaNP-7 was linked to isotopically labeled proteins. The observed PCS is dependent on the 
orientation of the Δχ tensor and the distance between Ln3+ and the given nuclei.
[15N] labeled proteins were tagged with CLaNP-7 and PCS of amide protons were 
measured. To allow for comparison with previously reported magnetic susceptibility 
anisotropy tensors (Δχ tensor),[3] ytterbium (Yb3+) and thulium (Tm3+) were used in 
this study. The orientations and anisotropy of the Δχ tensor of a series of CLaNP-7 
labeled Pdx and P450cam mutants were determined. Assessment of intramolecular 
PCS provides not only validation of the probe attachment, but also the fraction of 
the protein that is labeled with a probe. It can be also used to calculate the position 
of Ln3+ ion, which is essential for the interpretation of intermolecular paramagnetic 
NMR experiments (chapter 3). In addition, the PCSs from paramagnetic tags at 
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multiple locations helped the NMR assignment of P450cam amide groups. Finally, the 
intramolecular PCS experiments were used to obtain information on the conformational 
change in P450cam upon binding of Pdx. In contrast to the recently proposed model 
of Pdx effector activity,[5] the result of PCS analysis indicates that P450cam does not 
undergo significant conformation change upon the binding of Pdx.
Results
Protein production
Most pairs of surface exposed cysteine residues were introduced at the proximal region 
of P450cam where Pdx has been reported to interact with P450cam.[6] Nevertheless, a 
control mutant was also created at the distal region of P450cam, E195C/A199C/C334A 
(mutant D). The locations of the tag in Pdx were selected close to the proposed Pdx-
P450cam binding interface. To avoid interference, exposed Cys residues at positions 
334 on P450cam and positions 73 and 85 on Pdx were substituted. These substitutions 
have been used in other studies.[7-8] Other Cys residues are present in both proteins, 
some of which are partially exposed on the protein surfaces. However, the results of 
size-exclusion chromatography and mass spectrometry analysis indicated that these 
were found neither to induce oligomerization nor interfere with the tagging. The 
P450cam and Pdx constructs are summarized in the Table 1.
Out of twelve P450cam constructs, six P450cam mutants (A–F) were over-expressed 
and purified. The average protein yields of these variants exceeded over 50 mg per 
liter of culture with [15N] isotopically enriched minimal media. The other six constructs 
(mutant G–M) yielded very little protein (less than 1 mg / L) and therefore, it was 
decided not to use them for CLaNP-7 labeling. For Pdx constructs, Pdx mutant II 
and III did not yield correctly folded proteins due to the extensive loss of iron-sulfur 
cluster. Pdx mutant I, on the other hand, showed the identical absorption spectrum as 
wild type and the protein yield reached 10 mg / L of culture with [15N] minimal media. 
Low yield of P450cam constructs was attributed to the inability to incorporate the 
heme group correctly and stably as indicated by the observation of a Soret peak at 
420 nm in their absorption spectra. The reason for the difficulty of gene expression of 
Pdx variants can be similar. The coordination of [2Fe-2S] cluster can be disturbed by 
double Cys mutations, which leads to instable or incorrectly folded protein.
Probe attachment and characterization
Isolated P450cam (mutant A–F) and Pdx (mutant I) were labeled with CLaNP-7 and 
15N-1H HSQC spectra were recorded. Figure 2 shows a section of the overlaid HSQC 
spectra of Pdx mutant I. 
As illustrated in Figure 2, the PCS is defined as the difference in the chemical 
shifts between paramagnetic Yb3+/Tm3+ samples and diamagnetic Lu3+ sample. By 
comparing the intensities of PCS peaks against those of the residual peaks, the fraction 
of CLaNP-7 labeling can be determined (Figure 3). For instance, if there is almost no 
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Table 1. Summary of P450cam and Pdx constructs prepared in this study. Most of the 
double cysteine mutations were designed to be in the vicinity of the proposed binding 
interface of Pdx-P450cam complex.[6] Some constructs yielded very little protein or P420 
species, which are indicated by “Unsuccessful”.
P450cam Mutations Probe positions CLaNP-7 attachement
Mutant A K126C/R130C/C334A Proximal side Yb3+ & Tm3+
Mutant B A333C/H337C/C334A Proximal side Yb3+ & Tm3+
Mutant C Q272C/E276C/C334A Proximal side Tm3+
Mutant D E195C/A199C/C334A Distal side Yb3+ & Tm3+
Mutant E A113C/Q117C/C334A Proximal side Yb3+
Mutant F A113C/N116C/C334A Proximal side Yb3+
Mutant G E40C/V44C/C334A Proximal side Unsuccessful
Mutant H Q69C/R72C/C334A Proximal side Unsuccessful
Mutant J Q69C/E73C/C334 Proximal side Unsuccessful
Mutant K Q227C/N229C/C334A Proximal side Unsuccessful
Mutant L R277C/R280C/C334A Proximal side Unsuccessful
Mutant M Q388C/N390C/C334A Proximal side Unsuccessful
Pdx Mutations CLaNP-7 attachement
Mutant I V6C/R12C/C73S/C85S Yb3+ & Tm3+
Mutant II K79C/N81C/C73S/C85S Unsuccessful
Mutant III E93C/D95C/C73S/C85S Unsuccessful
attachment of CLaNP-7, a single peak would be observed at the chemical shift for a 
given residue. In contrast, if half of the sample were labeled with Yb3+/Tm3+-CLaNP-7, 
two peaks would appear in the NMR spectrum for a given residue, with 1:1 intensity 
ratio. And lastly, if almost all of the protein is labeled, the intensity of the residual peak 
would become very small.
For Pdx mutant I, no peaks of untagged Pdx were observed. By estimating the 
maximum intensity using the noise level, it is estimated at least 95% of the Pdx was 
labeled with CLaNP-7. The attachment of CLaNP-7 was also confirmed by mass 
spectrometry analysis. The theoretical molecular mass of 100% [15N] labeled Pdx mutant 
I was calculated to be 11528.8 and that of Yb3+-CLaNP-7 complex would be 12407.6 
(from online ExPASy-Compute pI/Mw; http://www.expasy.ch/tools/pi_tool.html). The 
observed molecular weight was 12400.2, which differed by 7 Da from the expected 
Yb3+-CLaNP-7 labeled Pdx. The difference can be attributed to the efficiency of the 
enrichment of [15N] isotope in the protein production. In the case of P450cam mutants, 
low intensities of residual peaks were present. By measuring the height of paramagnetic 
peaks, we concluded that 80–90% of the protein was labeled with CLaNP-7 in all cases. 
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The extension of the assignment of P450cam nuclei by PCS data
PCS depends on the orientation and anisotropy of Δχ tensors of lanthanoids.[9] Δχ 
tensors can be represented by their axial (Δχax) and rhombic (Δχrh) components, both 
of which were characterized for Yb3+/Tm3+-CLaNP-7 previously.[3] The assignments 
for amide resonances of oxidized Pdx were based on previous work.[10] The amide 
resonances of oxidized, camphor bound P450cam were kindly provided by Dr. Mathias 
Hass (Leiden University).
Figure 2. Overlay of the HSQC spectra of Ln3+-CLaNP-7 labeled Pdx. Blue, green and red peaks 
represent Lu3+, Yb3+ and Tm3+ containing samples, respectively. The PCSs are illustrated for 
several residues by a solid lines.
Figure 3. Schematic representation of determination of CLaNP-7 labeling in NMR spectrum. Blue 
and red peaks represent untagged and tagged protein, respectively. (A) almost 0% CLaNP-7 
labeling. (B) 50% CLaNP-7 labeling. (C) >95% CLaNP-7 labeling.
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For Yb3+-CLaNP-7 labeled P450cam mutant A, B, D, E and F, the number of PCS 
measured were 133, 117, 158, 133 and 129, respectively. Due to the broadening caused 
by relaxation enhancement of Tm3+, the number of PCS measured for Tm3+-CLaNP-7 
samples were smaller (97, 97, 109, and 109 for mutant A, B, C and D, respectively). To 
illustrate the regions experiencing PCS from different positions of Ln3+, PCSs caused 
by Yb3+/Tm3+ were plotted against P450cam residue number (Figure 4). 
Figure 4. Experimentally observed PCSs were plotted against the P450cam residue number. The 
panel A, B, C, D, E and F represent P450cam mutant A, B, C, D, E and F, respectively. Green 
columns are for Yb3+ and red columns for Tm3+ data. For the mutant E and F, only Yb3+ data sets 
were available due to the limited amount of sample. In case of mutant C, only the Tm3+ data were 
analyzed for the same reason.
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The PCS measurements of the six different positions cover 45% (188/414) of the 
residues for the entire protein. It is worth noting that the regions nearby heme (248–252 
and 350–360) were hardly accessible. The loss of NMR signals is attributed to the 
relaxation enhancement from the heme iron. In the presence of substrate, camphor, 
the heme iron becomes high spin, which causes the line broadening of the resonances 
of nuclei within 8 Å of the iron.[11] Some residual peaks previously assigned by multiple 
3D NMR experiments[6, 11-13] were corrected according to the back-calculated and 
experimentally observed PCS values.
In case of Pdx mutant I, the number of PCS measured for Yb3+ and Tm3+ were 
37 and 15, respectively. To illustrate the accuracy of the PCS measurement, back-
calculated PCS was plotted against experimentally obtained PCS. Figure 5 shows the 
scatter plot of Yb3+/Tm3+-CLaNP-7 labeled Pdx mutant I. 
Figure 5. Plot of back-calculated PCS versus experimentally observed PCS of Pdx mutant I. 
Green and red points represent the Yb3+ and Tm3+ samples, respectively. The ideal correlation is 
indicated by the solid line.
Most of the data points exhibit good correlations between the back-calculated and 
observed PCS. The back-predicted PCSs were calculated from the crystal structures 
of Pdx C73S and P450cam C334A (PDB entries, 1XLP[14] and 1DZ4,[15] respectively). 
If Cys substitutions or the attachment of paramagnetic tag significant perturb the 
structures of the proteins, deviations would be detected between the observed and 
back-calculated PCS. The agreement of observed and back-calculated PCS provides 
a validation of CLaNP-7 attachment as well as the integrity of the 3D structure. Δχax 
and Δχrh values were estimated by program Numbat.[9] The list of Δχ tensors and 
associating quality (Q) factors were summarized in the Table 2. See Materials and 
Methods for the Q factor definition.
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Table 2. Intramolecular PCS experiments. 
Sample CLaNP-7 # assignments Δχ (10-32 m3) Q
[15N] P450cam mutant A
(K126C/R130C/C334A)
Yb3+ 133 Δχax = 6.3 ± 0.3
Δχrh = 8.5 ± 0.5
0.04
Tm3+ 97 Δχax = 54.6 ± 2.6
Δχrh = 16.9 ± 0.8
0.04
[15N] P450cam mutant B
(A333C/H337C/C334A)
Yb3+ 117 Δχax = 5.9 ± 0.4
Δχrh = 6.7 ± 0.4
0.06
Tm3+ 97 Δχax = 56.9 ± 1.2
Δχrh = 13.0 ± 0.8
0.04
[15N] P450cam mutant C
(Q272C/Q276C/C334A)
Tm3+ 109 Δχax =44.7 ± 2.0
Δχrh = 8.0 ± 2.0
0.07
[15N] P450cam mutant D
(E195C/A199C/C334A)
Yb3+ 158 Δχax = 6.7 ± 0.3
Δχrh = 6.3 ± 0.4
0.07
Tm3+ 109 Δχax =44.7 ± 0.8
Δχrh = 21.3 ± 1.1
0.04
[15N] P450cam mutant E
(A113C/Q117C/C334A)
Yb3+ 133 Δχax = 7.4 ± 0.4
Δχrh = 7.6 ± 0.6
0.06
[15N] P450cam mutant F
(A113C/N116C/C334A)
Yb3+ 129 Δχax = 5.1 ± 0.1
Δχrh = 7.2 ± 0.4
0.14
[15N] Pdx mutant I
(V6C/R12C/C73S/C85S)
Yb3+ 37 Δχax = 6.4 ± 0.7
Δχrh = 8.6 ± 1.3
0.06
Tm3+ 15 Δχax = 49.0 ± 0.5
Δχrh = 15.7 ± 1.2
0.02
The Δχ tensors derived from PCS analysis were comparable to those found in the 
model proteins in a previous study.[3] Q factor analysis indicates that the back-predicted 
PCSs agree well with the experimentally obtained PCSs. Also, in line with the suggestions 
with a previous study,[16] the positions of Ln3+ were found to be 8 ± 2 Å distance away 
from the alpha carbons of two substituted Cys residues. In the case of P450cam mutant F, 
however, the distances between Ln3+ and the alpha carbons of C113 and C116 were 
measured to be 8 Å and 12 Å, respectively (Figure 6). The calculated position cannot 
be achieved if CLaNP-7 were anchored at A113C/N116C via two disulfide bridges. It is 
concluded that CLaNP-7 was attached to Cys113 via a single arm.
Previously, it had been shown that single point attachment of CLaNP significantly 
reduces the observed Δχ tensors.[17] This is due to the mobility of the probe on protein 
surface averaging out PCSs. For mutant F, a slightly smaller Δχax and larger Q factor 
were found as compared to the other mutants. However, the overall change was not as 
significant as the previously reported.[17] It is speculated that the mobility of CLaNP-7 
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for mutant F was restricted by the interactions of the residues closeby. The problem of 
single-arm attachment was circumvented by a change of the mutation site from N116 
to the adjacent residue, Q117 (mutant E).
Intramolecular paramagnetic NMR of [13C, 15N] P450cam in the presence 
of Pdx
The PCS measurements above were obtained by two-dimensional 15N-1H TROSY/HSQC 
experiments. To further extend the PCS analysis, P450cam mutant A was enriched 
with [13C, 15N] isotopes. An HNCO experiment was recorded with Lu3+/Tm3+-CLaNP-7 
labeled samples. The Δχax and Δχrh calculated from experimentally obtained PCS were 
compatible to previously determined values. Due to the limited availability of the 
sample, the total number of PCS measured for 3D experiment was 95, which is slightly 
smaller than for the 2D experiment (Table 1). The calculations of Δχ tensors and 2D/3D 
NMR assignment of P450cam allows to study dynamics of the conformational states 
of P450cam by PCS measurements. Recently, Tripathi et al. proposed the effector role 
of Pdx on the basis of the crystal structures of the Pdx-P450cam complex, to consist 
of a conformation change in P450cam, opening up its substrate access channel.[5] 
According to their model, P450cam adopts a closed conformation in the absence of 
Pdx while it assumes the open conformation when it is bound to Pdx. To assess the 
dynamics of P450cam upon Pdx binding, the intramolecular PCS of P450cam were 
determined in the absence and presence of Pdx. P450cam mutant A was enriched 
with [13C] and [15N] isotopes and labeled with Lu3+/Tm3+-CLaNP-7. Subsequently, 
excess oxidized Pdx was added to the NMR samples and a series of three dimensional 
HNCO spectra were acquired. In case of the diamagnetic dataset (Lu3+), chemical shift 
perturbations (CSPbinding) were observed nearby the Pdx binding site in accord with a 
previous report.[11] The chemical shift perturbation (ΔδTm) measured in the Pdx bound 
Figure 6. Cartoon representation of the position of Ln3+ on P450cam mutant F. Yellow and cyan 
spheres illustrate the initially predicted and experimentally derived positions of Ln3+, respectively. 
Gray, red and blue spheres in the ribbon represent the substituted residues C113 and C116 of 
P450cam.
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sample reflects the contributions of Pdx binding (CSPbinding) and a change in the PCS 
(ΔPCS) due to a conformation change in P450cam as shown in the following equations:
	 ∆δTm = CSP(binding) + ∆PCS [1]
	 ∆δLu = CSP(binding) [2]
	 ∆PCS = ∆δTm – ∆δLu  [3]
The contribution of Pdx binding can thus be subtracted, using the chemical shift 
changes in the diamagnetic sample. The ΔPCS attributed to the conformation change 
was derived by the comparison of PCS between Pdx-free and Pdx-bound samples.
The observed ∆PCS were plotted against P450cam residue number and color-
coded on the P450cam surface (Figure 7).
Figure 7. Effect of Pdx binding on PCS in P450cam mutant A. (A) The differences in PCS (∆PCS) 
are plotted against the P450cam residue number. (B) Surface representation of P450cam, color 
coded for the residues with |∆PCS| ≥ 0.030, red; 0.030 > |∆PCS| ≥ 0.025, orange; 0.025 > |∆PCS| 
≥ 0.020, yellow; 0.020 > |∆PCS|, blue and no data, gray. Pdx as found in the complex (chapter 3) 
is shown in ribbons.
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The changes of the PCS were not only observed at the Pdx binding site but 
also in other regions of P450cam. The residues Glu40, Leu312, Lys313 and Val414, 
experiencing the largest change of PCS, are located at the A helix, β4 sheet and 
C-terminal loop. In our current study, the predicted ∆PCSs were not calculated 
for the open conformation of P450cam. Therefore, it is hard to quantify the extent 
of ∆PCSs for those residues upon the conformation change. However, the overall 
magnitude of PCS change is close to the experimental errors. It suggests that those 
residues undergo minor structural change upon binding of Pdx. It should be noted 
that not the entire surface of P450cam was sampled for ∆PCS due to the interference 
of the large broadening effect of Tm3+-CLaNP-7. Currently, further intramolecular 
PCS measurements are undertaken to clarify the effect of Pdx binding on P450cam. 
P450cam mutant D is selectively enriched with [15N] Leu and labeled with Yb3+/
Lu3+-CLaNP-7. The preliminary results also indicate that P450cam does not undergo 
significant conformation change upon binding of Pdx, which is in the line with the 
suggestions of the current study (Dr. Simon Skinner, personal communication).
Discussion
Determination of Δχ tensors
One of the most important results presented here was obtained by analysis of the 
intramolecular PCS data for the respective mutants. Using this approach, we were able 
to demonstrate the attachment of CLaNP-7 to the proteins and derive the positions of 
the Ln3+ ions and the orientations of the Δχ tensors. Our finding of Δχ tensors was in 
accord with the results for the model protein, pseudoazurin, and was not dependent 
on pH as described by Liu et al. for cytochrome c.[3] Characteristically, the Δχ tensor of 
Yb3+-CLaNP-7 exhibits rather a large rhombicity compared to Yb3+-CLaNP-5. It can be 
attributed to the change of the coordination system of Yb3+ and overall charge of Yb3+-
CLaNP-7. However, for Tm3+, the Δχrh is similar for both CLaNPs. CLaNP-7 was recently 
synthesized in our group to reduce the overall charge of CLaNP from 3+ to 1+.[3] 
Interestingly, the different properties of CLaNP-7 opened up the possibility to apply 
paramagnetic NMR experiments to P450cam. When Ln3+-CLaNP-5 was added to wild 
type P450cam, it led to the formation of a large amount of aggregated protein. On the 
other hand, P450cam showed much more tolerance toward Ln3+-CLaNP-7 incubation. 
The formation of oligomers was significantly less than with CLaNP-5 treatment. The 
hydrophobicity of CLaNP-7 enables the enrichment of probe-labeled P450cam. 
Standard ion-exchange chromatography and/or size-exclusion chromatography often 
result in the insufficient separation of probe-free and probe-labeled proteins. The 
attachment of CLaNP-7 creates a hydrophobic patch on a protein surface that changes 
its elution point in the affinity to hydrophobic interaction chromatography (HiTrap 
Phenyl FF hydrophobic column). 
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The Δχ tensors derived from the experimentally obtained PCS suggested that 
all of the mutants were labeled with CLaNP-7 via two arms, except for P450cam 
mutant F (A113C/N116C). Fitting of the Ln3+ position based on the PCS showed that 
CLaNP-7 was anchored at P450cam mutant F via a single disulfide bond. A plausible 
explanation is that the side chain of the second mutation site, N116C, was orientated 
away from the protein surface and was inaccessible for the formation of a disulfide 
bridge. Single point attachment can generate significant rotational freedom to 
CLaNP-7, reducing the magnitude of PCS due to the averaging effect as was seen 
for CLaNP-5.[17] However, the reduction in Δχ tensor values was rather limited in the 
present case. The problem of single-arm attachment was overcome by a change of 
the mutation site to the adjacent residue Q117. It was demonstrated that the Δχ 
tensor and metal location of P450cam mutant E (A113C/Q117C) agree well with 
the expected tensor, both in size and orientation. The study of P450cam mutant F 
highlighted a methodology for finding double-point attachment of CLaNP based on 
Δχ tensor analysis of intramolecular PCS.
One of the essential parameters for the analysis of paramagnetic NMR experiments 
is the fraction of probe labeled protein. Different techniques were applied to estimate 
the efficiency of labeling on proteins. Atomic absorption spectroscopy showed the 
presence of Ln3+ and heme iron in P450cam samples. However, it did not allow 
us to determine the fraction of labeling. The reliability of the data was limited by 
the formation of aggregated proteins during sample preparation. Alternatively, 
the labeling efficiency can be calculated from the fraction of free thiol on protein 
surface. The determination of free thiol content was performed by using Ellman’s 
reagent.[18] P450cam comprises eight endogenous cysteine residues, of which one 
surface exposed Cys was substituted to Ala. Unfortunately, however, it was not possible 
to calculate the amount of Ellman’s reagent on proteins, since its absorption heavily 
overlaps with that of the P450cam Soret band. The absorbance of camphor bound 
P450cam, with ε391nm = 108 mM-1cm-1, dwarfs that of Ellman’s reagent with ε412nm = 
14.2 mM-1cm-1.[19] Another conventional way to determine probe labeling on proteins 
is mass spectrometry (MS). The limited mass range of the MS available to us, only 
enabled us to measure molecular weights of less than 30 kDa. Since the molecular 
mass of P450cam is 47 kDa, MS analysis could not be performed. For Pdx (12 kDa), 
the MS data confirmed the complete labeling with CLaNP-7. It is worth noting that the 
fraction of probe labeling drops when Pdx was stored at –80°C. The disulfide bonds 
that connect CLaNP-7 and Pdx become susceptible to reduction during rapid thawing 
of the samples at room temperature. To estimate the fraction of probe labeling in 
P450cam, we decided to utilize the peak intensities in the NMR spectra. By measuring 
the height of paramagnetic peaks, we concluded that more than 80–90% of P450cam 
was labeled with CLaNP-7. It should be noted that these values represent the samples 
after purification. Due to the formation of oligomers and presence of probe-free 
P450cam, the yield of Ln3+-CLaNP-7 labeled P450cam immediately after the reaction 
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was usually less than 20%. Another quick and easy estimation of fraction of CLaNP-7 
labeling can be obtained from absorption spectra recorded on the NMR samples. 
CLaNP-7 gives maximum absorption peak at the wavelength of 390 nm due to the 
presence of nitro-phenyl group. Absorption spectrum analysis revealed that the ratio 
of A390nm/A280nm increases from 1.4 to ≥ 2.1 when P450cam is labeled to 80–90%. For 
Pdx with complete labeling, the ratio of A400nm/A280nm exceeds 1.95.
The extension of NMR assignments by PCS analysis
The determination of Δχ tensors of Ln3+ at multiple positions on the protein surface 
aided in the extension of the assignment of P450cam NMR spectra. Due to the 
relatively large size of the protein, conventional 3D NMR experiments require long 
acquisition time as well as a high concentration of protein. Furthermore, in order to 
obtain high resolution spectra, it is necessary to isotopically enrich proteins with [2H], 
[15N] and [13C]. The production of such isotopically labeled proteins was expensive due 
to a low protein yield. In this study, it was demonstrated that with the use of PCS data, 
the preparations and experiments of NMR can be simplified. P450cam samples used 
in this report were enriched solely with [15N], which yielded as much as 50 mg per a 
liter of culture. In addition, simple 2D HSQC spectra were recorded with a protein 
concentration of merely 100 μM (equivalent to 2–3 mg of protein per sample).
The six series of PCS data yielded assignments for 45% of the residues of the entire 
protein. The regions where PCS were not measured were the distal side of P450cam 
and the active site nearby the heme. The PCS measurement of the distal side nuclei 
can be achieved by extending the mutation sites of probe attachment. Here, most of 
the CLaNP-7 labeling sites were designed at the proximal side of the protein to study 
the interaction of Pdx-P450cam complex. The spin state of the heme iron influences 
the NMR peaks of the residues in close vicinity. When heme iron is high spin, those 
peaks broaden out beyond detection.[11] The problem of the line broadening can be 
eliminated by the replacement of substrate with substrate analogues. Phenylimidazole 
is one of the substrate analogues that is known to associate with heme iron and act 
as a sixth ligand.[20] The coordination of a strong sixth ligand changes the spin state 
of the iron and reduces the line broadening. Since information of the active site helps 
to reveal the nature of the catalytic reaction of P450cam, further assignments by 
paramagnetic NMR analysis in that region are desirable.[21]
Intramolecular paramagnetic NMR effects upon Pdx binding
To evaluate the effects of Pdx binding, isotopically enriched P450cam was labeled 
with CLaNP-7 and the changes in PCSs were measured upon addition of Pdx. Due 
to the limited availability of the sample as well as the interference of broadening 
effect of Tm3+, only 95 peaks were analyzed, which represents only a limited region 
of P450cam. The results of the PCS analysis indicated that P450cam undergoes a 
minor conformational change upon the binding of Pdx. These results are in contrast 
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to the proposed model of the effector activity of Pdx by Tripathi et al. in which Pdx 
binding causes the conformation change of P450cam to adapt open conformation.[5] 
Goodin and co-workers examined the conformational shift of P450cam by double 
electron-electron resonance (DEER) spectroscopy.[22] The results of DEER suggested 
that it is dependent on the oxidation state of Pdx. The binding of oxidized Pdx induces 
the conformational transition to open state while reduced Pdx favors the closed 
conformation. The discrepancy of the results can be attributed to the experimental 
conditions. Tripathi et al. drew the conclusion on the basis of the crystal structures 
of Pdx-P450cam complex. However, the formation of the crystals of Pdx-P450cam 
complex was only observed under conditions that favor P450cam to be in the open 
conformation. 
The changes of the specificity and selectivity of electron transfer partner between 
the first and second ET play a key role in the regulation of the catalytic reaction of 
P450cam. To study the second ET complex, the paramagnetic NMR experiments were 
repeated with dithionite reduced states of Pdx and carbon monoxide bound P450cam. 
However, the disulfide bridges between CLaNP-7 and P450cam were vulnerable to 
the reducing environment. The reduced state of P450cam was also prepared in the 
reconstituted system of Pdx-P450cam in the presence of a catalytic amount of PdR. 
However, the NMR spectra indicated that the paramagnetic NMR effect was still lost 
due to the loss of CLaNP-7. The detachment of the probe under reducing conditions 
has recently been overcome by the modification of CLaNP molecule. The two methyl 
thiosulfate groups of CLaNP arms were substituted with bromide groups. This novel 
probe, called CLaNP-9, reacts with cysteine residues to form covalent thioether 
bridges via two-point attachment. Preliminary data suggested that CLaNP-9 labeled 
P450cam remains intact even in the presence of strongly reducing agents such as 
dithionite. As a future perspective, the effector activity of Pdx in the second ET could 
be investigated by intramolecular paramagnetic NMR experiments.
Material and Methods
Chemicals
Ln3+-CLaNP-7 was kindly provided by Dr. Wei-Min Liu. The plasmids harboring the 
cDNA of Pdx and P450cam were generous gift from Prof. Stephen G. Sligar, University 
of Illinois at Urbana–Champaign, U.S.[12] The genes were subcloned into the pET28a 
expression vectors using NcoI and XhoI restriction enzymes by Anneloes Blok (Leiden 
University), without use of the His tag sequence. Column material was obtained from 
GE Healthcare, Munich, Germany.
Mutagenesis
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Protein production
Isotopically enriched P450cam variants were produced as previously described.[23] The 
pET28a plasmid containing P450cam gene was transformed into BL21 pLysS strain. 
Single colonies were picked and inoculated into 5 mL LB medium with 50 μg/mL 
kanamycin at 37°C for 4 hours. 20 μL of the pre-culture was transferred to 100 mL 
[15N] M9 minimal medium with 50 μg/mL kanamycin overnight at 37°C. 10 mL of M9 
pre-culture was transferred into 500 mL of [15N] M9 minimal media with 50 μg/mL 
kanamycin and grown at 37°C until A600nm = 0.4–0.6. Gene expression was induced by 
adding 0.5 mM IPTG, 0.2 mM 5-aminolevulinic acid, 1 mM camphor (1% MeOH) and 
100 μM FeCl3-6H2O. The cultures were allowed to grow at 22°C for 70–80 hours. Cells 
were resuspended in a KPi buffer (20 mM KPi, pH 7.4, 50 mM KCl, 1 mM camphor, 1% 
MeOH, 1 mM DTT, 1 mM PMSF and 1 mM DNAse). Samples were flash frozen in N2 (l) 
and stored at –80°C. 
The resuspended cells were defrosted rapidly at room temperature. A few mg of 
crystal of lysozyme crystals were added and the sample was stirred for 30 minutes 
at 22°C. The lysate was further disrupted by French-press and sonication. Following 
centrifugation at 35000 r.p.m. for 30 minutes at 4°C, protamine sulfate was added 
to a lysate with 10 mg/g of cell pellet and incubated in cold room for 30 minutes. 
The sample was then centrifuged with 35000 r.p.m. for 30 minutes at 4°C. The pH 
of the supernatant was adjusted to around 7.4 by addition of a few drops of KOH. 
Ammonium sulfate powder was added slowly to the sample to achieve 70% (w/v). 
The sample was then stirred in cold room for 30 minutes. Following centrifugation 
at 35000 r.p.m. for 30 minutes at 4°C, the pellet was resuspended with KPi buffer A 
(20 mM KPi, pH 7.4, 1 mM camphor, 1% MeOH, 1 mM DTT) and dialyzed overnight in 
4 L of KPi buffer B (20 mM KPi, pH 7.4, 50 mM KCl, 1 mM camphor 1% MeOH, 1 mM 
DTT). The dialysate was loaded on a HiTrap Q sepharose FF anion-exchange column 
(60 mL). The protein was eluted with a linear gradient of 0.1–0.4 M KCl in KPi buffer A 
and the brown fractions were collected. The fractions were pooled and concentrated 
by ultrafiltration using a Centricon 3K (Millipore) and injected into a Superose 12 size 
exclusion column pre-equilibrated with KPi buffer C (20 mM KPi, pH 7.4, 150 mM 
KCl, 1 mM camphor, 1% MeOH, 1 mM DTT). Ammonium sulfate crystals were added 
(30% w/v) to the pooled fractions and the sample was stirred for 20 minutes at 4°C. 
Subsequently, the sample was centrifuged for 20 minutes to remove precipitation and 
the supernatant was applied to a HiTrap Phenyl FF hydrophobic column (10 mL). The 
brown fractions containing P450cam were collected after elution with a linear gradient 
30–0% ammonium sulfate in KPi buffer A. Then the fractions were dialyzed overnight 
in 4 L of KPi buffer B. The dialysate was loaded on a HiTrap Q sepharose HP anion-
exchange column (10 mL). The protein was eluted with a linear gradient of 0.1 – 0.3 M 
KCl in KPi buffer A. The fractions with the A391nm/A280nm value greater than 1.2 were 
collected. Approximately, 50 mg of P450cam was obtained from 1 L of culture.
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The [15N] enriched Pdx mutant was produced and purified as previously described.[23] 
The concentration of Pdx was determined with ε412nm = 11.0 mM-1 cm-1. Approximately 
5 mg of Pdx was obtained from 1 L of culture.
Ln3+-CLaNP-7 labeling
Purified double-cysteine P450cam and Pdx samples were incubated with 5 mM DTT 
in 20 mM KPi, pH 7.4, 50 mM KCl, 1 mM camphor, 1% MeOH for 30 minutes on 
ice. DTT was removed by using a PD-10 column. The protein solution was mixed 
with seven molar equivalents of Ln3+-CLaNP-7 and gently stirred overnight at 4°C 
in argon degassed KPi buffer B (without DTT). Unlabeled protein, protein oligomers 
and surplus of Ln3+-CLaNP-7 were removed by three chromatography steps, on a 
HiTrap Q HP anion-exchange column, a HiTrap Phenyl FF hydrophobic column and a 
Superose 12 size exclusion column. The Ln3+-CLaNP-7 incubated sample was filtered 
and loaded on a HiTrap Q sepharose HP anion-exchange column (10 mL). The protein 
was eluted with a linear gradient of 0.1-0.4 M KCl in KPi buffer A (without DTT) and 
the first peak fractions were collected. Ammonium sulfate crystals were added (30% 
w/v) to the pooled fractions and the sample was stirred for 20 minutes at 22°C. 
Subsequently, the sample was centrifuged for 20 minutes to remove precipitation 
and the supernatant was applied to a HiTrap Phenyl FF hydrophobic column (2 mL). 
The brown fractions containing P450cam were collected after elution with a linear 
gradient 30–0% ammonium sulfate in KPi buffer A (without DTT). Finally, the pooled 
fractions were briefly buffer-exchanged and concentrated by ultrafiltration using a 
Centricon 10K (Milliplore) and injected into a Superose 12 size exclusion column pre-
equilibrated with 50 mM Tris-HCl, pH 7.4, 100 mM KCl and 1 mM camphor, 1% MeOH, 
6% D2O. The fractions with A391nm/A280nm larger than 2.1 were pooled and concentrated. 
Approximately, 80–90% of proteins were lost during the labeling procedure possibly 
due to oligomerization and probe-free protein.
NMR samples and experiments
NMR samples contained 50–170 µM [15N] Pdx or [15N] P450cam variants labeled with 
Ln3+-CLaNP-7, in 50 mM Tris-HCl, pH 7.4, 100 mM KCl, 1 mM camphor and 6% D2O. 
2D 15N-1H HSQC and 15N-1H TROSY spectra[24] were recorded at 298 K on a Bruker 
Avance III 600 MHz spectrometer equipped with a TCI-Z-GRAD cryoprobe. In case 
of 3D HNCO experiments, NMR samples contained 70–100 µM [13C, 15N] P450cam 
mutant A labeled with Tm3+/Lu3+-CLaNP-7 with three molar equivalents of Pdx (C73S).
NMR assignment
All NMR data were processed in NmrPipe[25] and analyzed in CCPNMR.[26] The 
assignments for oxidized Pdx amide resonances were based on previous work.[10] 
The partial assignments of the amide resonances for oxidized P450cam were kindly 
provided by Dr. Mathias Hass through personal contact. 
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PCS analysis
PCS measurements were carried out as previously described.[4] The crystal structures 
of P450cam (PDB entry 1DZ4[15]) and Pdx (PDB entry 1XLP[14]) were used to fit the 
experimentally obtained PCS data. The position of the lanthanoid and the Δχ 
tensor describing the anisotropy of the paramagnetic effect were calculated using 
Numbat.[9] 
The correlations between observed and back calculated PCS were expressed in 
a quality factors (Q). It is defined as the ratio of the rmsd between experimentally 
observed and back-calculated data and the rms of the sum of them (Eq. 4).
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back-calculated data and the rms of the sum of them (Eq. 4).
( ) ( ){ }























1. M. Ubbink, Biochem Soc Trans, 2012, 40, 
415-418.
2. P. H. Keizers, B. Mersinli, W. Reinle, J. 
Donauer, Y. Hiruma, F. Hannemann, M. 
Overhand, R. Bernhardt, M. Ubbink, 
Biochemistry, 2010, 49, 6846-6855.
3. W. M. Liu, P. H. Keizers, M. A. Hass, A. 
Blok, M. Timmer, A. J. Sarris, M. Overhand, 
M. Ubbink, J Am Chem Soc, 2012, 134, 
17306-17313.
4. M. A. Hass, P. H. Keizers, A. Blok, Y. Hiruma, 
M. Ubbink, J Am Chem Soc, 2010, 132, 
9952-9953.
5. S. Tripathi, H. Li, T. L. Poulos, Science, 
2013, 340, 1227-1230.
6. W. Zhang, S. S. Pochapsky, T. C. Pochapsky, 
N. U. Jain, J Mol Biol, 2008, 384, 349-363.
7. D. P. Nickerson, L. L. Wong, Protein Eng, 
1997, 10, 1357-1361.
8. I. F. Sevrioukova, C. Garcia, H. Li, B. Bhaskar, 
T. L. Poulos, J Mol Biol, 2003, 333, 377-392.
9. C. Schmitz, M. J. Stanton-Cook, X. C. Su, 
G. Otting, T. Huber, J Biomol NMR, 2008, 
41, 179-189.
10. T. A. Lyons, G. Ratnaswamy, T. C. 
Pochapsky, Protein Sci, 1996, 5, 627-639.
11. S. S. Pochapsky, T. C. Pochapsky, J. W. Wei, 
Biochemistry, 2003, 42, 5649-5656.
12. B. P. Unger, I. C. Gunsalus, S. G. Sligar, J 
Biol Chem, 1986, 261, 1158-1163.
13. N. U. Jain, E. Tjioe, A. Savidor, J. Boulie, 
Biochemistry, 2005, 44, 9067-9078.
14. I. F. Sevrioukova, J Mol Biol, 2005, 347, 
607-621.
15. I. Schlichting, J. Berendzen, K. Chu, A. M. 
Stock, S. A. Maves, D. E. Benson, R. M. 
Sweet, D. Ringe, G. A. Petsko, S. G. Sligar, 
Science, 2000, 287, 1615-1622.
16. P. H. Keizers, A. Saragliadis, Y. Hiruma, M. 
Overhand, M. Ubbink, J Am Chem Soc, 
2008, 130, 14802-14812.
17. P. H. Keizers, J. F. Desreux, M. Overhand, 
M. Ubbink, J Am Chem Soc, 2007, 129, 
9292-9293.
18. G. L. Ellman, Arch Biochem Biophys, 1959, 
82, 70-77.
19. P. W. Riddles, R. L. Blakeley, B. Zerner, 
Methods Enzymol, 1983, 91, 49-60.
20. T. L. Poulos, A. J. Howard, Biochemistry, 
1987, 26, 8165-8174.
21. S. P. Skinner, M. Moshev, M. A. Hass, P. H. 
Keizers, M. Ubbink, J Biomol NMR, 2013, 
56, 401.
22. W. K. Myers, Y. T. Lee, R. D. Britt, D. B. 
Goodin, J Am Chem Soc, 2013, 135, 
11732-11735.
50
Validation and characterization of lanthanoid tags for P450cam...
23. Y. Hiruma, M. A. Hass, Y. Kikui, W. M. 
Liu, B. Olmez, S. P. Skinner, A. Blok, A. 
Kloosterman, H. Koteishi, F. Lohr, H. 
Schwalbe, M. Nojiri, M. Ubbink, J Mol Biol, 
2013, 425, 4353-4365.
24. K. Pervushin, R. Riek, G. Wider, K. Wuthrich, 
Proc Natl Acad Sci U S A, 1997, 94, 12366-
12371.
25. F. Delaglio, S. Grzesiek, G. W. Vuister, 
G. Zhu, J. Pfeifer, A. Bax, J Biomol NMR, 
1995, 6, 277-293.
26. W. F. Vranken, W. Boucher, T. J. Stevens, R. 
H. Fogh, A. Pajon, M. Llinas, E. L. Ulrich, J. 




Validation and characterization of lanthanoid tags for P450cam...

CHAPTER 3
The structure of the cytochrome 
P450cam-putidaredoxin complex 
determined by paramagnetic NMR 
spectroscopy and crystallography
Part of this chapter was published as Hiruma, Y.; Hass, 
M.A.; Kikui, Y.; Liu, W.M.; Olmez, B.; Skinner, S.P.; Blok, A.; 
Kloosterman, A.; Koteishi, H.; Löhr, F.; Schwalbe, H.; Nojiri, M.; 
Ubbink, M. (2013) The Structure of the Cytochrome P450cam-
Putidaredoxin Complex Determined by Paramagnetic NMR 
Spectroscopy and Crystallography, J Mol Biol 425, 4353–4365.
Abstract
Cytochrome P450cam catalyzes the hydroxylation of camphor in a complex process 
involving two electron transfers from the iron sulfur protein putidaredoxin. The enzymatic 
control of the successive steps of catalysis is critical for a highly efficient reaction. The 
injection of the successive electrons is part of the control system. To understand the 
molecular interactions between putidaredoxin and cytochrome P450cam the structure 
of the complex was determined both in solution and in the crystal state. Paramagnetic 
NMR spectroscopy using lanthanoid tags yielded 446 structural restraints that were 
used to determine the solution structure. An ensemble of 10 structures with an RMSD 
of 1.3 Å was obtained. The crystal structure of the complex was solved, showing a 
position of putidaredoxin that is identical to the one in the solution structure. The NMR 
data further demonstrate the presence of a minor state or set of states of the complex 
in solution, which is attributed to the presence of an encounter complex. The structure 
of the major state shows a small binding interface and a metal-to-metal distance of 
16 Å, with two pathways that provide strong electronic coupling of the redox centers. 
The interpretation of these results is discussed in the context of electron transfer. The 
structure indicates that the electron transfer rate can be much faster than the reported 
value, suggesting that the process may be gated. 
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Introduction
Cytochromes P450 (CYP) are heme-containing monoxygeneases, catalyzing 
hydroxylation reactions of a variety of aromatic and aliphatic compounds.[1] The CYP 
superfamily is one of the most extensively studied groups of metalloenzymes, because 
of its importance, for example in steroidal hormone biosynthesis, drug metabolism 
and degradation of xenobiotic compounds in human beings. Approximately four 
thousands CYP genes have been identified and at least fifty seven CYPs have been 
reported in humans.[2] Cytochrome P450cam (P450cam, also called CYP101A1) from 
Pseudomonas putida is the best characterized CYP family member, providing a 
paradigm for CYP structure and function.[3] P450cam catalyzes the regio- and stereo-
specific hydroxylation of D-camphor by using molecular oxygen and two electrons 
from NADH. Putidaredoxin reductase (PdR) oxidizes NADH and transfers the electrons 
to putidaredoxin (Pdx), which shuttles them to P450cam.[3] The two electron transfers 
from Pdx, to the ferric and oxy-forms of P450cam, respectively, differ.[4-5] Ferric 
P450cam is able to accept an electron from diverse reducing agents, whereas oxy-
P450cam is highly specific for Pdx. With other reductants, such as dithionite, oxy-
P450cam generates less than 5% of the maximum amount of hydroxylated camphor.[6-7] 
It has been suggested that in the second electron transfer step Pdx serves as an 
effector molecule for P450cam as well as an electron donor.[6, 8] Thus, understanding 
the interactions between Pdx and P450cam at the atomic level can help to understand 
the catalytic mechanism of this enzyme. Site-directed mutagenesis and calorimetric 
and spectroscopic methods have been applied to study the complex.[4, 9-14] The 
structures of Pdx and P450cam separately have been elucidated.[15-16] For P450cam 
many structures in the closed form have been reported, with various ligands in the 
cavity near the heme but with no obvious substrate access channel. With very large 
ligands, the channel is forced open, as was shown in several crystal structures.[17-18] 
Recently, also the crystal structure of the substrate free form in the open state was 
solved, showing a clear access channel to the active site.[19] 
Solving the structure of the complex with conventional NMR structure determination 
of the complex is challenging, due to its size (58 kDa), as well as the paramagnetic 
nature of the heme and the iron-sulfur cluster, which broadens out many NMR signals. 
Zhang et al. proposed a model of the oxidized Pdx-P450cam complex based on 
NMR restraints. In combination with NMR chemical shift perturbations, they used 
paramagnetic relaxation enhancements (PRE) and residual dipolar couplings (RDC) 
to determine the distances and orientations of the complex.[14] This model has been 
optimized in silico in several studies and used to predict the mechanism of electron 
transfer from Pdx to P450cam.[20-22] It cannot, however, account for all mutagenesis 
results.[23] For instance, it has been reported that the substitution of Arg66 of Pdx 
significantly alters the affinity for P450cam. This residue has been proposed to be the 
key residue to participate in salt bridge formation in the binding interface,[23] which is 
not observed in the model. 
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Paramagnetic NMR techniques offer a new, alternative method for structure 
determination of protein complexes.[20, 24-25] In particular lanthanoid tags provide very 
useful paramagnetic centers. The introduction of such tags at specific sites on the 
protein surface causes paramagnetic effects on the NMR signals of surrounding nuclei, 
both in the same protein and in a bound partner. Due to the very large magnetic 
moment of unpaired electrons, more than 600 times larger than that of protons, the 
interactions with nuclear spins extend to tens of Å, yielding well-defined, long-range 
restraints that can be used for structure determination. The paramagnetic effects 
used in this study are pseudocontact shifts (PCS), PRE and RDC induced by partial 
alignment by the anisotropy of the magnetic susceptibility of the lanthanoid. To obtain 
a high resolution structure, the position of the paramagnetic center needs to be rigid 
and well-defined relative to the protein. It has been demonstrated that double-armed 
lanthanoid tags provide such rigid attachment, which is reflected in large PCS and 
RDC.[26-27] 
Here, we report the structure of the oxidized Pdx-P450cam complex based on a 
set of 446 restraints for structure calculation obtained by using three double-armed 
paramagnetic lanthanoid tags attached to Pdx and P450cam. After the structure had 
been determined, we also solved the crystal structure of the complex. The solution 
structure based on paramagnetic restraints is represented by an ensemble of ten 
structures with an average RMSD from the mean of 1.3 Å for the position of Pdx. 
The crystal structure is identical to the solution structure within the variation of the 
ensemble. These results demonstrate the accuracy of the paramagnetic approach for 
structure determination. The structure shows the details of the molecular interaction 
and suggests two pathways for the electronic coupling between the metal centers. 
The NMR data also provide evidence for a minor state or set of states in solution, 
which could represent the encounter complex.
Results
Protein tagging with lanthanoid probes
To determine the structure of the Pdx-P450cam complex in solution, a set of 
intermolecular distance and orientation restraints were obtained from the effects 
of paramagnetic tags attached to both proteins. The tags were attached to Cys 
residues. To avoid interference, exposed Cys residues at positions 334 on P450cam 
and positions 73 and 85 on Pdx were substituted. These substitutions have been used 
in other studies.[28-29] Other Cys residues are present in both proteins, but these were 
found not to interfere with the tagging. The tag used in this work is a caged lanthanoid 
NMR probe (CLaNP), version 7,[30] which binds covalently to two Cys residues that are 
in close proximity. The two-point attachment of CLaNP-7 ensures a low mobility of the 
probe on the protein surface, and minimal averaging of the paramagnetic effects. Pairs 
of surface exposed cysteine residues were introduced at the proximal side of P450cam, 
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namely K126C/R130C/C334A (mutant A), and A333C/C334A/H337C (mutant B), as 
well as on Pdx, V6C/R12C/C73S/C85S (mutant I). Mutant I is located at the back of 
Pdx, relative to the iron-sulfur cluster but the positions A and B on P450cam are in 
proximity of the potential binding site for Pdx, so to determine whether CLaNP-7 
attached to these sites affects the binding, the dissociation constants for the complex 
with Pdx were determined using calorimetry and were found to be very similar to 
the one for Pdx and WT P450cam (Figure 1), indicating that the CLaNP tag does not 
interfere with complex formation at these locations.
Figure 1. Isothermal titration calorimetry (ITC). The top panels of each graph represent the heat 
release upon titration of Pdx into a solution of P450cam. The bottom panels show the integrated 
areas for the individual peaks plotted against the Pdx / P450cam molar ratios. The errors of KD 
represent the SD derived from the curve fits. (a) Tm3+-CLaNP-7 P450cam mutant A sample. (b) 
Tm3+-CLaNP-7 P450cam mutant B sample. (c) WT P450cam sample.
Intramolecular PCS were measured for P450cam and Pdx linked to CLaNP-7 loaded 
with Yb3+, and used to determine the location of the lanthanoid ion and the orientation 
of principal components of the anisotropy of the magnetic susceptibility (Δχ) tensor (see 
Chapter 2 for details). This information is required in order to use the intermolecular 
PCS as accurate restraints for structure determination. To obtain the restraints, the 
proteins were isotopically labeled with 15N and the resonances of backbone amide 
groups were observed in standard two-dimensional heteronuclear correlation spectra. 
Thus, all NMR restraints are between the tags and backbone amide groups. Pdx was 
also perdeuterated to improve the spectral quality of the Pdx bound to P450cam. 
Assignments for Pdx were based on published data[31] and for P450cam the assignments 
of the oxidized, camphor-bound form were based partly on published assignments[32] 
and extended by comparison with assignments of other forms of P450cam available in 
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the lab (kindly provided by Simon Skinner at Leiden University) and the intramolecular 
PCS measured with Yb3+-CLaNP-7 (see Chapter 2 for details).
Intermolecular paramagnetic effects
Three types of interprotein paramagnetic effects were measured; PRE, PCS and RDC. 
P450cam carrying a CLaNP-7 loaded with a gadolinium ion (Gd3+) induces PRE on 
isotope labeled Pdx. As a control, an identical sample was used with CLaNP-7 loaded 
with a lutetium ion (Lu3+), a diamagnetic lanthanoid. The PRE depends on the inverse 
sixth power of the distance between the Gd3+ and the nucleus, providing sensitive 
intermolecular distance restraints.
Thulium (Tm3+) containing CLaNP-7 induces PCS that depend on the position of the 
nucleus within the frame defined by the Δχ tensor of the lanthanoid. Tm3+ also partially 
aligns the protein complex in solution causing residual dipolar couplings (RDC) that 
report on the orientation of the protein relative to the Δχ tensor. Representative data 
of these three paramagnetic effects are shown in Figure 2. For mutants A, B and I in 
total 509 intermolecular restraints were obtained (Table 1).
Figure 2. Intermolecular paramagnetic effects. 1H-15N correlation spectra of 15N-labeled, 
perdeuterated Pdx in complex with P450cam mutant A tagged with CLaNP-7 containing either 
Lu3+, Gd3+ or Tm3+ illustrate intermolecular PRE (a), PCS (b) and RDC (c). In (b) several PCS are 
indicated by lines. Panel (c) illustrates how the 1H-15N RDC is determined by comparison of 
HSQC and TROSY spectra. The difference in the 15N resonance position between the spectra is 
half the J-coupling for the diamagnetic sample and half the J-coupling plus half the RDC for the 
paramagnetic sample.[33] Spectra were acquired at 14 T (600 MHz).
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Table 1. Intermolecular paramagnetic NMR restraints. The correlations between observed 
and back-calculated data were assessed with Q (Eq. 2).
Sample CLaNP-7 Inter-NMR # restraints Q (closed) Q (open)
P450cam mutant A
(K126C/R130C/C334A)
Gd3+ PRE 60 0.25 0.22
Tm3+ PCS 54 0.03 0.04
RDC 48 0.14 0.15
P450cam mutant B
(A333C/H337C/C334A)
Gd3+ PRE (63)* 0.58 0.44
Tm3+ PCS 43 0.07 0.12
RDC 37 0.34 0.32
Pdx mutant I
(V6C/R12C/C73S/C85S)
Tm3+ PCS 103 0.08 0.08
RDC 101 0.28 0.36
Total 446
*Left out in the calculation of the final ensemble, because these data were strongly affected by a minor 
state (see text).
Structure calculation
The structure calculation of the Pdx-P450cam complex was carried out by Dr. Mathias 
Hass (Leiden University). The top ten lowest energy solutions represent an ensemble 
with an average backbone RMSD of 1.3 (SD = 0.6) Å relative to the mean (Figure 3, 
panel i). A comparison of experimental (red symbols) and back-calculated restraints 
from the ensemble of structures (blue lines in Figure 3a-f for Pdx and Figure 3g-h 
for P450cam) shows that almost all of the PCS and RDC restraints are satisfied. Also 
the PRE-derived distances of mutant A agree well with the experimental data. Only 
mutant B tagged with Gd3+ shows poor correlations between back-calculated and 
experimentally obtained distances (Figure 3, panel f). 
For several stretches of residues stronger PRE were measured than were predicted 
from the ensemble, and these effects are well outside the error margins. The residual 
PREs and their distribution over the Pdx surface are illustrated in Figure 4. 
The PRE is known to be extraordinarily sensitive to lowly populated states for 
cases in which this state experiences a much higher PRE than the ground state. We 
conclude that the determined ensemble represents the major state that occasionally 
visits other conformations where Pdx is closer to the Gd3+-tag at P450cam residues 
333 and 337. It is well established that in electron transfer complexes of weak to 
moderate affinity the encounter state is significantly populated.[34] Thus, we attribute 
the observed dynamics within the Pdx-P450cam complex to an equilibrium between 
the well-defined, ET active state and the encounter state, similar to what was 
described for the ET complex of cytochrome c peroxidase and cytochrome c.[35] It 
cannot be excluded that the CLaNP attached to mutant B in some way induces such 
a minor state. Further research is required to exclude this possibility and to map 
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Figure 3. Violation analysis and solution ensemble of the Pdx-P450cam complex. The PCS (a, d, 
g), RDC (b, e, h) and PRE derived distances (c, f) are plotted against Pdx (a-f) and P450cam (g, h) 
residue numbers. Red circles and blue lines represent experimental and back-calculated effects 
for the ten lowest energy solutions, respectively. For PCS, the error bars are within the circular 
symbols. The panel (a), (b) and (c) represent mutant A, (d), (e) and (f) show the data for mutant B 
and (g) and (h) are for mutant I. The PCS and RDC data were obtained with CLaNP-7 loaded with 
Tm3+ and the PRE data using Gd3+-CLaNP-7. (i) The crystal structure (red) and the top 10 lowest 
energy solution structures (blue) of the oxidized Pdx-P450cam complex are shown in a ribbon 
representation. The Pdx molecules are shown in Cα traces. The overlaid structures represent an 
ensemble with an average backbone RMSD of 1.3 ± 0.6 Å relative to the mean. 
the area sampled by Pdx in this encounter state. The final ensemble of the complex 
was calculated without the PRE restraints from mutant B, because they are strongly 
influenced by the minor state. 
Crystal structure determination
Then, the crystal structure was solved to a resolution of 2.5 Å using mutant A of 
P450cam and Pdx C73S by Dr. Nojiri and co-workers (Osaka University, Japan). 
Curiously, P450cam is present with the access channel to the heme in the open state, 
similar to the substrate free structure of P450cam described by Lee et al.[19] It is 
thought that camphor binding induces P450cam to close the channel,[19] and thus 
the open state is probably due to the absence of camphor and not to presence of 
Pdx in our structure. In the catalytic cycle, Pdx donates an electron to the camphor 
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Figure 4. PRE residuals (∆PRE) were derived by subtracting the back-calculated PREs from the 
experimentally obtained PREs. (a) ∆PRE were plotted against Pdx residue number. Red and 
blue points represent mutant A and mutant B, respectively. (b) Surface representation of Pdx, 
showing the residues affected by Gd3+ attached to mutant B. Pdx residues were color coded 
according to ∆PRE with ≥ 30, red; 20-30, orange; 5-20, yellow; < 5 s-1, blue. Unobserved 
residues are in gray.
bound state only,[23] so it appears counter intuitive that Pdx would induce opening at 
the same time. This point is discussed further at the end of the Discussion session. A 
careful comparison of the Pdx structure in the complex with the reduced and oxidized 
forms of Pdx,[15] suggests that Pdx is in the reduced state in the crystal, which would 
indicate it was reduced by synchrotron radiation, as has been reported for free Pdx 
before.[15] 
Pdx is bound at the proximal side of the heme, in the same orientation as found in 
the solution structure (Figure 5a). An overlay of the backbone of Pdx observed in the 
crystal structure (in red) with those in the solution model (blue) after superposition of 
the P450cam molecules is shown in Figure 3i. It can be seen that the position of Pdx in 
the crystal structure falls within the ensemble observed in solution. The average RMSD 
for the Cα atoms between the mean of the solution structures and the crystal structure 
is 1.7 Å, which is indeed within the variation of the solution ensemble.
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Figure 5. (a) The crystal structure (orange) and the solution structure closest to the mean (gray) 
of the oxidized Pdx-P450cam complex are shown in a ribbon representation with the P450cam 
structures aligned.The positions of Ln3+ ions, Δχ tensors and redox centers of Pdx and P450cam 
are depicted in sticks and spheres. (b) Detail of the interface showing a σA-weighted 2Fo–Fc map 
contoured at 1.0σ. P450cam and Pdx are shown with pink and orange carbons, respectively. 
(c) Detail of the interface showing residues that provide strong electronic coupling between the 
redox centers.
Description of the structure
The backbone structure of Pdx is essentially unchanged upon binding P450cam. The 
orientations of the side chains are expected to be most reliable in the crystal structure, 
because the NMR restraints used in this study were derived from backbone amide 
protons only. However, most of them are in very similar positions and conformations. 
The most striking difference is the orientation of Pdx Tyr33, which is far from P450cam 
in the solution complex, whereas in the crystal structure it makes contact with Asp125 
of P450cam (Figure 5b) and the pyrrolidine ring of Pro122 of P450cam lies parallel 
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to the aromatic ring of Tyr33. Kinetic studies have shown the importance of this Tyr 
residue for the complex formation.[23] Tyr33 is known to be flexible. It is positioned 
in different orientations in the various structures of Pdx[15] and in solution it shows 
dynamics on the μs-ms timescale in oxidized Pdx.[36]
In previous studies, it was suggested that the formation of a salt bridge between 
Pdx Asp38 and P450cam Arg112 plays a vital role in the binding and electron transfer 
in the Pdx-P450cam complex.[9, 13, 37] In the crystal and solution structures the residues 
are very close and a H bond can be formed between Asp38Oδ1 and Arg112Nε 
(2.73 Å, Figure 5c). The Arg residue is also H bonded to one of the heme propionates. 
On the basis of the model of the complex by Zhang et al. Pdx Trp106 has been 
proposed to function as a recognition site in the Pdx-P450cam interaction.[14] In the 
crystal structure, this residue is close to the interface, interaction mostly with P450cam 
Ala113 (Figure 5b). A key residue that seems to stabilize the Pdx-P450cam complex is 
Pdx Arg66, which interacts with P450cam Glu76 by a salt bridge (Table 2). In addition 
to the prominent electrostatic interactions, Pdx-P450cam complex is predominantly 
stabilized by hydrophobic and van der Waals interactions. Table 2 summarizes those 
residues forming close contacts to the neighboring atoms with less than 4 Å apart. 
Val28 of Pdx is positioned in the proximity of Met121 and His361 of P450cam. The 
part of the Pdx [2Fe-2S] cluster loop including Asp38, Cys39, Gly40, Ser42 and Ser44 
interacts with heme-binding loop of P450cam. Another residue suggested to be 
important by the previous study[23] is P450cam Arg109 which forms a van der Waals 
interaction with Pdx Met70.
Table 2. Summary of interacting residues in the Pdx-P450cam binding interface (< 4 Å).
Pdx P450cam
Electrostatic interactions / H-bonds Tyr33 (Oη) Asp125 (Oδ)
Asp38 (Oδ) Arg112 (Nε)
Arg66 (Nη) Glu76 (O)
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Discussion
Here, we conducted three different paramagnetic NMR experiments to obtain 446 
restraints for structural calculations, namely, PCS, PRE and RDC. Tm3+ containing 
CLaNP-7 induces PCS and RDC while Gd3+ containing CLaNP-7 causes PRE. Due 
to the difference in the distance dependency, PRE is known to be more sensitive 
to detect lowly populated states of protein conformations than PCS and RDC.[38] As 
illustrated in the mutant B, the back-predicted PCS agree well with experiment and 
also the distances derived from the crystal structure matched those derived from the 
observed PCS within error, suggesting that PCS data mostly represent the major form 
of the complex. On the other hand, most Pdx residues experienced significantly larger 
PRE than predicted by the major form of the complex. The additional PRE is attributed 
to a minor state or ensemble of states in which Pdx visits sites much closer to the 
location B on the surface of P450cam. The existence of such encounter states has 
been well-documented for complexes of redox enzymes and electron carrier proteins.
[34] It is thought they facilitate ET by reducing the dimensionality of the search for the 
binding site.[34] For mutant A and mutant I no additional PRE was detected, suggesting 
that in the encounter state Pdx mostly faces P450cam with the same face found in the 
final structure is located towards the site of mutation B, but not A. 
A NMR based model of the complex has been reported before by Zhang et al.[14] 
(no PDB entry). The most notable difference between our structure and the model 
proposed by Zhang et al. is the orientation of Pdx with the respect of P450cam. 
Our structure is rotated by about 90° around an axis roughly perpendicular to the 
P450cam heme. As a result, the major part of the interaction network in the binding 
interface differs from the previous model, with the prominent interaction between 
Pdx Asp38 and P450cam Arg112 being a notable exception. Zhang et al. derived 
their model by the combination of 23 RDC orientational restraints and seven PRE 
distances originating from Pdx labeled with a nitroxide spin label at Pdx Cys73.[14] The 
experimental distances between Cys73 and the seven amide groups of P450cam were 
reported and could be compared and a good match was found (Table 3), given the 
uncertainty in the location of the radical due to the considerable rotational freedom 
of the MTSL spin label.
As predicted in the previous studies, extensive hydrophobic interaction networks 
dominate the binding interface.[14] Site-directed mutagenesis studies have highlighted 
the importance of Pdx Trp106 for the complex formation.[11] In our crystal structure, 
the indole ring of Trp106 is located in a hydrophobic pocket formed by carbon atoms 
from Arg106, Arg112, Ala113 and Asn116 of P450cam. Ala113 appears to be the 
prominent interaction residue. It allows the bulky side chain of Trp106 to be inserted 
in the binding interface. Tyr33 of Pdx is another key residue being responsible for the 
complex formation. Notably, NMR studies demonstrated that both Tyr33 and Trp106 
are highly mobile when Pdx is free in solution.[25] The dynamic nature of these residues 
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has also been observed in X-ray crystallography and fluorescence measurements.[15, 39] 
Presumably, when Pdx binds to P450cam, they play a role as recognition motifs and 
facilitate binding that is optimal for ET. 
The shortest distance between the [2Fe-2S] cluster and heme iron in the ensemble 
of solution structures is 15.7 ± 0.4 Å and 16.3 Å in the crystal structure. To establish 
which amino acids contribute most to enhancing the electron transfer between the 
iron-sulfur cluster and the heme, the program HARLEM[40] was used. The results from 
HARLEM suggest two coupling pathways (Figure 5c) involving the Fe1 of the [2Fe-2S] 
cluster and ligand Cys39 of Pdx, and then either via P450cam Leu356 and Cys357 
to the heme Fe or via Pdx Asp38 and P450cam Arg112 and the heme propionate 
to the conjugated heme ring. The latter route is in line with suggestions in previous 
studies.[21, 23, 37] The rate of ET to oxidized P450cam has been reported to be 41 ± 1 s–1 
at 20°C.[23] With the given distance, the maximum, activationless rate is estimated by 
HARLEM to be much larger, on the order of 105 s-1. This implies that the measured rate 
can only represent true electron transfer if the reorganization energy is large (>1.3 eV), 
suggesting that the transfer could be gated. It remains unclear what conformational 
change could represent the gate. 
It is interesting to compare the structures of the Pdx-P450cam complex with that of 
Pdx bound to its other partner, PdR (PDB entry 3LB8[41]). The total buried surface area 
for the PdR-Pdx complex is 1520 Å2, larger than that of the Pdx-P450cam complex 
(1157 Å2). It has been suggested that PdR-Pdx complex formation is driven by one 
central PdR Arg310-Pdx Asp38 salt bridge and extensive hydrophobic interactions. 
An important electron transfer coupling pathway between the FAD group in PdR and 
the [2Fe-2S] cluster in Pdx has been predicted[41] to involve a contact between PdR 
Trp330 and Pdx Cys39, analogous to the Pdx Cys39-P450cam Leu356 contact in the 
Table 3. Comparisons of PRE derived distance restraint.
P450cam residue #
Model of Zhang et al. Our structure
(experimental, Å)a (back-calculated, Å)a (back-calculated, Å)b
230 16.3 14.8 15.4
228 19.2 16.8 16.3
226 17.4 17.2 21.6
85 21.0 21.1 17.8
77 17.7 17.4 13.1
70 21.3 22.9 23.2
67 23.4 26.6 25.9
a Previously reported.[14] b Distances are reported from the nitrogen atom of the lysine side chain that 
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Pdx-P450cam complex. Together, these results suggest that Pdx shuttles electrons 
from PdR to P450cam using the same electron entry and exit patch and with very 
similar interaction modes. 
While this manuscript was under review, Tripathi et al. published the crystal structure 
of the Pdx-P450cam complex that was obtained via cross-linking of the two proteins.[42] 
It is interesting to compare our complex with those reported in that study. Tripathi 
et al. found a position and orientation of Pdx relative to P450cam that is essentially 
identical to ours. Table 4 lists the interface characteristics of the different structures. 
Table 4. Interface propertiesa.
Buried surface area (Å) Gap volume indexb Fraction non-polar atoms
NMR ensemble 
(PDB entry 2M56)c






1323 ± 15 5.4± 0.3 0.30± 0.03
a determined with 2P2Idb[43]; b Gap volume/Buried surface area; measure of the surface complementarity; 
c This work; d average of four models in the asymmetric unit.[42]
The larger variation in the data for the NMR ensemble probably represents the 
uncertainty in the side chain positions, due to the absence of side chain restraints. 
The orientation of some residues in the interface differs between the two structures. 
In particular, P450cam residues Arg109, Asn116 and Leu358 are oriented differently 
(Figure 6). 
In their structure of the reduced complex 2 (PDB entry 4JX1) Arg109 and Asn116 
are hydrogen-bonded to Pdx Gln105 and Trp106, respectively, which is not the case 
in our structure. Arg109 is pointing in another direction, and something similar is 
seen in the other two structures reported by Tripathi et al. (PDB entries 4JWS and 
4JWU), so the exact role of those residues in stabilizing the interaction with Pdx via 
Trp106 need to be established. It may differ for the oxidized and reduced states of 
the complex. This is important because, as indicated by Tripathi et al., the Arg106 is 
located in the C-helix, which could act as a relay between the Pdx binding site and 
the opening of P450cam via the B’ and F and G helices. Tripathi et al. also found that 
P450cam is present in a state that resembles the open state of P450cam, similar to our 
crystal structure. It is not clear whether the open state found in the crystal structures 
is a consequence of crystal packing. In both cases, contacts of the F or G helices with 
neighboring molecules in the crystal are observed, which could imply that only the 
open state of the complex is able to crystallize. We have fitted our NMR data with 
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the open and closed states of P450cam, leading to the same position and orientation 
of Pdx relative to P450cam and the quality of the fit was similar (see Table 1). Further 
NMR experiments that are able to distinguish between the open and closed states 
of P450cam in the complex are required to establish whether Pdx binding causes the 
opening of P450cam also in solution.
In conclusion, this work has shown that paramagnetic NMR spectroscopy is able 
to produce accurate structures of protein complexes in solution. In this case, the 
backbone structure of the free protein was used and treated as a rigid body. Allowing 
for backbone rearrangement upon binding is possible in principle with a more extensive 
dataset. Paramagnetic effects on side chains could also be added to determine details 
of the interface. The advantage of the approach is that the paramagnetic effects in the 
complex can be determined rapidly, using only sensitive two-dimensional experiments, 
such as HSQC and TROSY spectra. This allows application to dilute samples, which is 
especially relevant for complexes of large proteins.
Experimental Section
Chemicals
CLaNP-7 was synthesized and chelated to Lu3+, Gd3+ and Tm3+ ions as reported 
previously.[30] The plasmids harboring the cDNA of Pdx and P450cam were generous 
gift from Prof. Stephen G. Sligar, University of Illinois at Urbana–Champaign, U.S.[44] 
The genes were subcloned into the pET28a expression vectors using NcoI and XhoI 
Figure 6. Overlay of the crystal structures of the oxidized Pdx P450cam complex (pink 
and orange, PDB entry 3W9C) and the reduced state (gray, PDB entry 4JX1).[42]
In their structure of the reduced complex 2 (PDB entry 4JX1) Arg109 and Asn116 are
hydrogen-bonded to Pdx Gln105 and Trp106 r spectively, which is not the case in our
structure. Arg109 is pointing in another direction, and something similar is seen in the
other two structures reported by Tripathi  et al. (PDB entries 4JWS and 4JWU), so the
exact role of those residues in stabilizing the interaction with Pdx via Trp106 need to be
established. It  may differ for the oxidized and reduced states of the complex. This is
important because, as indicated by Tripathi  et al., the Arg106 is located in the C-helix,
which could act as a relay between the Pdx binding site and the opening of P450cam via
the B’ and F and G helices. Tripathi et al. lso f und that P450cam is present in a state
that resembles the open state of P450cam, similar to our crystal structure. It is not clear
whether the open state found in the crystal structures is a consequence of crystal packing.
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Figure 6. Overlay of the crystal structures of the oxidized Pdx P450cam complex (pink and 
orange, PDB entry 3W9C) and the reduced state (gray, PDB entry 4JX1).[42]
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restriction enzymes, without use of the His tag sequence. Column material was 
obtained from GE Healthcare, Munich, Germany. 
Mutagenesis
Site-directed mutagenesis was performed using QuikChange protocol (Stratagene, La 
Jolla, CA).
Protein production
15N, 2H enriched Pdx was produced and purified as previously described[8] with an 
additional purification step. The resuspended cells (20 mM KPi, pH 8.0, 50 mM KCl, 
1 mM DNase, 1 mM PMSF) were disrupted by French-press. Following centrifugation 
at 35000 r.p.m. for 30 minutes at 4°C, the sample was loaded on a HiTrap DEAE 
sepharose FF anion-exchange column. The protein was eluted with a linear gradient 
of 0.1–0.4 M KCl in 20 mM KPi, pH 8.0 and the brown fractions were collected. 
Ammonium sulfate crystals were added (30% w/v) and the solution was stirred for 
20 minutes at 4°C. Subsequently, the sample was centrifuged for 20 minutes to remove 
precipitation and the supernatant was applied to a HiTrap Phenyl FF hydrophobic 
column. The brown fractions containing Pdx were collected after elution with a linear 
gradient 30–0 % ammonium sulfate in 20 mM KPi, pH 8.0. Finally, the pooled fractions 
were briefly buffer-exchanged and concentrated by ultrafiltration using a Centricon 
(Millipore) and injected into a Sephadex G75 size exclusion column pre-equilibrated 
with 50 mM Tris-HCl, pH 7.4, 100 mM KCl and 1 mM camphor. The fractions with 
A325nm/A280nm larger than 0.68 were pooled and concentrated. The concentration of 
Pdx was determined with ε412nm = 11.0 mM-1cm-1.[45] Approximately 12 mg of Pdx was 
obtained from 1 L of culture. Isotopically enriched P450cam variants were produced 
and purified as previously described for the wild type protein.[46] In addition to the 
established purification protocol, a HiTrap Phenyl FF hydrophobic column was used 
at the end of purification procedure to obtain a A391nm/A280nm value greater than 1.40. 
Approximately, 50 mg of P450cam was obtained from 1 L of culture.
Ln3+-CLaNP-7 labeling
Purified double-cysteine P450cam and Pdx samples were incubated with 5 mM DTT in 
20 mM KPi, pH 7.4, 150 mM KCl, 1 mM camphor, for 1 hour on ice. DTT was removed by 
using a PD-10 column. The protein solution was mixed with seven molar equivalents of 
Ln3+-CLaNP-7 and incubated overnight at 4°C. Unlabeled protein, protein oligomers 
and surplus of Ln3+-CLaNP-7 were removed by three chromatography steps, on a 
HiTrap Q HP anion-exchange column, a HiTrap Phenyl FF hydrophobic column and a 
Superose 12 size exclusion column. 
NMR samples and experiments
NMR samples contained 50–100 µM [2H, 15N] Pdx (WT) or [2H, 15N] P450cam (C334A) 
with three molar equivalents of Ln3+-CLaNP-7 labeled P450cam or Pdx mutants, 
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respectively, in 50 mM Tris-HCl, pH 7.4, 100 mM KCl, 1 mM camphor and 6% D2O. 2D 
15N-1H HSQC and 15N-1H TROSY spectra[47] were recorded at 290 K on a Bruker Avance 
III 600 MHz spectrometer equipped with a TCI-Z-GRAD cryoprobe. NMR data were 
processed in NmrPipe[48] and analyzed in CCPNMR.[49]
NMR assignment
The assignments for oxidized Pdx amide resonances were based on previous work.[31] 
For P450cam the assignments of the oxidized, camphor-bound form were based partly 
on published assignments[32] and extended by comparison with assignments of other 
forms of P450cam available in the lab (kindly provided by Dr. Simon Skinner at Leiden 
University) and the intramolecular PCS measured with Yb3+-CLaNP-7 (see Chapter 2 
for details).
Restraint analysis
Gd3+-induced intermolecular PRE (R2,para) were determined as described by Battiste and 
Wagner[50] and converted to restraints as published.[35] The ratios of the peak height, 
Ipara/Idia, of amide signals in the presence of Gd
3+-CLaNP-7 labeled binding partner (Ipara) 
and the corresponding Lu3+-CLaNP-7 labeled protein (Idia) were normalized by dividing 
them by the averaged values of the ten largest Ipara/Idia ratios (0.96, 1.09 and 0.94 for 
P450cam mutant A, P450cam mutant B and Pdx mutant I samples, respectively). PRE 
(R2,para) were converted into distances using Eq. 1:
 
Restraint analysis. Gd3+-induced intermolecular PRE (R2,para) PRE were determined as
described  by Battiste  and  Wagner[50] and  converted  to  restraints  as  published.[35] The
ratios  of  the peak  height,  Ipara/Idia,  of  amide signals  in  the presence  of  Gd3+-CLaNP-7
labeled binding partner (Ipara) and the corresponding Lu3+-CLaNP-7 labeled protein (Idia)
were normalized by dividing them by the averaged values of the ten largest Ipara/Idia ratios
(0.96,  1.09  and  0.94  for  P450cam mutant  A,  P450cam mutant  B  and  Pdx  mutant  I





































where r is the distance between Gd3+ ion and a given amide proton; fbound is the fraction of
the bound 15N protein (fbound = 0.9); flabeled is the fraction of the CLaNP-7 labeled protein
(flabeled = 0.8-0.9); γ is the gyromagnetic ratio of proton; g is the electronic g factor; β is the
Bohr magneton; ωh is the Lamor frequency of protons;  µ0 is vacuum permeablility; S is
spin quantum number for Gd3+ (S = 7/2);  τc is the rotational correlational time of Gd3+-
proton vector. τc was estimated to be 30 ns using HYDRONMR[51] for the Pdx-P450cam
complex. The intermolecular distances were calculated according to Eq. 1 and divided in
three classes of restraints: i) residues with resonance peaks that completely broaden out in
the paramagnetic spectrum. For these residues, only an upper limit of the distance was
calculated.  ii) residues with resonances visible in the paramagnetic spectrum and with
R2,para ≥ 3.0 s–1. Error margins were set to ± 3 Å to accommodate for experimental errors.
iii) residues with R2,para < 3.0 s–1. These residues were considered to be too remote from
the Gd3+ ion to cause a significant PRE and therefore only the lower limit was calculated
and found to be 44 Å for mutant A.
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where r is the distanc  between Gd3+ ion and a given amide proton; fbound is the fracti  
of the bound 15N protein (fbound = 0.9); flabeled is the fraction of the CLaNP-7 labeled protein 
(flabeled = 0.8-0.9); γ is the gyromagnetic ratio of proton; g is the electronic g factor; β is 
the Bohr magneton; ωh is the Lamor frequency of protons; µ0 is vacuum permeablility; 
S is spin quantum number for Gd3+ (S = 7/2); τc is the rotational correlational time of 
Gd3+-proton vect r. τc was estimated to be 30 ns using HYDRONMR[51] for the Pdx-
P450cam complex. The intermolecular distances were calculated according to Eq. 1 and 
divided in three classes of restraints: i) residues with resonance peaks that completely 
broaden out in the paramagnetic spectrum. For these residues, only an upper limit of 
the distance was calculated. ii) residues with resonances visible in the paramagnetic 
spectrum and with R2,para ≥ 3.0 s
–1. Err r margins wer  set to ± 3 Å to accommodate for 
experimental errors. iii) residues with R2,para < 3.0 s
–1. These residues were considered to 
be too remote from the Gd3+ ion to cause a significant PRE and therefore only the lower 
limit was calculated and found to be 44 Å for mutant A.
The quality of fit between observed (Oobs) and back-predicted (Osim) observables 
(PRE, PCS, RDC) was expressed in a Q values, Eq. 2. Note that the sum of observable 
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and back-predicted values is used in the denominator because this makes the Q 
insensitive to the phenomenon that small Oobs with large Osim give larger Q values than 
the other way around, unlike the standard Q with only Oobs in the denominator. 
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PCS, RDC) was expressed in a  Q values, Eq. 2. Note that the sum of observable and
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the phenomenon that small  Oobs with large Osim give larger  Q values than the other way
around, unlike the standard Q with only Oobs in the denominator. 
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Isothermal titration calorimetry. Calorimetric measurements were performed on a VP-
ITC (MicroCal). The sample cell contained 50 µM of CLaNP-7 labeled P450cam mutants
and the injection syringe 1 mM of WT Pdx in 50 mM Tris-HCl, pH 7.4, 100 mM KCl, 1
mM camphor. Titration experiments were carried out at 290 K with 30 injections of 10
µL with 20 sec duration and 350 sec between each injection. The sample was mixed at
351 r.p.m. 
Interface  calculation. The  buried surface  areas  were  calculated  using naccess[52] and
ASA.py,[53] with  similar  results.  For  the  PdR-Pdx  complex  (PDB  entry  3LB8),  the
interface area found by us is much larger than the small area reported,[41] for reasons that
are unclear.
X-ray  crystallography.  Cocrystallization,  data  collection  and  processing  of  Pdx-





Calorimetric measurements were performed on a VP-ITC (MicroCal). The sample cell 
contained 50 µM of CLaNP-7 labeled P450cam mutants and the injection syringe 
1 mM of WT Pdx in 50 mM Tris-HCl, pH 7.4, 100 mM KCl, 1 mM camphor. Titration 
experiments were carried out at 290 K with 30 injections of 10 µL with 20 sec duration 
and 350 sec between each injection. The sample was mixed a  351 r.p.m. 
Interface calculation
The buried surface areas were calculated using naccess[52] and ASA.py,[53] with similar 
results. For the PdR-Pdx complex (PDB entry 3LB8), the interface area found by us is 
much larger than the small area reported,[41] for reasons that are unclear.
X-ray crystallography
Cocrystallization, data collection and processing of Pdx-P450cam complex were 
performed by Dr. Nojiri and co-workers (Osaka University, Japan).
Note: The atomic coordinates of the solution structures and the NMR restraints as well 
as atomic coordinates and structure factors of the crystal structure have been deposited 
in the Protein Data Bank, www.pdb.org (PDB ID codes 2M56 and 3W9C, respectively). 
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CHAPTER 4
Hot spot residues in the 
cytochrome P450cam-
putidaredoxin binding interface
Part of this chapter was published as Hiruma, Y.; Gupta, A.; 
Kloosterman, A.; Olijve, C.; Olmez, B.; Hass, M.A.; Ubbink, M. (2014) 
Hot Spot Residues in the Cytochrome P450cam-Putidaredoxin Binding 
Interface, ChemBioChem 15, 80-86
Abstract
Cytochrome P450cam (P450cam) is a heme containing monooxygenase that catalyzes 
hydroxylation of D-camphor to produce 5-exo-hydroxycamphor. The catalytic cycle 
of P450cam requires two electrons, both of which are donated by a [2Fe-2S] cluster 
containing ferredoxin, putidaredoxin (Pdx). Recently, atomic resolution structures 
of the Pdx-P450cam complex have been solved by X-ray crystallography as well 
as paramagnetic NMR spectroscopy. The binding interface revealed the potential 
electron transfer pathways and interactions between Pdx Asp38 and P450cam Arg112 
as well as hydrophobic contacts between Pdx Trp106 and P450cam residues. Several 
polar residues are found in the interface that had not been recognized to be relevant 
for binding before. In this study, site-directed mutagenesis, kinetic measurements and 
NMR studies were employed to probe the energetic importance and role of the polar 
residues in the Pdx-P450cam interaction. A double mutant cycle (DMC) analysis of 
kinetic data shows that favorable interactions exist between Pdx Tyr33 and P450cam 
Asp125 as well as Pdx Ser42 and P450cam His352. The results show that alanine 
substitutions of these residues and several others do not influence the rates of electron 
transfer. It is concluded that these polar interactions contribute to partner recognition 
rather than electronic coupling of the redox centers.
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Introduction
Cytochrome P450 (P450) is a superfamily of heme-containing monooxygenases that 
participate in a variety of biological metabolisms. From bacteria to humans, P450 
members are found in all kingdoms and at least 15,000 P450 genes have been currently 
reported.[1] The most common reaction that P450 enzymes catalyze is the insertion of 
oxygen atom into a chemically inert organic substrate (R-H + O2 + 2H
+ + 2e ↔ R-OH 
+ H2O). Due to their specificities and efficiencies, P450 enzymes are widely applied 
in industrial fields including bioconversion, bioremediation and biosensors.[2] One of 
the most extensively characterized P450 family members is P450cam (CYP101A1). 
P450cam from Pseudomonas putida catalyzes the regio- and stereo-specific 
hydroxylation of D-camphor. The activation and cleavage of the oxygen molecule 
in the P450cam catalytic cycle is accompanied with two electron transfers (ETs) from 
the physiological ET partner protein, putidaredoxin (Pdx). Pdx shuttles electrons 
between the FAD-containing putidaredoxin reductase (PdR) and the monoxygenase, 
P450cam.[3] Interestingly, ferric P450cam can accept the first electron from diverse 
chemical reductants and Pdx homologues (ET1), but the second (ET2) requires Pdx as 
donor. The stringent requirement for Pdx in ET2 has been explained by the effector 
activity. Pdx not only provides the electron but also causes the start of the catalytic 
reaction.[4-6] However, the underlying mechanism of the effector role of Pdx remains 
under debate. Recently, X-ray crystallography and NMR have uncovered the three 
dimensional structures of Pdx-P450cam complex (see chapter 3 for the details).[7, 8] 
Pdx binds to the proximal surface of P450cam in which the intermolecular distance 
between iron sulfur cluster and heme iron is approximately 16 Å. Compared with the 
previously proposed model of Zhang et al.,[9] Pdx is rotated nearly 90° relative to 
P450cam. The crystal structures of the Pdx-P450cam complex show which residues 
constitute the interface.[7, 8] The functional role of Pdx Trp106 had been recognized as 
early as the 1970’s.[5] In the complex it is in contact with Ala113 of P450cam.[7] Another 
key interaction, between Pdx Asp38 and P450cam Arg112, was confirmed by the 
atomic resolution structures. The potential hydrogen bond between the side chains 
of these residues is thought to be essential for one of the electron transfer coupling 
pathways.[8, 10] Moreover, several other polar residues are found in the interface that 
had not been recognized to be relevant for binding before. For instance, in the crystal 
structures, Pdx Ser42 and Ser44 are positioned in the close proximity to P450cam 
His352 (less than 5 Å). Another potentially important residue, P450cam His361 is 
located at the core of the binding interface. The imidazole side chain of P450cam 
His361 is pointed towards the [2Fe-2S] cluster of Pdx and had previously been 
proposed to be the part of the ET2 pathway.[11] The flexibility of Pdx Tyr33 is vital to 
the interaction of PdR-Pdx complex. Upon binding to P450cam, the side chain of Pdx 
Tyr33 adapts a rigid configuration and forms a hydrogen bond to P450cam Asp125. 
In this study, site-directed mutagenesis, kinetics and NMR studies were employed 
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to further probe energetic importance and role of the polar residues involved in 
Pdx-P450cam interaction. Our experimental results indicated that turnover rates of 
ET remain intact upon the substitution of these residues by alanine. However, the 
mutations influence the dissociation rates and binding affinities of the Pdx-P450cam 
complex. The relevance of the work for understanding the effector activity of Pdx 
binding will be addressed in discussion. 
Results
Previous mutagenesis studies highlighted that the key residues in the formation of 
the Pdx-P450cam complex and ET include Pdx Asp38, Arg66, Trp106 and P450cam 
Arg109 and Arg112.[11, 12] The crystal structures of Pdx-P450cam complex revealed 
a number of other residues that exhibit close contacts (< 4Å) in the interface and 
participate in polar interactions.[7, 8] To characterize the contributions of residues, Pdx 
Ser42 and Ser44 and P450cam His352 and His361 were substituted to alanine. In 
addition, Pdx Y33A and P450cam D125A constructs were prepared. These residues 
are not found in the core but on the rim of the binding interface, yet were predicted 
to be important in partner recognition.[8, 11] Figure 1 illustrates the mutation sites used 
in this study.
To investigate the effects of the mutations on the ET1 reaction, pre-steady state 
kinetics were studied by stopped-flow spectrophotometry. As described in the early 
studies,[13, 14] the rate of ET1 can be derived from the rate of formation of carbon 
Figure 1. The crystal structure of the Pdx-P450cam complex (PDB entry, 3W9C)[8] is shown in a 
ribbon representation. The residues substituted by alanine and the heme are labeled and shown 
in sticks. The [2Fe-2S] cluster is represented in spacefill. 
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monoxide (CO) bound ferrous P450cam (P450camred-CO). Equation 1 shows the model 




To investigate the effects of the mutations on the ET1 reaction, pre-steady state kinetics
were studied by stopped-flow spectrophotometry. As described in the early studies, the
rate of ET1 can be derived from the rate of formation of carbon monoxide (CO) bound















The Soret absorption maximum at 447 nm of P450camred-CO was monitored for reactions
with increasing concentrations of reduced Pdx (Pdxred). The reverse ET reaction of Pdx is
neglected because k2[CO] » k-ET1. The reaction can be described by a rapidly established
binding/dissociation equilibrium and a slow ET reaction.  Thus,  ten milliseconds after
mixing, a steady state condition is valid for Pdxred-P450camox, and its concentration can























By varying the [Pdx],  KD and  kET1 can be fitted.  The first  points of the stopped-flow




To investigate the effects of the mutations on the ET1 reaction, pre-steady state kinetics
were studied by stopped-flow spectrophotometry. As described in the early studies, the
rate of ET1 can be derived from the rate of formation of carbon monoxide (CO) bound















The Soret absorption maximum at 447 nm of P450camred-CO was monitored for reactions
with increasing concentrations of reduced Pdx (Pdxred). The reverse ET reaction of Pdx is
neglected because k2[CO] » k-ET1. The reaction can be described by a rapidly established
binding/dissociation equilibrium and a slow ET reaction.  Thus,  ten milliseconds after
mixing, a steady state condition is valid for Pdxred-P450camox, and its concentration can























By varying the [Pdx],  KD and  kET1 can be fitted.  The first  points of the stopped-flow
curves,  before  the steady state  of  the intermediate  is  established,  contain information
99
  (1)
The Soret absorption maximum at 447 nm of P450camred-CO was monitored 
for reactions with increasing concentrations of reduced Pdx (Pdxred). The reverse ET 
reaction of Pdx is neglected because k2[CO] » k-ET1.
[14] The reaction can be described 
by a rapidly established binding/dissociation equilibrium and a slow ET reaction. Thus, 
ten milliseconds after mixing, a steady state condition is valid for Pdxred-P450camox, 
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Because kET1 « koff, kon·[Pdx], eq ation (2) can be written as:
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By varying the [Pdx], KD and kET1 can be fitted. The first points of the stopped-
flow curves, before the steady state of the intermediate is esta lished, contain 
information about the rate of formation of the Pdxred-P450camox complex. Therefore 
the reaction curves were simulated numerically to extract the values of kET1, KD and 
koff (Figure 2).
The circles in Figure 2A represent the experimental datasets of P450cam H352A 
for a range of concentrations of Pdxred. The curves were simulated globally to extract 
the kinetic parameters. Figure 2B shows the simulated c ncentrations for all species as 
function of reaction time for [Pdx] = 2.5 μM, as an example. Note the subtle biphasic 
behavior representing the pre-steady state and steady state phases of the reaction. 
The koff values are derived from the first few time points, limiting their precision, 
whereas those of kET1 and KD are derived from the steady state phase and are better 
defined. The kon was calculated from the KD and koff values (KD = koff / kon). Table 1 
summarizes kET1, KD, kon and koff for the WT and mutant complexes. 
Figure 2C shows the simulated kobs values, obtained from an exponential fit of the 
simulated [P450camred-CO] as a function of time to present the results in a familiar 
way. An advantage of the numerical simulation is that no steady-state assumption is 
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Figure 2. Analysis of ET1 reaction by stopped-flow spectrophotometry. A) A447 is plotted as a 
function of the reaction time for several Pdxred concentrations. The kET1 curves were simulated 
numerically to obtain koff and KD. B) The simulated concentrations of all species as function of 
time for the curve of [Pdx] = 2.5 μM are plotted. C) 
about  the  rate  of  formation  of  the  Pdxred-P450camox complex.  Therefore  the  reaction
curves were simulated numerically to extract the values of kET1, KD and koff (Figure 2).
Figure 2. Analysis of ET1 reaction by stopped-flow spectrophotometry. A) A447 is plotted
as a function of the reaction time for several Pdxred concentrations. The kET1 curves were
simulated  numerically  to  obtain  koff and KD.  B)  The  simulated  concentrations  of  all
species as function of time for the curve of [Pdx] = 2.5 µM are plotted. C) simobsk  was
100
 was plotted against concentration of 
Pdxred for the WT and mutant proteins. The labels indicate the Pdx and P450cam WT or variants, 
respectively. The simulated kobs values were obtained by an exponential fit of the simulated 
curves for the [P450camred-CO], as shown in panel B. The lines connect the positions to guide 
the eye. The stopped flow measurement was carried out by 1:1 mixing of 2 μM P450camox and 
5–150 μM Pdxred at 22°C in CO saturated 50 mM Tris-HCl buffer, pH 7.4, containing 100 mM KCl, 
1 mM camphor, 1 mM glucose and an oxygen-scrubbing system.
made. With this assumption the binding and dissociation are taken to be so fast that 
a steady state is reached for the Pdxred-P450camox species within the dead time of the 
stopped-flow apparatus. In that case, the absorption changes for the formation of 
the P450camred-CO species obey simple exponential behavior, yielding the classical 
kobs. For low Pdx concentrations, the simulated kobs values deviate from this kobs.
Also no pseudo first-order assumption ([Pdx] » [P450cam]) needs to be made. The 
simulations show that for low [Pdx] this condition is not met, which slightly influences 
the rates obtained.
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The kET1 value of wild type (WT) complex was determined to be 42 ± 1 s
-1, which 
corresponds to the previously reported value of 41 ± 1 s-1.[11] Compared to WT complex, 
kET1 values of Pdx and P450cam variants remain intact. In contrast, KD values for Pdx 
Y33A and S42A mutants were 20–30-fold higher than for WT (see Table 1). The koff values 
of these variants were one order of magnitude higher, indicating that the substitution of 
Pdx Tyr33 and Ser42 alter the binding affinity rather than ET1. The mutations of P450cam 
Asp125 and His352, which form hydrogen bonds to Pdx Tyr33 and Ser42, respectively, 
result in modest changes of KD with four to eight fold increase. To investigate the 
extent of the interaction of Tyr33(Pdx)–Asp125(P450cam) and Ser42(Pdx)–His352(P450cam), double-
mutant cycle (DMC) analysis was performed. The free energy of interaction, ∆∆Gint 
(see Experimental Procedures, eq. 6),[16] between the residue pairs was calculated to 
be –4.2 kJ/mol and –3.7 kJ/mol for Tyr33(Pdx)–Asp125(P450cam) and Ser42(Pdx)–His352(P450cam), 
respectively. Since the experimental error of ∆∆Gint for this system was calculated to be 
±1.0–1.7 kJ/mol, both cases indicate significant favorable interactions. 
Having established the effect of mutations on the ET1 process, we examined the 
steady state kinetics of NADH oxidation. Camphor turnover activity of P450cam is 
known to be tightly coupled with two ET events (ET1 and ET2). Since the ET steps 
are rate limiting in the P450cam reaction cycle,[14] the catalytic turnover was measured 
by the NADH consumption rate in the PdR-Pdx-P450cam reconstituted system as 
previously described.[17] In this assay, Pdx is kept in the reduced state by ensuring 
[PdR] » [P450cam]. The spectral changes at 340 nm, indicative of NADH oxidation, 
were used to determine the steady state P450cam turnover rate. To minimize the 
contributions of the binding affinities to the ET rates, the concentration of Pdx was 
100 μM, which is above the KD values determined in the stopped-flow experiments. 
As shown in Table 3, the catalytic turnover of WT(Pdx)-WT(P450cam) complex was found 
Table 1. Kinetic parameters of ET1. The reaction conditions were the same as given in the 
caption of Figure 2.
Pdx P450cam kET1 (s
-1) KD (μM) kon (10
7 M-1s-1) koff(10
2 s-1)
WT WT 42 ± 1 2.2 ± 0.2 3.6–11.4 0.8–2.5 
Y33A WT 40 ± 1 50 ± 5 6–8 30–40
S42A WT 42 ± 2 55 ± 8 5.5–7.5 30–41 
S44A WT 42 ± 1 6 ± 0.5 6.7–11.7 4–7
WT D125A 36 ± 2 9 ± 0.5 5.6–11.1 5–10
WT H352A 42 ± 2 16 ± 2 5.6–10.6 10–19
WT H361A 35 ± 3 11 ± 2 7–13 7–12
Y33A D125A 42 ± 1 38 ± 2 2.6–5.3 10–20
S42A H352A 42 ± 2 90 ± 10 2.2–5.6 20–50
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to be 38.2 ± 0.2 s-1, which is close to the reported value of 35.9 ± 1.1 s-1.[17] Similar 
values were measured for all mutant complexes (Table 2). On the basis of equation (3), 
the maximum turnover at [Pdx] = 100 μM (kmax) can be predicted assuming ET1 is the 
rate limiting step.[11] The results indicate that the effect of the mutations is solely on 
binding affinity and that the ET steps are not affected significantly. 
Table 2. The steady state turnover activities of P450cam catalytic cycle. NADH consumption 
rates were monitored at 340 nm at 22°C.The reaction mixture contained 0.05 μM P450cam, 
100 μM Pdx, 1.0 μM PdR and 400 μM NADH in 50 mM Tris-HCl buffer, pH 7.4, consisting 
of 100 mM KCl and 1 mM camphor.
Pdx P450cam kmax NADH consumption (s
-1) relative to WT-WT (%)
WT WT 41.1 38.2 ± 0.2 100
Y33A WT 26.7 34.9 ± 2.5 91
S42A WT 27.1 34.1 ± 0.7 89
S44A WT 39.6 37.4 ± 0.6 98
WT D125A 33.0 40.3 ± 0.7 106
WT H352A 36.2 36.3 ± 0.6 95
WT H361A 31.5 34.1 ± 0.4 89
Y33A D125A 30.4 26.3 ± 0.3 69
S42A H352A 22.1 17.9 ± 0.6 47
The mutations Y33A and S42A resulted in a large decrease of the affinity of Pdx 
for P450cam. To address the question of why these mutants significantly perturb 
the binding mode, NMR 15N HSQC spectra (Figure 3A) were recorded of all the Pdx 
mutants and compared to the Pdx WT to see if the mutation caused substantial 
structural changes. The differences of the chemical shifts between Pdx mutants and 
WT (in absence of P450cam) were evaluated using the average of chemical shift 
differences (∆δavg) (Figure 3C–E).
The NMR spectra of both Pdx S42A and S44A variants overlapped well with Pdx 
WT without significant ∆δavg (Figure 3A, D, E), indicating that they are not structurally 
different. It is noted that NMR signals of the amide of residues 36-50 are broadened 
beyond detection because they are close to the paramagnetic [2Fe-2S] cluster in Pdx 
(Figure 3C–E). In the NMR spectrum of Pdx Y33A several peaks were shifted when 
compared to the spectrum of Pdx WT (Figure 3A). The ∆δavg values shown in Figure 3C 
were mapped on the crystal structure of Pdx (PDB: 1XLP)[18], Figure 3B. The large values 
of ∆δavg were observed not only the residues directly adjacent to the mutation site but 
also extended to spatially neighboring residues. Pdx residue Asp103, in particular, 
was not found in the spectrum, possibly due to its large chemical shift change or its 
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extensive line broadening. Taken together, we conclude that the structure of Pdx Y33A 
mutant is likely to be altered by mutation, which may contribute to the reduction of 
the affinity for P450cam.
Discussion
The structure of the Pdx-P450cam complex provided molecular insight into the 
ET pathway and effector role of Pdx (see chapter 3 for the details).[7, 8] In this work, 
mutagenesis was employed to examine the importance of several polar interface 
residues highlighted by the structure of the complex. Most of these had not been 
considered to be important before the structure was available.
Figure 3. NMR chemical shift perturbation analysis of Pdx mutants. A) Overlaid HSQC spectra. 
Cyan, red, blue and green resonances represent Pdx WT, Y33A, S42A and S44A variants, 
respectively. Arrows indicate the largest chemical shift changes observed for Pdx Y33A. B) Ribbon 
representation of Pdx (PDB entry, 1XLP) colored according to the ∆δavg values of Y33A with ∆δavg 
≥ 0.10 and Asp103, red; 0.10 > ∆δavg ≥ 0.05, orange; 0.05 > ∆δavg ≥ 0.03, yellow; 0.03 > ∆δavg, 
blue and no data, gray. C–E) ∆δavg was plotted against Pdx residue number for Pdx Y33A C), Pdx 
S42A D) and Pdx S44A E).
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Stopped-flow studies indicated that most of the mutations do not influence 
the rate of ET1 reaction. This is in line with the suggestions in the previous study 
(chapter 3), where the ET pathways were predicted by the program HARLEM.[8] None 
of the residues studied in this report are directly involved in the suggested ET1 
pathways. However, Pdx Y33A and S42A substitutions lower the binding affinity by 
20–30 fold. Pdx Tyr33 is located at the beginning of the loop region that surrounds 
the [2Fe-2S] cluster (Figure 3B). An NMR study demonstrated that Tyr33 is mobile on 
the Pdx surface and occupies several conformational states on the μs–ms timescale.[19] 
The result of our NMR data indicated that the substitution of Tyr33 with alanine 
changes the structure of the loop region, which transmits to distant residues of Pdx, 
including Asp103. The functional role of Tyr33 has been recognized in the binding of 
Pdx both to PdR and P450cam.[8, 20] The DMC analysis indicated that Pdx Tyr33 has a 
favorable interaction with P450cam Asp125. As illustrated in the crystal structures of 
the complex,[7, 8] Pdx Tyr33 adapts a rigid configuration upon P450cam binding and 
forms a hydrogen bonding to P450cam Asp125. Pdx Ser42 and Ser44 are positioned 
adjacent to the [2Fe-2S] cluster (Figure 1) and are part of the polar interactions 
within the interface. In the DMC analysis, Pdx Ser42 was shown to have a favorable 
interaction with P450cam His352. The chemical shift perturbation analysis showed 
that the structure of Pdx S42A mutant is similar to Pdx WT, suggesting that the side 
chain of Ser42 make a major contribution to the interaction. P450cam His361 is 
located at the proximal site of heme-binding loop and is in close vicinity to Cys357, 
the axial ligand of the heme iron. A previous mutagenesis study demonstrated that 
substitution of the adjacent residue Gln360 with glutamate causes the KD to increase 
with 25-fold and the kET1 to decrease with 5-fold.
[12] Moreover, a computational 
study predicted that along with Gln360, His361 is a part of the ET2 pathway.[11] The 
stopped flow measurements on P450cam H361A resulted in the small reduction of 
the binding affinity and ET1 rate, which suggests that P450cam His361 plays a minor 
role in ET.
To investigate if the mutations influence the overall ET (ET1+ET2), the catalytic 
turnover activity of P450cam was monitored by measuring the NADH consumption 
rate. In accord with the results of the ET1 reaction, all Pdx and P450cam mutants 
exhibit a turnover rate close to that of WT (considering the higher KD in some cases). 
It is concluded that the polar interactions in the Pdx-P450cam interface studied here 
contribute to the complex formation rather than ET reactions.
In this work, the polar residues that were targeted for the substitution were 
established on the basis of the crystal structures of Pdx-P450cam complex. In the 
structures, P450cam is found in open[7] and semi-open conformation (see chapter 3 
for the details).[8] The authors of reference[7] interpreted this finding to implicate that 
Pdx forces P450cam into the open state upon binding and related this to the effector 
activity. The authors of reference[8] suggested the open state may be a crystallization 
effect. A very recent study employing double electron-electron resonance (DEER) 
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spectroscopy provide evidence showing that P450cam adapts a closed conformation 
in the ET events in solution.[21] To evaluate the changes in the binding interface with 
the conformational state of P450cam, the crystal structures of Pdx-P450cam complex 
(PDB entries, 3W9C, 4JX1 and 4JWS)[7, 8] were superimposed with the closed state of 
free P450cam (PDB entry, 1DZ4),[22] as shown in Figure 4. 
The crystal structures of both the oxidized (3W9C[8] and 4JWS[7]) and dithionite 
reduced, CO bound (4JX1[7]) Pdx-P450cam complex have been reported. However, 
the actual redox state of the metals is difficult to establish in the crystal because the 
metals are probe to reduction by X-ray radiation.[18]
The comparison reveals that majority of the prominent interactions in the binding 
interface changes only very subtly between the different P450cam conformations 
(open, semi-open and closed). The hydrogen bond between Asp38(Pdx)–Arg112(P450cam), 
Figure 4. Superimposed structures of Pdx-P450cam complex. Gray, purple, yellow and cyan 
represent the oxidized complex (PDB entry, 3W9C), the closed conformation of P450cam (1DZ4), 
the reduced, cross-linked Pdx-P450cam complex with camphor bound (4JX1) and oxidized, 
cross-linked Pdx-P450cam complex (4JWS), respectively.
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important for ET, remains intact. The minimal distance between Pdx Trp106 and 
P450cam A113 is only slightly larger in the model of the complex of Pdx with the closed 
state of P450cam than in the ox-ox complex (4.4 Å vs. 3.8 Å in 3W9C). The H-bond 
between the Pdx Tyr33 and P450cam Asp125 is also present in both these complexes. 
Only the P450cam His352 is significantly further from Pdx Ser42 (5.5 Å vs. 4.2 Å). 
Given that the complex of the closed state with Pdx bound is not a crystal structure 
but a superposition, these differences can be considered small and it is reasonable 
to assume that Pdx is capable to bind both closed and open conformational states of 
P450cam. Thus, we believe it is plausible that the open/closed state of the complex is 
influenced by the crystal packing effects, as we suggested before (see chapter 3)[8] and 
was also concluded by Myers et al.[21] This implies that the question of what represents 
the effector activity remains open. Various suggestions have been made. The classic 
model of a “push” effect suggests that Pdx binding is physically transmitted to the 
heme-binding loop of P450cam and accelerates ET by influencing the axial thiolate 
ligand of heme iron.[23] Another mechanism suggested by Asciutto et al. involves 
cis/trans isomerization of the Ile88–Pro89 peptide bond of P450cam.[24] Upon the 
complex formation, the structural perturbation in the Pdx binding site mechanically 
conveys to remote regions of P450cam, which leads to the closure of the substrate 
access channel. The substrate is thereby trapped in the active site of P450cam, which 
minimizes the solvation of the substrate and the diffusion of physiologically harmful 
peroxide intermediates.[24] Structural studies of the complex in solution using NMR 
spectroscopy can complement the frozen solution (EPR) and crystal studies (X-ray 
diffraction) and may be able to shed more light on the issue.
In conclusion, mutagenesis studies presented in this report show the importance 
of the interactions of the polar residues in the Pdx-P450cam interface. These polar 
interactions were found to be important in the partner recognition, rather than in ET. 
Experimental procedures
Cloning
The plasmid harboring the cDNA of PdR was purchased from GeneArt®, Life 
technologies (Invitrogen). The gene was designed to be subcloned into the pET28a 
expression vector by introducing NcoI and XhoI restriction sites. A His tag sequence 
was not included. The pET28a vectors containing cDNA of Pdx and P450cam were 
prepared as described in chapter 3.[8] Pdx Y33A, Pdx S42A, Pdx S44A, P450cam 
D125A/C334A, P450cam H352A/C334A and P450cam H361A/C334A constructs 
were prepared by following the Quikchange® site-directed mutagenesis protocol 
(Stratagene, La Jolla, CA). The cysteine of P450cam at position 334 was substituted 
with alanine. The C334A mutation has been reported to prevent the dimerization of 
the protein and retain the catalytic turnover activity.[17] P450cam C334A was treated 
as WT in this report.
84
Hot spot residues in the cytochrome P450cam-putidaredoxin binding interface
Protein production
All Pdx and P450cam variants were produced as described in chapter 3.[8] The gene 
expression and purification of PdR was performed by following the previous report with 
several modifications.[25] Briefly, pET28a plasmid harboring PdR gene was transformed 
into the BL21 Star™ (DE3) chemically competent E. coli strain (Life technologies, 
Invitrogen). Single colonies were picked and inoculated into 5 mL LB medium with 
50 μg/mL kanamycin at 37°C for 4 hours. Two mL of pre-culture was transferred into 
500 mL LB medium with 50 μg/mL kanamycin and incubated at 37°C until A600nm = 
0.6–0.7. Gene expression was induced by adding 0.5 mM IPTG. The cultures were 
incubated at 22°C for 40–50 hours. Cells were resuspended in a KPi buffer (20 mM KPi, 
pH 8.0, 150 mM KCl, 1 mM DTT, 1 mM PMSF and 1 mM DNase). Samples were flash 
frozen in N2 (l) and stored at –80°C. 
The resuspended cells were defrosted rapidly at room temperature. A few mg 
of crystals of lysozyme were added and the sample was stirred for 30 minutes at 
22 °C. The lysate was further disrupted by French-press and sonication and spun down 
by centrifugation at 35000 r.p.m. for 30 minutes at 4°C. The pH of supernatant was 
adjusted to ~7.5 by addition of a few drops of KOH. Ammonium sulfate powder was 
added slowly to the sample to 30% (w/v). The sample was then stirred in cold room 
for 30 minutes. Following centrifugation at 35000 r.p.m. for 30 minutes at 4°C, the 
supernatant was dialyzed overnight against 4 L of KPi buffer A (20 mM KPi, pH 7.5, 
1 mM DTT). The dialysate was loaded on a HiTrap DEAE FF anion-exchange column 
(60 mL). The protein was eluted with a linear gradient of 0.1-0.3 M KCl in KPi buffer A 
and the yellow fractions were collected. The fractions were pooled and concentrated 
by ultrafiltration using a Centricon 3K (Millipore) and injected into a Superose 12 size 
exclusion column pre-equilibrated with KPi buffer B (20 mM KPi, pH 7.4, 150 mM KCl, 
1 mM DTT). Ammonium sulfate crystals were added (30% w/v) to the pooled fractions 
and the sample was stirred for 20 minutes at 4°C. Subsequently, the sample was 
centrifuged for 20 minutes to remove precipitation and the supernatant was applied 
to a HiTrap Phenyl FF hydrophobic column (10 mL).The yellow fractions containing 
PdR were collected after elution with a linear gradient 20–0% ammonium sulfate in 
KPi buffer A. The fractions with the A280nm/A455nm value below 7.0 were collected. Then 
the fractions were pooled and dialyzed overnight against 4 L of KPi buffer B. The 
concentration of PdR was calculated using extinction coefficient of 11.0 mM-1cm-1 at 
455 nm wavelength.[26] Approximately 30 mg of PdR was obtained from 1 L of culture.
Stopped flow spectrophotometry assay
Stopped flow experiments were performed on SX-18MV Microvolume Stopped-Flow 
Spectrofluorometer (Applied Photophysics). D-glucose (1 mM) and 1 unit/mL (final 
concentration) of oxygen scrubbing proteins, glucose oxidase and catalase were added 
to Tris buffer C (50 mM Tris-HCl, pH 7.4, 100 mM KCl, 1 mM camphor, 1% MeOH) and 
made anaerobic by flushing argon and subsequently carbon monoxide (CO) gases for 
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20 minutes each. Immediately prior to experiment, NADH was added to Pdx reaction 
mixtures and incubated for a few minutes at room temperature. Final reaction mixtures 
contained 5–150 μM Pdxred, 0.1 μM PdRred, 400 μM NADH and saturated level of CO, 
whereas the P450cam reaction mixture contained 2 μM P450camox and CO. The 
absorption at 447 nm wavelength was monitored for one second at 22°C. 
DMC analysis
The dissociation constant (KD) relates to the difference in free energy between bound 
and unbound states, equation (4)
	 ∆GB = RT ln KD  (4)
The difference in ∆GB caused by a substitution of a residue by alanine (∆∆GB) is 
calculated by equation (5)
	 ∆∆GB = RT ln (KDmut / KDWT) (5)
where KD
mut and KD
WT are the dissociation constants of the Pdx and/or P450cam mutants 
and WT complex, respectively. The free energy of interaction (∆∆Gint) between two 
residues equals to: 
	 ∆∆Gint = ∆∆GBmut, mut(Pdx, P450cam)– ∆∆GBmut(Pdx) – ∆∆GBmut(P450cam) (6)
where ∆∆GBmut, mut(Pdx, P450cam)represents ∆∆GB of P450cam and Pdx variants derived from 
equation (5). A negative value of ∆∆Gint indicates that the interaction between the 
mutated residues is attractive whereas a positive value of ∆∆Gint suggests a repulsive 
interaction.[16]
NADH consumption rates
All of the P450cam WT and variants were exchanged into Tris buffer C by Superprose 12 
size exclusion column immediately before each experiment. The NADH consumption 
rates were measured on Perkin Elmer Lambda 25 spectrophotometer as described 
by Nickerson and Wong.[17] Briefly, 400 μM of NADH (final concentration) was added 
to 0.2 mL reaction mixture containing 0.05 μM P450cam, 100 μM Pdx, 1.0 μM PdR to 
initiate the reaction. The absorption at 340 nm was monitored for 180 s at 22°C. The 
catalytic turnover of NADH oxidation was determined from the slope of a linear region 
in the plot of A340 vs. time. The concentration of NADH was estimated using extinction 
coefficient of 6.22 mM-1cm-1 at 340 nm.
NMR
Approximately 1 mM of 15N Pdx WT and variants were prepared in Tris buffer C with 
6% D2O for lock. All NMR samples were measured on a Bruker Avance III 600-MHz 
spectrometer equipped with a TCl-Z-GRAD cryoprobe at 298 K. 15N HSQC spectra 
were processed with NMRPipe[27] and analyzed by CCPNMR.[28] The NMR assignment 
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of Pdx amide resonances were based on previous work.[29] Chemical shift perturbations 
(CSP average) were analyzed as previously described.[30]
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CHAPTER 5
Paramagnetic NMR analysis 
reveals the encounter state of the 
Pdx-P450cam complex
Abstract
The physiological complex of putidaredoxin (Pdx) and cytochrome P450cam (P450cam) 
is a paradigm for the electron transfer process of the P450 superfamily. In this project, 
we have determined the major and minor states of Pdx-P450cam complex by using 
three different types of paramagnetic NMR techniques. The results of pseudocontact 
shifts and residual dipolar couplings support the previously determined structures of 
the complex. On the other hand, the distance restraints derived from paramagnetic 
relaxation enhancements (PREs) showed the significant deviations from the expected 
values. We performed PRE analysis at multiple positions of Pdx and P450cam and 
concluded that small fractions of the complex exhibit dynamic nature of the interactions. 
Our finding of the encounter complex provides the insight of the specificity of protein-
protein interaction and the efficiency of electron transfer in Pdx-P450cam complex.
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Introduction
Recently, the concept of encounter complex has gained attention to describe protein–
protein complex formation. It is an intermediate stage in the binding process in 
which proteins adapt multiple orientations to search for the specific binding site on 
the protein partner. This transient state of the protein complex often exists only as a 
small fraction compared with the large population of free proteins and final complex.
[1] Therefore, it was technically challenging to study such a lowly populated state 
of the complex in a sample. However, recent development of paramagnetic NMR 
analysis,[1] flash photolysis[2] as well as double-mutant cycles in the combination of 
kinetics[3] have opened up possibilities to study the nature of encounter complex. The 
biological function of encounter complex is thought to accelerate the formation of the 
final complex by reducing the dimensionality of the search of specific binding site.[1] 
The encounter complex is particularly well-documented in the complex formation of 
electron carrier proteins where rapid ET and sufficient specificity of the protein-protein 
interaction are required to achieve high turnover rate of the complex.[1]
In Pseudomonas putida, putidaredoxin (Pdx) and cytochrome P450cam (P450cam) 
form a redox complex in the camphor hydroxylation reaction. Pdx shuttles electrons 
from putidaredoxin reductase (PdR) to P450cam, which in turn acts as a terminal 
oxygenase to catalyze regio- and stereo-specific hydroxylation of D-camphor.[4] 
Recently, the atomic resolution structure of Pdx-P450cam complex has been solved 
by X-ray crystallography as well as paramagnetic NMR analysis (see Chapter 3).[5-6] 
The binding interface of Pdx and P450cam is dominated by hydrophobic contacts 
and polar interactions, including the prominent hydrogen bond between Pdx Asp38 
and P450cam Arg112.[5-6] As suggested in previous studies, Pdx was found to interact 
with P450cam and PdR with the same interface.[5-8] A mutagenesis study showed that 
surface exposed Tyr33, Arg66 and Trp106 of Pdx are primarily involved in partner 
recognition.[9] Interestingly, they exhibit large mobility on protein surface when Pdx 
is not bound to redox partners.[10] As previously proposed for the PdR-Pdx complex 
formation,[8] the interaction between Pdx and P450cam is most likely facilitated by Pdx 
searching for the steric complementarity on the P450cam surface area. Upon reaching 
the optimal binding geometry, the mobility of the bulky side chains is reduced by 
specific interactions with P450cam or ordered water molecules in the interface. 
The presence of an encounter complex of Pdx-P450cam has been implicated 
by paramagnetic NMR analysis in our previous study (Chapter 3).[5] Three different 
paramagnetic NMR effects, namely, pseudocontact shifts (PCS), paramagnetic 
relaxation enhancements (PRE) and residual dipolar couplings (RDC) were generated by 
lanthanoid probes and 446 restraints were used for structural calculations. The distance 
restraints derived from PCS and PRE agree well with those calculated for the final 
solution structure and the crystal structure, except for one set of PRE data. Curiously, 
the results of this dataset indicated that a minor population of Pdx visits a remote 
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region on P450cam (Chapter 3).[5] To further characterize the encounter complex of 
the Pdx-P450cam complex, a caged lanthanoid NMR probe (CLaNP) as well as a MTSL 
spin label were attached to P450cam and Pdx, respectively. In line with the previous 
study (Chapter 3),[5] many of the obtained PRE data were not in agreement with a single 
binding orientation of Pdx. The present study indicates that Pdx explores the region 
nearby the J and K helices as well as β1 sheet of P450cam in the encounter state.
Results
Protein tagging with paramagnetic probes
To study the interaction of Pdx-P450cam complex, a paramagnetic probe, CLaNP-7, 
was attached to P450cam. In our previous study, CLaNP-7 was demonstrated to be a 
useful tool for the structure determination of the Pdx-P450cam complex (see Chapter 
3).[5] The bidentate fashion of CLaNP attachment requires two surface-exposed Cys 
residues that are in close vicinity.[11] In addition to the previously described P450cam 
mutants, K126C/R130C/C334A (mutant A) and A333C/C334A/H337C (mutant B), two 
other variants were prepared, namely, Q272C/E276C/C334A (mutant C) and E195C/
A199C/C334A (mutant D). The probe attachment site of mutant C is relatively close 
to the mutation site B. The PRE data from this site provided the evidence for an 
encounter complex in the previous study.[5] The position of mutant D is located at the 
G-helix of P450cam, which is in proximity to putative potassium binding site.
Intramolecular PCSs were measured for P450cam mutants C and D and the derived 
distance and orientation restraints were used to calculate the position of the lanthanoid 
ion (Ln3+) and the orientation of the anisotropy of the magnetic susceptibility, the ∆χ 
tensor. These are essential parameters to convert intermolecular paramagnetic NMR 
effects to accurate restraints, especially for the structure calculations on the encounter 
complex. To perform the intramolecular PCS experiments, P450cam mutant C and D 
were uniformly labeled with 15N isotopes. Subsequently, the proteins were linked to 
Lu3+ or Tm3+ loaded CLaNP-7 (Lu3+/Tm3+-CLaNP-7) and two-dimensional HSQC spectra 
were recorded in the absence of Pdx. The principle axial and rhombic components of 
∆χ tensors (∆χax, ∆χrh) were calculated to be ∆χax = 44.7 ± 0.8, ∆χrh = 21.3 ± 1.1 and 
∆χax = 44.7 ± 2.0, ∆χrh = 8.0 ± 2.0 (*10-32 m3) for Tm3+-CLaNP-7 labeled P450cam 
mutant C and D, respectively. The variability of ∆χrh values is attributed to the mobility 
of the tag on protein surfaces.[12] The ∆χ tensor values derived from intramolecular 
PCS analysis were summarized in Table 2 in Chapter 2.
Intermolecular paramagnetic NMR effects
Having established the attachment site of CLaNP-7, we next measured three types 
of paramagnetic NMR effects, PCS, RDC and PRE to determine the binding mode 
of Pdx-P450cam complex. Tm3+-containing CLaNP-7 has been shown to induce both 
PCS and RDC, which were extensively used for the structural calculations of Pdx-
P450cam complex in the previous study (see Chapter 3).[5] PCSs provide long-range 
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distance information (up to 60 Å) as well as orientation restraints since it depends 
on the orientation of the ∆χ tensor.[13] In addition to PCS, orientation restraints can 
be independently determined by RDC analysis. The attachment of Tm3+-CLaNP-7 
partially aligns the protein complex to the external magnetic field, which gives rise 
to amide proton residual dipolar couplings. Gd3+-containing CLaNP-7 (Gd3+-CLaNP-7) 
causes PREs, which provides distance restraints up to 45 Å. In contrast to PCS derived 
distances, which often agree well with those calculated from the crystal structure, the 
distance information obtained from PREs can reflect the lowly populated states of 
protein conformations. To obtain intermolecular paramagnetic NMR restraints, NMR 
spectra were acquired for isotopically enriched 2H, 15N Pdx in the presence of Lu3+/
Tm3+/Gd3+-CLaNP-7 labeled P450cam. The PCS, RDC and PRE data for mutant C are 
shown in Figure 1. For the mutant D, only PREs were obtained, Figure 2. To illustrate 
the correlation with the previously determined structures of the final complex, a 
comparison was made between experimentally measured (red circles) and back-
calculated restraints (blue lines) from the ensemble of ten solution structures (PDB 
entry 2M56[5]).
Although small deviations were observed for Pdx residues 50-70 and 90-95, the 
intermolecular PCS of mutant C are in reasonable agreement with those predicted 
from the final complex. The predicted RDCs also correspond reasonably well with 
most of the experimental data. The Q factors (eq. 2 in the Materials and Methods) 
calculated from the experimental and back-predicted data are 0.07 and 0.34 for PCS 
and RDC, respectively In contrast to the PCSs and RDCs, the PRE derived distances 
show poor correlations between experimentally determined and back-calculated 
distances. For almost all of the residues, experimental distances were shorter than 
predicted. To illustrate the extent of deviations, the additional PREs (∆PRE) were 
calculated by subtracting the calculated PRE from the experimentally measured PRE 
and color coded on the Pdx surface as shown in Figure 1D. The Pdx residues with the 
largest ∆PRE (Figure 1D, red) were observed not only at the region closest to the probe 
attachment site but also on the other side of Pdx. The distribution of the ∆PREs on the 
protein surface cannot be explained by a single orientation of Pdx-P450cam complex 
since these residues are too far away from the paramagnetic center to be affected. 
The additional PRE effects are in line with those found for mutant B.[5] Taken together, 
intermolecular PRE analysis of mutant C indicates that Pdx visits other orientations 
than the one observed in the final, well-defined complex. The agreement of RDC and 
PCS data with the predicted values suggests the population of the encounter complex 
to be small. 
To investigate the extent of surface area being sampled by the encounter complex, 
paramagnetic tags were attached also Pdx. Pdx V6C/R12C/C73S/C85S (mutant I) was 
linked to Gd3+-CLaNP-7 to measure intermolecular PRE on P450cam. Moreover, Pdx 
wild type (WT) was produced for the attachment of an MTSL spin label. Zhang et al. 
demonstrated that the endogenous surface-exposed Cys73 can be labeled with MTSL 
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Figure 1. Intermolecular paramagnetic NMR effects on Pdx for P450cam mutant C tagged with 
CLaNP-7. The PCSs (A), RDCs (B) and PRE derived distances (C) were plotted against the Pdx 
residue number. Red circles and blue lines illustrate the experimentally measured restraints and 
back-calculated restraints from ten best solution structures of the complex (PDB entry 2M56), 
respectively. The experimental errors associated with PCS are within the circular symbols. (D) 
Surface representation of Pdx, showing the additional PREs (∆PRE) caused by Gd3+-CLaNP-7 
labeled P450cam mutant C. Pdx residues were color coded according to ∆PRE ≥ 30 s-1, red; 
20-30 s-1, orange; 5-20 s-1, yellow; < 5 s-1, blue. Unassigned residues and P450cam are shown 
in gray. The blue sphere represents the position of the Gd3+. P450cam is shown in ribbon 
representation with the heme in sticks and the iron as a red sphere. Pdx is shown in the orientation 
found in the final complex. 
without causing significant perturbations in the Pdx-P450cam complex.[14] Figure  2 
illustrates the PRE derived distances for the respective positions of paramagnetic 
probes on Pdx and P450cam.
The experimental PRE distances and those calculated from the final structure were 
found to be in good agreement for mutant A. For mutant D, with the exception of a 
few residues, significant PREs were not detected, which is represented by large lower 
limit of error bars in Figure 2. The absence of the additional PREs indicates that Pdx 
does not sample the region around position D of P450cam. However, several stretches 
of P450cam residues exhibit stronger PRE than those predicted for Pdx mutant I and 
MTSL at Cys73. In comparison to Gd3+-CLaNP-7, the distances that MTSL allows to 
measure are limited to the range of 14–22 Å.[15] As illustrated in the Figure 3, additional 
PREs are observed at the remote regions from the predicted Gd3+/MTSL attachment 
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Figure 2. PRE analysis of Pdx-P450cam complex. In the central panel, the positions of Gd3+ and 
MTSL are represented by blue spheres on the Pdx-P450cam complex (PDB entry, 2M56). In the 
side panels, inter-protein PRE distances are plotted against the protein residue number for the 
respective positions.
sites. The regions with significant ∆PRE (>5 s-1) include 21–26 and 65–70 and 332–333, 
which are located in the proximity of the J, K helices as well as β1 sheet of P450cam. 
The largest deviations were observed for Pdx residues from the position B and C 
on P450cam. The Q factors calculated from the experimental and back-predicted PREs 
show 0.58 and 0.86 for mutant B and C, respectively (Table 1). 
Table 1. Summary of Q factors for intermolecular paramagnetic NMR restraints.
Sample Probes Q (PRE) Q (PCS) Q (RDC)
P450cam mutant A CLaNP-7 0.25 a 0.03 a 0.14 a
P450cam mutant B CLaNP-7 0.58 a 0.07 a 0.34 a
P450cam mutant C CLaNP-7 0.86 0.08 0.47
P450cam mutant D CLaNP-7 0.42
Pdx mutant I CLaNP-7 0.59 0.08 a 0.28 a
Pdx WT MTSL 0.76
described in Chapter 3[5]
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It is worth mentioning that experimental PCSs correlate well with the predicted 
ones, with Q factors of 0.07–0.08. Therefore, the observed PRE deviations cannot 
be explained by significant perturbations in the complex caused by Ln3+-CLaNP-7 
attachment. Taken together, the results indicate that the surface area of P450cam being 
sampled by Pdx in the encounter complex is localized nearby J, K helices as well as β1 
sheet. It should be noted that the conformational space being sampled by Pdx can be 
larger than the surface area covered in the current study. It can be further characterized 
by attaching paramagnetic probes at multiple locations of the protein surfaces.
To investigate the interactions that drive the encounter state of Pdx-P450cam 
complex, the regions nearby J, K helices as well as β1 sheet were analyzed in the 
crystal structure (PDB entry 3W9C).[5] It is worth mentioning that both of the proteins 
contain a large number of acidic residues, which results in isoelectric points (pI) of Pdx 
and P450cam of 4.5 and 5.2, respectively. As illustrated in Figure 4, the regions of 
P450cam affected by ∆PREs compose the clusters of basic and hydrophobic residues.
Previous mutagenesis studies as well as the structural analysis of the crystal 
structures revealed the importance of the hydrogen bond between Pdx Asp38 and 
P450cam Arg112 as well as the hydrophobic contact between Pdx Trp106 and P450cam 
Ala113 for the formation of Pdx-P450cam complex.[5-6, 9, 16] Moreover, the mutagenesis 
and kinetics data presented in the Chapter 4 highlighted interactions of several polar 
residues in the Pdx-P450cam interface. These polar interactions were found to be 
important in partner recognition, rather than in ET. Taken together, we propose that 
the encounter state of Pdx-P450cam complex is driven by polar interactions as well 
as short-range interactions, including hydrogen bonding and hydrophobic contacts.
Figure 3. Surface representation of P450cam, showing the additional PREs. (A) Gd3+-CLaNP-7 
labeled Pdx mutant I. The scheme of color code was the same as given in the caption of Figure 
1D. (B) Pdx WT labeled with MTSL at Cys73. P450cam residues were color coded according to 
∆PRE with ≥ 50 s-1, red; 30-50 s-1, orange; 7-30 s-1, yellow; < 7 s-1, blue. Unassigned residues and 
P450cam are shown in gray. The blue spheres represent the positions of the Gd3+ ions. Pdx is 
shown in ribbon representation with the [2Fe-2S] cluster as brown and yellow spheres. 
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Discussion
The paramagnetic NMR analysis with lanthanoid probes provides information about 
both the structural and dynamic nature of the protein-protein interaction in the solution 
state. PCSs and RDCs caused by Tm3+-containing CLaNP-7 generate distance and 
orientation restraints that help to determine the major conformational state, which 
often agrees well with those of crystal structures.[5, 17-18] On the other hand, due to the 
strong distance dependency, PRE is known to be extremely sensitive to detect lowly 
populated conformational states of proteins.[1] We compared the results of the PCS, 
RDC and PRE analyses of Ln3+-CLaNP-7 labeled mutants (A, B, C and I) and showed that 
Pdx visits minor orientation(s) in the Pdx-P450cam complex. The Q factors were found 
to be as small as 0.03–0.07 for PCS, which reflects the good correlations between 
experimentally measured and predicted PCS. Reasonably small Q factors were also 
found in RDC datasets. In contrast, poor correlations were observed for PRE derived 
distances. All of the residues with significant deviations showed stronger PREs than 
expected and also the distributions of the PREs on the Pdx surface are not consistent 
with the stereospecific complex and this effect was observed for probes at multiple 
positions on P450cam. Clearly, a single Pdx-P450cam complex cannot account for the 
observed PREs. In line with the suggestions to the previous study,[5] we concluded that 
additional PREs can be attributed to a lowly populated encounter state of the Pdx-
P450cam complex.
To compare the results of the PREs obtained by Zhang et al. and those in the 
current study with Gd3+-CLaNP-7, a nitroxide spin label was attached to Pdx WT, 
using the endogenous surface exposed Cys73. Significant PREs were observed for 
Figure 4. Electrostatic surface of Pdx-P450cam complex (PDB entry 3W9C). Blue and red 
represent basic and acidic, respectively. (A) Electrostatic surface representation of Pdx. Blue 
ribbon represents P450cam. (B) Electrostatic surface representation of P450cam. Orange ribbon 
represents Pdx. Basic patches of P450cam were annotated.
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nuclei in several stretches across P450cam in addition to the previously described 
residues.[14] Some of these affected residues were located at more than 22 Å away 
from the predicted MTSL attachment site. Moreover, the regions with ∆PRE caused 
by MTSL correspond to those induced by Gd3+-CLaNP-7 from mutant I. The results 
of PRE analysis with nitroxide spin label indicate that the encounter complex of Pdx-
P450cam is not an artifact of the attachment of Gd3+-CLaNP-7, but rather represents 
true dynamics in the Pdx-P450cam interaction.
The fraction of encounter complex, relative to the fraction of the stereospecific 
structure, varies among protein complexes. For the interaction of yeast cytochrome 
c and cytochrome c peroxidase it has been shown that the fraction of its encounter 
state is 30%.[19] Other complexes have been described to exist only as encounter 
complexes.[20-21] In our current study, the fraction of encounter state of Pdx-P450cam 
complex was not quantified. However, the good agreement of PCS and RDC data 
with the predicted values suggests the population of the encounter complex to be 
relatively small (less than 10%).
The PRE analysis for multiple positions of Pdx and P450cam indicates that in 
the encounter state Pdx is localized close to the J and K helices as well as the β1 
sheet. These regions all have basic and hydrophobic residues clustered together. 
Previous mutagenesis studies as well as X-ray crystallography demonstrated that 
the interactions of Pdx and P450cam are dominated by polar interactions, hydrogen 
bonding and hydrophobic contacts.[5-6, 9, 22] Given the overall negative charge of both 
proteins, it is reasonable to assume that Pdx visits mostly basic/hydrophobic patches 
of the P450cam surface. Based on isothermal titration calorimetric results, Aoki et 
al. compare the association of Pdx with P450cam to antigen-antibody binding.[23] 
The specificity of an antigen-antibody interaction is established by van der Waals 
interactions, hydrogen bonding and loss of the mobility upon the complex formation. 
The C-terminal Pdx Trp106 plays an essential role in the partner recognition in complex 
formation.[5-6, 9, 22] Moreover, it exhibits significant flexibility on protein surface.[10] The 
dynamics of the bulky hydrophobic residue could be a key determinant in the search 
for optimal binding geometry.
In general, the encounter state facilitates the formation of final well-defined 
complex. However, recent experimental evidences demonstrated that not all 
encounter state of protein complexes proceed to final productive complexes such 
complexes are called futile encounters.[1, 24-25] In general, the further away the partner 
binds in the encounter complex, the higher the chances that it dissociates without 
forming the productive complex. The surface of P450cam sampled by Pdx extends 
from the proximal side to the regions nearby J and K helices as well as β1 sheet. 
Some of these sites are rather far away from the putative binding site. Therefore, it is 
reasonable to conclude that not every Pdx binding leads to the formation of the ET 
complex. Nonetheless, the localized areas of P450cam being visited by Pdx suggest 
that the lowly populated encounter complex is relevant to the formation of the final 
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Pdx-P450cam complex. As illustrated in the electrostatic surface of P450cam (Figure 
4), the prominent basic patches of R342, K344, R72 and R364 compose a path to 
guide the Pdx to the putative binding site. Thereby, it reduces the three dimensional 
search via collisions to a two dimensional search on the P450cam surface. Moreover, 
the charge interaction prolongs the lifetime of the encounter facilitating the formation 
of the ET active complex. It has been shown that Pdx shuttles electrons between PdR 
and P450cam through the same interface.[8] 
In conclusion, we investigated the dynamics of the Pdxox-P450camox interaction by 
PRE analysis. A small population of the complex is found to exist as an encounter state. 
Further biochemical and structural studies are required to elucidate the biological 
function of the encounter complex. 
Material and Methods
Chemicals
CLaNP-7[13] was kindly provided by Wei-Min Liu (Leiden University) and chelated to 
Lu3+, Gd3+ and Tm3+ ions. MTSL ((1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-
methanesulfonothioate) and MTS ((1-acetyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-
methanesulfonothioate) were purchased from Toronto Research Chemicals, North 
York, Ontario, Canada.
Mutagenesis
To prepare double cysteine mutants of Pdx and P450cam, site-directed mutagenesis 
was carried out using QuikChange protocol (Stratagene, La Jolla, CA).
Protein production
Pdx and P450cam variants were produced as described in Chapter 3. 
Paramagnetic probe attachments
Pdx and P450cam variants were labeled with Ln3+-CLaNP-7 as previously described.[5] 
For MTS(L) tagging, Pdx WT was incubated with 5 mM DTT in 20 mM KPi, pH 7.0, 
50 mM KCl for 30 minutes on ice. DTT was removed by using a PD-10 column. The 
protein solution was mixed with five molar equivalents of MTS(L) and incubated for 
one hour at 4°C. Oligomers and surplus of spin labels were removed by two steps 
of chromatography, on a HiTrap Q HP anion-exchange column and a Superose 12 
size exclusion column, respectively. The MTS(L) incubated sample was filtered and 
loaded on a HiTrap Q HP anion-exchange column (2 mL). The protein was eluted with 
a linear gradient of 0.1–0.4 M KCl in 20 mM KPi, pH 7.4 and the first peak fractions 
were collected and subsequently loaded on a Superose 12 size exclusion column pre-
equilibrated with 50 mM Tris-HCl, pH 7.4, 100 mM KCl and 1 mM camphor, 1% MeOH, 
6% D2O. The eluted brown fractions were pooled and concentrated. Approximately, 
80–90% of proteins were lost during the labeling procedure presumably because 
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MTSL labeling hampers the stability of the iron sulfur cluster. The loss of [2Fe-2S] 
cluster results in unfolding and oligomerization of the protein.
NMR samples and experiments
NMR samples contained 100–200 µM [2H, 15N] Pdx (WT) or [2H, 15N] P450cam (C334A) 
with two molar equivalents of Ln3+-CLaNP-7 labeled P450cam or Ln3+-CLaNP-7/
MTS(L) tagged Pdx mutants, respectively, in 50 mM Tris-HCl, pH 7.4, 100 mM KCl, 
1 mM camphor and 7% D2O. 2D 
15N-1H HSQC and 15N-1H TROSY spectra[22] were 
recorded at 290 K on a Bruker Avance III 600 MHz spectrometer equipped with a TCI-
Z-GRAD cryoprobe. 
NMR assignment
All NMR data were processed in NmrPipe[26] and analyzed in CCPNMR[27]. The amide 
resonances of oxidized Pdx and P450cam were assigned based on previous work and 
Chapter 3.[5, 28] 
PCS and RDC analysis
PCS and RDC measurements were performed as reported in Chapter 3.[5] 
PRE analysis
PRE datasets of Gd3+-CLaNP-7 and MTSL were analyzed as described in Chapter 
3.[5, 15] The peak height of the amide resonances of the proteins were compared in the 
presence of partner protein with diamagnetic probe (Lu3+-CLaNP-7 or MTS) and with 
paramagnetic probe (Gd3+-CLaNP-7 or MTSL) and they were represented as Idia and 
Ipara, respectively. The Ipara/Idia ratios were normalized by dividing them by the averaged 
values of the 10 largest Ipara/Idia values (0.96, 1.09, 1.15, 0.95, 1.0 and 0.97 for P450cam 
mutant A, B, C, D, Pdx mutant I and MTSL samples, respectively). Intermolecular 
distance restraints were calculated using the equation 1.
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where  r is the distance between an unpaired electron (Gd ion or nitroxide) and a given
amide proton; fbound is the fraction of the bound 15N protein. Given a dissociation constant
of  Pdx-P450cam  as  5–10  µM,  fbound was  set  to  0.9;  flabeled is  the  fraction  of  the
paramagnetic probe attached protein.  flabeled were estimated to be 0.8-0.9 as described in
Chapter  2  and  1.0  for  Gd3+-CLaNP-7  and  MTSL,  respectively;  γ is  the  proton
gyromagnetic ratio; g is the electronic g-factor; β is the Bohr magneton; ωh is the Lamor
frequency of protons; µ0 is vacuum permeability; S is spin quantum number of nitroxide
and Gd3+;  τc is  the rotational  correlational  time of niroxide/Gd3+-proton vector.  τc was
estimated to be 30 ns on the basis of  HYDRONMR[29] for the Pdx-P450cam complex.
The intermolecular distances were divided in three classes of restraints: i) residues with
resonance peaks that broaden out beyond detection in the paramagnetic spectrum. For
these residues, only an upper limit of the distance was calculated and found to be 14 and
20 Å for MTSL and Gd3+ samples, respectively. ii) residues with R2,para ≥ 7.0 s–1 (MTSL)
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of restraints: i) residues with resonance peaks that broaden out beyond detection in 
the paramagnetic spectrum. For these residues, only an upper limit of the distance 
was calculated and found to be 14 and 20 Å for MTSL and Gd3+ samples, respectively. 
ii) residues with R2,para ≥ 7.0 s
–1 (MTSL) and R2,para ≥ 3.0 s
–1 (Gd3+). Error margins were set 
to ± 4 Å and ± 3 Å for MTSL and Gd3+ samples, respectively. iii) residues with R2,para 
< 7.0 s–1 (MTSL) and R2,para < 3.0 s
–1 (Gd3+). These residues were considered to be too 
remote from the paramagnetic center to induce a significant PRE and therefore only 
the lower limit was calculated and found to be 22 Å and 44 Å for MTSL and Gd3+ 
samples, respectively.
The correlations between observed (Oobs) and back-predicted (Osim) observables 
(PRE, PCS and RDC) were assessed with Q values using equation 2.[19] 
  [2]
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For Q (PRE), the residues with observed PRE of R2,para < 7.0 s–1 (MTSL) and R2,para <  3.0
s–1 (Gd3+) were excluded from the calculation. These residues were considered to be too
remote from the paramagnetic center to induce a significant PRE. 
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P450 enzymes bind to a variety of different compounds to catalyze monooxygenation 
reactions. However, the mechanisms of substrate recognition and product release 
of P450 enzymes are poorly understood. In the presence of substrates, the crystal 
structures of P450cam have been shown to adapt the closed conformation. In this 
state, there is no channel through which substrates can access the active site of 
P450cam. In this project, utilizing the paramagnetic inhibitor, N-(3-(1H-imidazole-1-yl)
phenyl)-1-oxylradical-2,2,5,5-tetramethyl-δ-3-pyrroline-3-carboxamide (1-PIM-3), the 
nature of the substrate access channel was investigated by X-ray crystallography as 
well as paramagnetic NMR techniques. X-ray crystallography revealed that P450cam 
exhibits the open conformation in the complex with 1-PIM-3. The substrate access 
channel was traced by paramagnetic relaxation enhancements, indicating that the A 
helix and the region nearby β1 sheet are part of the substrate access channel. 
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Introduction
Cytochrome P450cam (CYP101A1) is an archetypical bacterial P450 for which more than 
a hundred structures have deposited in the protein data bank. Recently, crystal structures 
of artificially cross-linked Pdx and P450cam were solved,[1] which raised questions about 
the conformational states of P450cam. In the presence of the substrate almost all of the 
P450cam structures show the “closed” conformation, in which there is no channel present 
large enough to allow substrate access to the active site. Substrate entry into P450cam 
had puzzled researchers for decades until Dunn et al. co-crystallized the protein with 
elongated substrate analogues.[2] These analogues protruded from the active site to the 
protein surface, forcing the substrate access channel to be opened. In 2010, Goodin and 
co-workers solved the crystal structure of P450cam in the absence of substrates, revealing 
that the opening of the substrate access channel primarily involves the movement of the 
F and G helices.[3] While the structure of the “open” conformation provides valuable 
information for understanding P450cam catalysis, it also leaves many questions to be 
unresolved: how fast is the exchange between the open and closed conformations? 
Which factors trigger the equilibrium shift? Is there a secondary substrate binding site 
inside the channel as suggested by a recent study?[1] Paramagnetic NMR techniques 
can be used to examine the substrate access channel in solution. When a substrate or 
inhibitor analogue with a paramagnetic center binds to the active site of P450cam, it 
should cause PREs mark on the residues comprising the substrate access channel. The 
PRE is dependent on distance between a paramagnetic center and observed residue 
and the sensitivity of the PRE allows the detection of minor conformational states of 
proteins.[4] Tracking the PRE effect on P450cam residues, the structure and dynamics of 
substrate access channel can be analyzed (Figure 1). In this chapter, the paramagnetic 
substrate analogue, 1-PIM-3-para, was used to characterize the substrate access channel 
of P450cam. The work demonstrates the proof-of-principle that small paramagnetic 
centers attached to ligands rather than protein can be helpful to characterize a complex.
Results & Discussion
1-PIM-3 binding to P450cam
The paramagnetic substrate analogue, 1-PIM-3-para, was designed on the basis of 
the known type I inhibitor of P450cam, 1-phenylimidazole, and a commonly used 
paramagnetic spin label, 1-oxyl-2,2,5,5-tetramethyl-δ-3-pyrroline-3-methyl (OTPM). 
The crystal structure of 1-phenylimidazole bound P450cam indicates that the closed 
conformation of P450cam remains intact while one nitrogen atom of the imidazole 
group binds the heme iron.[5] The coordination of the sixth ligand to the iron provides 
an important advantage to the NMR analysis since it suppresses the endogenous 
PRE effect caused by the high spin state of the heme iron. The diamagnetic inhibitor 
analogue, 1-PIM-3-dia was prepared by replacing OTPM with 1-methoxy-2,2,5,5-
tetramethyl-δ-3-pyrroline-3-methyl (MTPM) group of 1-PIM-3-para.
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Figure 1. Schematic representation of mapping the channel with PREs. The paramagnetic 
inhibitor analogue, 1-PIM-3-para reaches the active site of P450cam through the substrate access 
channel. The red colored regions of P450cam represent the residues that exhibit PRE. 
To determine the affinity of 1-PIM-3 to P450cam, a competitive binding assay was 
carried out with UV/VIS spectrophotometry (Figure 2). 
Figure 2. Competitive binding assay of 1-PIM-3 and camphor to P450cam. (A) Overlaid traces of 
absorption spectra of P450cam. Upon the titration of 1-PIM-3, the maximum absorption peak at 
391 nm shifts to the 417 nm. (B) The plot of ∆A417 against the concentration of 1-PIM-3. The blue 
points and red line represent the experimentally derived ∆A417 values and the simulated curve, 
respectively. 
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In the presence of the physiological substrate, camphor, the changes of the Soret 
maximum peak at 417 nm wavelength of P450cam were monitored with increasing 
concentration of 1-PIM-3. The dissociation constant (K D) of 1-PIM-3 was estimated to 
be 7.5 ± 0.5 μM by simulating the curve with the binding affinity for 1-PIM-3 as well 
as camphor and the maximal change of the absorbance at 417 nm (∆A417) as variable 
(Figure 2B). The KD of camphor was found to be 7 ± 1 μM, which is in line to the 
previous study of KD = 10.2 ± 0.6 μM.
[6] The details of the simulation are described 
in the Materials and Methods. The obtained KD value of 1-PIM-3 is compared with 
of those of camphor and 1-phenylimidazole in Table 1. The binding affinity of 
1-PIM-3 is comparable to that of camphor. The difference of KD by 70–80 folds with 
1-phenylimidazole is attributed to the presence of OTPM function group. 
Table 1. Dissociation constant (K D) of P450cam substrate and inhibitors.
Compounds KD (μM)
Camphor 7 ± 1 
1-phenylimidazole 0.1a
1-PIM-3 7.5 ± 0.5
(a) previously determined by Poulos, T.L. and Howard, A.J.[5] 
Crystal structure of P450cam bound to 1-PIM-3
Having established the affinity of 1-PIM-3 for P450cam, we obtained the structural 
information of P450cam bound to 1-PIM-3 by X-ray crystallography. The formation of 
crystal was observed under the same conditions as described by Lee, Y.T. et al.[7] The 
crystal structures of both 1-PIM-3-para and -dia bound P450cam were solved with 
maximum resolution of 2.2 Å and 2.0 Å, respectively. Data processing and refinement 
were carried out by Dr. Igor Nederlof (Biophysical Structural Chemistry group at 
Leiden University).
In line with the findings for 1-phenylimidazole,[5] the crystal structure of 1-PIM-3 
shows that the nitrogen atom of imidazole group coordinates the heme iron (Figure 3A). 
While the electron density of the 1-phenylimidazole group as well as the amide linker 
is well-defined, that of the OTPM functional group was less clear. This observation 
points toward mobility of the OTPM group, which has also been reported for MTSL 
labeled samples in NMR studies.[8-9] 
To further characterize the 1-PIM-3 binding, a comparison was made with the crystal 
structure of P450cam bound to 1-phenylimidazole.[5] The position of the axial nitrogen 
atom of imidazole group is very similar (Figure 3B), indicating that the nature of type 
I inhibition of 1-phenylimidazole is conserved in 1-PIM-3. However, the orientation 
of the 1-PIM-3 imidazole ring was found to be rotated by 55 degrees relative to that 
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of 1-phenylimidazole. It is also worth mentioning that the position of OTPM group 
coincides to the previously observed second substrate binding site.[1] The potential 
link between the occupancy of the second binding site and conformation state of 
P450cam will be studied in future.
Interestingly, 1-PIM-3 bound P450cam is present with substrate access channel 
in the open conformation, which distinctively differs from the closed conformation 
of P450cam bound to 1-phenylimidazole (Figure 4). The conformations of substrate 
access channel can be classified by the structural features of antiparallel F and G helices 
and intervening F–G loop.[7] The F–G loop region exhibits the largest movement upon 
the conformational change in P450cam.
The superimposed structures of the F–G loop illustrate that 1-PIM-3 bound 
P450cam adopts the structural features of the open conformation (Figure 4). In fact, 
the degree opening appears to be even slightly larger than in the substrate-free 
structure. It is plausible that the presence of bulky OTPM functional group forces the 
protein into this conformation. Other residues that are known to correlate with the 
conformation change are shown in Figure 4B and C. The formation of the unusual 
hydrogen bond between hydroxyl group of Thr252 and carboxyl backbone of Gly248 
is a unique feature of the closed conformation. It has been reported to regulate 
the position of catalytic water in the active site.[10] Another characteristic aspect of 
P450cam conformational states is the arrangement of the B’ helix. In the intermediate 
and open states, the B’ region exhibit large mobility and does not form the defined 
secondary structure. However, the binding of a potassium ion enhances the stability 
Figure 3. Crystal structure of P450cam bound to 1-PIM-3-dia. (A) Details of the electron density 
map with a maximum resolution of 2.0 Å. The structure was solved by molecular replacement 
using P450cam in the open conformation (PDB entry 3L61[10]). (B) Positions and orientations of 
ligands are superimposed. Gray, pink and yellow sticks represent 1-PIM-3-dia, 1-phenylimidazole 
and camphor, respectively.
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of B’ helix. It increases the binding affinity of camphor by ten-folds, which leads to the 
closed conformation.[10] Taken together, we concluded that 1-PIM-3 binding forces the 
substrate access channel of P450cam into the open state.
PRE analysis of P450cam bound to 1-PIM-3
To investigate the dynamics and structural components involved in the substrate 
access channel, a paramagnetic NMR experiment was carried out. In the current study, 
due to the limited availability of [2H, 15N] labeled proteins, [15N] isotopically enriched 
P450cam C334A/H352A mutant was used to optimize the experimental conditions. The 
catalytic activity of this mutant was shown to be intact in a previous study (Chapter 4). 
The two dimensional 15N–1H HSQC spectra were acquired for the P450cam samples 
in the presence of 1-PIM-3-para/-dia. In addition to the amide-proton resonances of 
P450cam, large peaks caused by dimethylformamide (DMF) were observed across the 
indirect dimension at 7.8 ppm of the 1H chemical shift (Figure 5A). The 3% of DMF 
used to solubilize 1-PIM-3 in the sample is the cause of this signal. The contribution 
of DMF peaks can be minimized by utilizing deuterated DMF in the future. The NMR 
spectra were overlaid with the closed conformation of P450cam in high spin and 
low spin states (kindly provided by Simon Skinner at Leiden University). Most of the 
assigned peaks in closed state were either shifted or disappeared, presumably due 
Figure 4. Superimposed structures of P450cam in different conformations. Blue, yellow, purple 
and gray structures represent closed (PDB entry, 1DZ4),[11] intermediate (1K2O),[2] open (3L61)[10] 
and 1-PIM-3, respectively. (A) Ribbon representation of the F and G helices and the F–G loop. 
(B) Cartoon representation of the B’ helix. The purple sphere represents a potassium ion. (C) Sticks 
depict the conformations for the indicated residues. Black dots represent a hydrogen bond.
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to the P450cam being in the open conformation and the chemical shift perturbations 
caused by 1-PIM-3 binding. Out of 414 residues, 116 residues were assigned on 
the basis of the assignments of closed conformation. As a future perspective, the 
number of unambiguous assignments can be increased by acquiring NMR spectra in a 
titration of camphor. In addition, the exchange regime (on the NMR time-scale) of the 
association and dissociation of 1-PIM-3-dia binding needs to be established. From the 
ratios of the peak intensities of 1-PIM-3-para/-dia (Ipara/Idia), the PREs were calculated. 
The observed PREs are a weighted average of 1-PIM-3 bound form and substrate-
free P450cam. Given the KD = 7.5 μM, ca. 90% of P450cam was bound to 1-PIM-3 in 
this experiment. Therefore, the observed PREs were extrapolated to the 100% bound 
Figure 5. PRE analysis of P450cam bound to 1-PIM-3. (A) Overlaid HSQC spectra of P450cam. 
Blue and red peaks represent 1-PIM-3-dia and -para samples, respectively. (B C) Ipara/Idia ratios 
(B) and PREs (C) are plotted against P450cam residue number. (D) Ribbon representation of the 
crystal structure of P450cam bound to 1-PIM-3. P450cam residues were color coded according 
to PRE with ≥ 30 s-1, red; 20–30 s-1, orange; 15–20 s-1, yellow; < 15 s-1, blue. Unassigned residues 
are shown in gray. (E) Zoom-in of the region affected by PRE. Sticks and sphere represent 1-PIM-
3-dia and heme.
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state by dividing the PREs by 0.9. The calculated PREs were color coded on P450cam 
as shown in Figure 5.
It has been reported that the secondary structural elements helices, F, G and 
I as well as the F–G loop exhibit distinct movements in the transition between 
the conformational states.[7] Due to the significant chemical shift changes, it was 
impossible to assign the resonances of residues in those elements. The B’ helix, 
comprising residues 90–95, is also known to be important for the conformation 
shift of P450cam. Significant PREs (>25 s-1) indicate that those residues are in close 
proximity of the paramagnetic center of 1-PIM-3. In addition to the previously 
described structural motifs, other regions, such as the A helix and the nearby β1 sheet 
also display strong PREs (Figure 5E). Most of these residues are located within 22 Å 
from the paramagnetic center, which agrees well with the distance range in which a 
nitoxide spin label is expected to cause PREs (14–22 Å). Further NMR experiments 
are required to characterize the dynamics and nature of the substrate access channel 
in the solution state.
Conclusions
The current study demonstrated binding of a paramagnetic inhibitor analogs to 
P450cam. The binding affinity of 1-PIM-3 was found to be KD = 7.5 μM, which is 
comparable to the physiological substrate, camphor. The crystal structure of P450cam 
bound to 1-PIM-3 exhibits a more open conformation than that of substrate-free 
form. The preliminary results of the PRE analysis indicate that paramagnetic ligand 
analogues can be used to characterize protein-ligand complexes. 
Materials and Methods
Chemicals
1-PIM-3-para/-dia were kindly provided by Wei-Min Liu (Leiden University). 
Protein production
P450cam C334A as well as [15N] isotopically enriched P450cam C334A/H352A were 
produced and purified as described in Chapters 3 and 4. Camphor was removed 
by Superose 12 gel filtration column (120 mL) pre-equilibrated with 20 mM Hepes, 
pH 7.4. The fractions containing P450cam with absorbance ratio of A417/A280> 1.55 
were pooled.
Competitive binding assay
The reaction mixtures (2 mL) contained 5 μM P450cam C334A in 20 mM Hepes, 
pH 7.4 and 100 mM KCl. First, P450cam was saturated with three molar equivalents of 
camphor. 1-PIM-3 was titrated into camphor bound P450cam and the change of the 
Soret maximum peak at 417 nm (∆A417) was monitored at 293K.
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The following model was used to describe the binding of camphor and 1-PIM-3.
  
(1)
where A, B, C, AB and AC represent P450cam, camphor, 1-PIM-3, camphor bound 
P450cam and 1-PIM-3 bound P450cam, respectively. The system is described by two 
KD values and the mass laws (eq. 2-7) 
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P450cam C334A as well  as [15N] isotopically enriched P450cam C334A/H352A were
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The experimental absorbance change at 417 nm was simulated with eq. 8 for each point
(i) in  the  titration,  by  varying  ABDK ,  
AC
DK and  
max
417A∆ ,  the  maximal  change  in






)( ∆Ai∆A ⋅=  (8)
The  error  associated  with  the  dissociation  constant  was  estimated  by  measuring  the
agreement between experimental and simulated data.
Crystallization
The stock solution contained 200 µM P450cam C334A in 20 mM Hepes, pH 7.4 and 2
mM 1-PIM-3-para/-dia (10% DMF). Crystals of P450cam bound to 1-PIM-3 were grown
by the sitting-drop vapor diffusion method at room temperature from 12–22% PEG 8000,
100  mM  sodium  cacodylate,  pH 5.5–7.0  and  100–200  mM  KCl.  The  crystals  were
mounted on nylon loops containing glycerol as a cryoprotectant and flash-frozen in liquid
nitrogen.
X-ray  diffraction  data  were  collected  at  European  synchrotron  radiation  facility  in
Grenoble. Data collection and crystal structure determination were performed by Dr. Igor
Nederlof (Biophysical Structural Chemistry group at Leiden University).
NMR samples and experiments
The fractions from Superose 12 column were pooled and buffer exchanged to 100 mM
cacodylic  acid,  pH 6.5, 200 mM KCl, 12.5% D2O by ultrafiltration using a centricon
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The experimental absorbance change at 417 nm was simulated with eq. 8 for each point
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The  error  as ociated  with  the  dis ociation  constant  was  estimated  by  measuring  the
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Crystallization
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Nederlof (Biophysical Structural Chemistry group at Leiden University).
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The error associated with the dissociation onstant was stimated by mea uring 
the agr ement betw en experimental and simulated data.
Crystallization
The stock solution contained 200 μM P450cam C334A in 20 mM Hepes, pH 7.4 and 
2  mM 1-PIM-3-para/-dia (10% DMF). Crystals of P450cam bound to 1-PIM-3 were 
grown by the sitting-drop vapor diffusion method at room temperature from 12–22% 
PEG 8000, 100 mM sodium cacodylate, pH 5.5–7.0 and 0–200 mM KCl. The crystals 
were mounted on nylon loops containing glycerol as a ryoprotectant and flash-f ozen 
in liquid nitrogen.
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X-ray diffraction data were collected at European synchrotron radiation facility 
in Grenoble. Data collection and crystal structure determination were performed by 
Dr. Igor Nederlof (Biophysical Structural Chemistry group at Leiden University).
NMR samples and experiments
The fractions from Superose 12 column were pooled and buffer exchanged to 100 mM 
cacodylic acid, pH 6.5, 200 mM KCl, 12.5% D2O by ultrafiltration using a centricon 
(5K). The NMR samples contained 250 μM [15N] P450cam C334A/H352A and 300 μM 
1-PIM-3-para/-dia in 80 mM cacodylic acid, 160 mM KCl, pH 6.5, 5 mM HEPES, 10% 
D2O and 3% DMF. Two-dimensional 
15N–1H HSQC spectra were recorded at 298 K on a 
Bruker Avance III HD 850-MHz spectrometer equipped with a TCI-Z-GRAD cryoprobe. 
NMR data were processed in NMRPipe[13] and analyzed in CCPNMR.[14]
NMR assignment
The amide resonances of P450cam C334A/H352A bound to 1-PIM-3-dia/-para were 
assigned on the basis of cyanide and camphor-bound oxidized P450cam C334A 
(provided by Simon Skinner, Leiden University).
Restraint analysis
The ratios of Ipara/Idia were normalized by dividing them by the averaged values of the 85 
largest Ipara/Idia ratios (0.96). PREs were determined as described in the Chapter 3 and 5.
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At the start of this research in 2009, the molecular details of interaction and ET in the 
Pdx-P450cam complex had yet to be elucidated due to the lack of atomic resolution 
structures. Zhang et al. had generated a model of the Pdx-P450cam complex by NMR 
experiments,[1] in which the interactions in the interface agreed well with mutagenesis 
studies.[2-3] The initial aim of the project was to validate their model by paramagnetic 
NMR techniques. By attaching Ln3+-CLaNP-7 at multiple locations on Pdx and 
P450cam surfaces, 446 distance and orientation restraints were obtained (Chapter 3). 
An ensemble of solution structures with average RMSD from the mean of 1.3 Å for the 
position of Pdx has obtained. Similar approach has been demonstrated by Keizers et 
al.[4] The structure complex of adrenodoxin (Adx) and adrenodoxin reductase (AdR) 
was determined by the combination of chemical shift perturbation, pseudocontact 
shift and paramagnetic relaxation enhancement. Adx is also [2Fe-2S] cluster 
containing ferredoxin, which hampers NMR studies by broadening the residual peaks 
around [2Fe-2S] cluster. However, using long-range restraints obtained from two Ln3+ 
attachment sites, they showed that the mean of ensemble solution structures is close 
to the crystal structure of the complex with an RMSD of 4.0 Å.[4] Strikingly, our structure 
generated by paramagnetic NMR restraints differs from the previously proposed model. 
Our collaborators, Dr. Nojiri and co-workers at Osaka University in Japan, crystallized 
the Pdx-P450cam complex. Their crystal structure closely resembles the solution 
structure. Structural analysis of the interface shows two potential ET pathways as well 
as several interaction networks. In addition to a putative hydrogen bond between Pdx 
Asp38 and P450cam Arg112 as well as hydrophobic contacts between Pdx Trp106 
and P450cam Ala113, several polar residues are found in the interface. Site-directed 
mutagenesis and kinetics analysis revealed that these residues, which had not been 
recognized to be relevant for the binding before, play an important role in the binding 
affinity of Pdx-P450cam (Chapter 4). While our manuscript was under review, Tripathi 
et al. published the crystal structure of the Pdx-P450cam complex that was obtained 
via cross linking of the two proteins.[5] Tripathi et al. found that P450cam is present in 
a state that resembles the open state of P450cam. On the basis of this observation, 
they concluded that the nature of effector role of Pdx (see Chapter 1) is to cause a 
conformation change in P450cam from the closed to open state.[5] The crystal structure 
of the complex solved by Dr. Nojiri and co-workers showed that the conformation of 
P450cam is in an intermediate state between open and closed.[6] It is not clear whether 
the open state found in the crystal structures is a consequence of crystal packing. In 
both cases, contacts of the F or G helices with neighboring molecules in the crystal are 
observed, which could imply that only the open state of P450cam in complex with Pdx 
is able to crystallize. To investigate whether Pdx binding indeed causes the opening of 
P450cam, Myers et al. used double electron-electron resonance (DEER) spectroscopy.[7] 




on the redox state of Pdx. Reduced Pdx binding to reduced P450cam-CO does not 
induce the transition of the P450cam conformation. However, the binding of oxidized 
Pdx shifts the equilibrium to the open state.[7] Further NMR experiments that are able 
to distinguish between the open and closed states of P450cam in the complex in 
solution are required. In Chapter 2, intramolecular PCS experiments are described, 
that were aimed at observing the dynamics of P450cam upon binding of oxidized Pdx. 
In contrast to the previous findings, our results indicated that a major conformational 
change of P450cam was not observed between presence and absence of Pdx. The 
discrepancy between the results of X-ray crystallography, DEER and paramagnetic 
NMR experiments can most likely be attributed to the experimental conditions. Crystal 
formation was only observed at low concentrations of potassium,[5-6] which favors the 
shift to the open state.[8] The DEER experiments were carried out an frozen solutions 
at 30/50K.[7] Paramagnetic NMR experiments allow the investigation of the sample in 
the solution state under a variety of the conditions at ambient temperature. Previously, 
Pochapsky and co-workers proposed the alternative roles of Pdx effector activity.[9] 
On the basis of the NMR data and structure calculations, they found that Pdx binding 
induces the trans-to-cis isomerization of Ile88-Pro89 amide bond.[10] The change to 
the cis conformer facilitates the rearrangement of the substrate to the orientation 
appropriate for hydroxylation reaction.[9] Furthermore, they reported that the effect 
of Pdx binding transmits to the distal side of P450cam, which leads to the complete 
closure of the substrate access channel. This mechanism potentially prevents the 
dissociation of the substrate and minimizes the formation of the unwanted peroxide 
intermediate.[9] Currently, further intramolecular PCS experiments are undertaken to 
elucidate the dynamics of P450cam upon Pdx binding. 
Encounter complex
The results in Chapter 3 demonstrated the accuracy of the paramagnetic NMR 
approach for structure determination. The long-range distance and orientation 
restraints provided by PCS, RDC and PRE analysis allowed the characterization of the 
58 kDa redox complex, which could not easily have been achieved by conventional 
NMR methods. Moreover, PRE analysis provided information about a lowly populated 
encounter state of Pdx-P450cam interaction (Chapter 5). The encounter complex is 
the intermediate state of protein-protein interaction, in which one protein samples the 
partner surface to find the binding site. This transient state accelerates the formation of 
the final, stereo-specific complex.[11] In the encounter state, Pdx visits the regions nearby 
the J and K helices as well as the β1 sheet of P450cam. Structural analysis revealed 
that almost entire surfaces of both Pdx and P450cam are covered by acidic residues. 
The local electrostatic interaction alone is insufficient to describe the driving force of 
Pdx-P450cam encounter complex. Mutagenesis and kinetics described in Chapter 4 
demonstrated that the polar residues in the interface contribute to the binding affinity 
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of Pdx-P450cam interaction. Given that the formation of stereo-specific complex is 
stabilized by the hydrogen bonds between Pdx Asp38 and P450cam Arg112 as well as 
hydrophobic contacts between Pdx Trp106 and P450cam Ala113,[6] we postulated that 
encounter state of Pdx-P450cam complex is driven by local electrostatic interactions 
as well as short-range interactions. The significance of hydrophobic interactions in the 
encounter complex has been also described in the ET complex of cytochrome f (cyt f) 
and plastocyannin (Pc) in cyanobacterium Nostoc sp PCC 7119.[12] The hydrophobic 
patch of cyt f guides Pc to the specific binding site. Further structure calculation of 
Pdx-P450cam encounter complex are currently undertaken to illustrate the functional 
significance of the encounter state.
P450cam substrate channel
The mechanism of the substrate entry and product release of P450cam has been 
illuminated by solving the crystal structure of P450cam bound to the ruthenium-
linker substrate analogue.[13] It traps the structure of P450cam to be in open state 
and allows to visualize the substrate access channel. In Chapter 6, a paramagnetic 
inhibitor molecule, 1-PIM3-para, was used to characterize the substrate binding 
channel by X-ray crystallography as well as paramagnetic NMR spectroscopy. In the 
biophysical structural chemistry group at Leiden University, Dr. Nederlof solved the 
crystal structure of P450cam bound to 1-PIM-3 with a maximum resolution of 2.0 Å. 
In contrast to other substrate analogues, P450cam was shown to adapt an open 
conformation when it is bound to 1-PIM-3. Preliminary results of PRE experiments 
indicated that the dynamics of substrate access channel extends over a wide range 
of P450cam structural component. Further NMR studies are required to elucidate the 
nature of substrate binding of P450cam.
In conclusion, the structure and dynamics of P450cam system were analyzed 
by paramagnetic NMR techniques. The stereo-specific final complex and transient 
encounter complex of Pdx and P450cam have been uncovered by pseudocontact shift, 
residual dipolar coupling and paramagnetic relaxation enhancement. Moreover, the 
result of X-ray crystallography has provided the significant insights of the interaction and 
raised the questions of the Pdx effector activity. Since paramagnetic NMR experiments 
detect the complex in solution under ambient temperature, paramagnetic NMR will 
further illuminate the molecular mechanism of P450cam system in future.
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Among the 15,000 reported cytochrome P450s, the best characterized P450 family 
member is P450cam (CYP101A1). The aim of the research described in this thesis is to 
advance our understanding of the mechanisms of P450cam-ligand interactions. The 
results of the studies provide general insights into P450 systems, since their catalytic 
mechanisms are closely related to that of P450cam. Chapter 1 provides a general 
introduction about the P450 superfamily, the catalytic cycle and electron transfer 
partners of P450cam as well as paramagnetic NMR methods. 
In chapter 2, a study is described in which a paramagnetic NMR probe, CLaNP-7, 
was attached at multiple sites of P450cam and Pdx to determine the structure of 
their complex in solution. The size and orientation of Δχ tensors of Ln3+-CLaNP-7 
and the metal positions were experimentally determined by pseudocontact shift (PCS) 
analysis. Out of twelve P450cam constructs, six P450cam mutants were produced. The 
other six constructs yielded very little protein and therefore, it was decided not to use 
them for CLaNP-7 labeling. The low yield of P450cam constructs was attributed to the 
substitution of double Cys mutations, which apparently leads to instable or incorrectly 
folded protein in some cases. The Δχ tensors derived from the experimentally obtained 
PCS suggested that all of the mutants were labeled with CLaNP-7 via two arms, except 
for P450cam mutant F (A113C/N116C). Fitting of the Ln3+ position based on the PCS 
showed that CLaNP-7 was anchored at P450cam mutant F via a single disulfide bond. 
Two of the mutants were found either too close or far away from the Pdx binding site. 
In total, four out of twelve mutants were used for the calculations, which indicates that 
designing probe positions on protein contains the elements of trial and error. These 
results form the prelude for the intermolecular paramagnetic NMR experiments to 
study Pdx-P450cam complex, which are discussed in chapter 3. 
In this chapter the structure of the oxidized Pdx-P450cam complex in solution is 
reported, based on a set of 446 restraints for structure calculation obtained by PCS, 
PRE and RDC analysis. After the structure had been determined, our collaborators 
also solved the crystal structure of the complex. The solution structure based on 
paramagnetic restraints is represented by an ensemble of ten structures with an 
average RMSD from the mean of 1.3 Å for the position of Pdx. The position for Pdx 
relative to P450cam observed in the crystal structure is identical to the one in the 
solution structure within the experimental precision of the ensemble. These results 
demonstrate the accuracy of the paramagnetic approach for structure determination. 
The structure demonstrated that the metal centers are 16Å away, allowing for a 
sufficiently fast ET. Two coupling pathways could be distinguished, connecting the 
FeS cluster to the conjugated heme ring system and iron, respectively. Strikingly, our 
structure of the Pdx-P450cam complex differs from the previously proposed model 
by Zhang et al. While our manuscript was under review, Tripathi et al. published the 
crystal structure of the Pdx-P450cam complex that was obtained via cross linking of 




the open state of P450cam. On the basis of this observation, they concluded that the 
nature of effector role of Pdx is to cause a conformation change in P450cam from the 
closed to open state. Further NMR experiments that are able to distinguish between 
the open and closed states of P450cam in the complex are required to establish 
whether Pdx binding causes the opening of P450cam also in solution. 
The importance of the interactions of polar residues that were newly identified to 
be part of the interface of the Pdx-P450cam complex, is demonstrated by mutagenesis 
and kinetic experiments (Chapter 4). These polar interactions contribute to partner 
recognition but do not influence the electron transfer rates.
In the Chapter 5, we have characterized the encounter state of the Pdx-P450cam 
complex using paramagnetic data from additional probes. The results of PCS and RDC 
analysis support the previously determined structures of the complex. At the same 
time the distance restraints derived from PRE showed significant deviations from the 
expected values for some probes. It is concluded that a small fraction of the complex 
exhibits a dynamic nature. In the encounter state Pdx is localized close to the J and K 
helices as well as the β1 sheet. These regions all have basic and hydrophobic residues 
clustered together. Previous mutagenesis studies as well as X-ray crystallography 
demonstrated that the interactions of Pdx and P450cam are dominated by polar 
interactions, hydrogen bonding and hydrophobic contacts. Given the overall negative 
charge of both proteins, it is reasonable to assume that Pdx visits mostly basic/
hydrophobic patches of the P450cam surface. The lowly populated encounter complex 
could be relevant to the formation of the final Pdx-P450cam complex. The prominent 
basic patches compose a path to guide the Pdx to the putative binding site. Thereby, 
it reduces the three-dimensional search via collisions to a two-dimensional search on 
the P450cam surface. Moreover, the charge interaction prolongs the lifetime of the 
encounter facilitating the formation of the ET active complex. 
The paramagnetic substrate analogue, 1-PIM-3-para, was used to characterize the 
substrate access channel of P450cam (Chapter 6). The crystal structure of P450cam 
bound to 1-PIM-3 exhibits a more open conformation than that of substrate-free form. 
The preliminary results of the PRE analysis indicate that paramagnetic ligand analogues 
can be used to characterize protein-ligand complexes. This work demonstrates the 
proof-of-principle that small paramagnetic centers attached to ligands rather than 
protein can be helpful to characterize a complex.
In conclusion, by utilizing paramagnetic NMR techniques, the structure and dynamics 
of the P450cam system were investigated. The analysis of PCS and RDC illuminated the 
stereo-specific final complex of Pdx and P450cam, while the results of PRE demonstrated 
the presence of a transient encounter complex. Furthermore, the significant insights of 
the interaction in the interface were uncovered by X-ray crystallography. Currently, the 
nature of Pdx effector activity is under debate. Since paramagnetic NMR experiments 
are applicable to solution studies at ambient temperature, PCS, RDC and PRE methods 




Van de 15.000 in de literatuur vermeldde cytochromen P450, is P450cam (CYP101A1) 
het best gekarakteriseerd. Het doel van het onderzoek dat wordt beschreven in dit 
proefschrift is het vergroten van onze kennis van het mechanisme van interacties tussen 
P450cam en liganden. De resultaten van de studies geven een algemeen inzicht in 
P450 systemen, aangezien hun katalytische mechanismen nauw verwant zijn aan dat 
van P450cam. Hoofdstuk 1 geeft een algemene inleiding over de P450 superfamilie, 
de katalytische cyclus en elektronenoverdrachtpartners van P450cam alsmede over 
paramagnetische kernspinresonantie (Nuclear Magnetic Resonance, NMR) technieken.
In Hoofdstuk 2 wordt een studie beschreven waarin een paramagnetische NMR 
sonde, CLaNP-7, is aangebracht op verschillende plaatsen op P450cam en Pdx om 
de structuur te bepalen van hun complex in oplossing. De grootte en oriëntatie van 
de Δχ-tensors van Ln3+-CLaNP-7 en de positie van het metaal zijn experimenteel 
bepaald door analyse van pseudocontact verschuivingen (pseudocontact shift, PCS). 
Van twaalf P450cam constructen zijn zes mutanten geproduceerd. De resterende 
constructen gaven een te lage eiwitopbrengst en zijn daarom niet gebruikt voor 
Caged Lanthanide NMR Probe (CLaNP) aanhechting. De lage eiwitopbrengst van de 
P450cam-constructen is te wijten aan het aanbrengen van dubbele cysteïne mutaties, 
die in sommige gevallen kunnen leiden tot instabiele of incorrecte vouwing van het 
eiwit. De Δχ-tensorsen afgeleid uit de analyse van experimenteel verkregen PCS 
suggereren dat alle varianten CLaNP-7 binden via twee armen, met uitzondering van 
mutant F (A113C/N116C). Bij het bepalen van de Ln3+ -positie gebaseerd op PCS, is 
aangetoond dat CLaNP-7 met een enkele zwavelbrug is gebonden aan deze P450cam 
variant. Twee van de mutanten bleken een CLaNP-aanhechtingsplaats te hebben die 
zich te ver weg of juist te dicht bij de Pdx bindingsplaats bevond. In totaal zijn 4 van 
de 12 mutanten gebruikt in de berekeningen, wat aantoont dat het ontwerpen van 
de posities van de sonde een kwestie is van uitproberen. Deze resultaten vormen 
de inleiding tot de paramagnetische NMR-experimenten gebruikt om het P450cam-
Pdx complex te bestuderen zoals beschreven in hoofdstuk 3. In dit hoofdstuk wordt 
de structuur van het geoxideerde Pdx-P450cam complex in oplossing beschreven, 
gebaseerd op een set van 446 restraints voor structuurberekeningen, verkregen uit 
PCS, paramagnetische relaxatieversterking (Paramagnetic Relaxation Enhancement, 
PRE) en residuële dipolaire koppeling (Residual Dipolar Coupling, RDC) analyse. 
Nadat de structuur in oplossing was bepaald, hebben onze collega’s tevens de 
kristalstructuur van dit complex bepaald. De structuur in oplossing gebaseerd op 
paramagnetische NMR-gegevens wordt weergegeven door een ensemble van tien 
structuren met een gemiddelde RMSD van 1.3 Å voor de positie van Pdx. De positie 
van Pdx ten opzichte van P450cam zoals gezien in de kristalstructuur is identiek 
aan die in oplossing, gegeven de experimentele precisie van het ensemble. Deze 




structuurbepaling. De structuur laat zien dat de metaalcentra zich 16 Å van elkaar 
bevinden, waardoor elektronenoverdracht met voldoende snelheid mogelijk is. Twee 
trajecten van elektronische koppeling konden worden bepaald, door de FeS cluster 
te koppelen aan respectievelijk de geconjugeerde heemring en de heemijzer. Onze 
structuur van het Pdx-P450cam complex wijkt af van de eerder voorgestelde structuur 
van Zhang et al. Terwijl ons manuscript werd beoordeeld voor publicatie, publiceerde 
Tripathi et al. de kristalstructuur van het Pdx-P450cam complex verkregen door de twee 
eiwitten te verbinden via een flexibel molecule. Tripathi et al. zagen dat P450cam in 
een toestand is die lijkt op de open vorm van P450cam. Gebaseerd op deze observatie 
concluderen zij dat het de functie is van Pdx om een conformationele verandering 
van de gesloten naar de open vorm bij P450cam te bewerkstelligen. Verdere NMR 
experimenten die onderscheid kunnen maken tussen de open en gesloten vorm van 
P450cam zijn nodig om te bepalen of binding van Pdx ook in oplossing het openen 
van P450cam veroorzaakt.
Het belang van polaire residuen die zijn geïdentificeerd als onderdeel van het 
bindingsoppervlak van het Pdx-P450cam complex is aangetoond met behulp van 
mutagenese en kinetische experimenten (Hoofdstuk 4). Deze polaire interacties 
dragen bij aan partnerherkenning, maar hebben geen invloed op de snelheid van 
elektronenoverdracht.
In hoofdstuk 5 wordt beschreven hoe wij de ontmoetingsstaat (encounter state) 
van het Pdx-P450cam complex hebben gekarakteriseerd door gebruik te maken van 
paramagnetische gegevens van aanvullende sondes. De resultaten van PCS- en RDC-
analyse onderschrijven de eerder bepaalde structuren van het complex. Tegelijkertijd 
laten de experimentele afstanden verkregen met PRE significante afwijkingen van 
de verwachte waardes zien voor sommige sondes. Hieruit wordt geconcludeerd 
dat een klein deel van het complex dynamisch van aard is. In de ontmoetingsstaat 
bevindt Pdx zich dicht bij de J en K helices en de β1 sheet. Deze gebieden bezitten 
geclusterde basische en hydrofobe residuen. Eerdere mutagenesestudies evenals 
Röntgen kristallografie tonen aan dat de interacties tussen Pdx en P450cam worden 
gedomineerd door polaire interacties, waterstofbruggen en hydrofobe contacten. 
Gezien de algehele negatieve lading van beide eiwitten, lijkt het redelijk om aan te 
nemen dat Pdx voornamelijk de basische/hydrofobe delen van het oppervlak van 
P450cam bezoekt. Het ontmoetingscomplex kan relevant zijn bij het vormen van 
het uiteindelijke Pdx-P450cam complex. De prominent aanwezige basische delen 
aan het oppervlak vormen een pad die Pdx naar de vermeende bindingsplaats kan 
leiden. Hierdoor wordt een drie-dimensionale zoektocht door botsingen beperkt 
tot een tweedimensionale over het oppervlak van P450cam. Bovendien verlengt 
de ladingsinteractie de levensduur van de ontmoeting, wat de vorming van een 
elektronenoverdracht-actief complex vergemakkelijkt.
1-PIM-3-para is een paramagnetisch substraatanalogon en is gebruikt om 
het substraat-toegangskanaal van P450cam te karakteriseren (Hoofdstuk 6). De 
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kristalstructuur van P450cam gebonden aan 1-PIM-3 vertoont een opener configuratie 
dan de substraatvrije vorm. De eerste resultaten van PRE-analyse geven aan dat 
paramagnetisch ligand-analogen gebruikt kunnen worden om eiwit-ligand complexen 
te karakteriseren. Dit werk levert het proof-of-priciple dat kleine paramagnetische 
centra, gebonden aan liganden in plaats van aan eiwitten, zeer behulpzaam kunnen 
zijn bij het karakteriseren van een complex.
Concluderend, door gebruik te maken van paramagnetische NMR technieken 
is de structuur en dynamiek van het P450cam-systeem onderzocht. De analyse van 
PCS en RDC heeft een stereospecifiek eindcomplex van Pdx en P450cam aan het 
licht gebracht, terwijl de resultaten van PRE de aanwezigheid van een kortlevend 
ontmoetingscomplex hebben aangetoond. Daarnaast is door gebruik te maken 
van Röntgen kristallografie significant inzicht verkregen in de interacties in het 
bindingsoppervlak van dit complex. Op dit moment staat de aard van de functie van 
Pdx ter discussie. Omdat paramagnetische technieken toepasbaar zijn op studies 
in oplossing bij kamertemperatuur, zijn PCS-, RDC- en PRE-methoden in staat in de 
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